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ABSTRACT 
Douglas M. Ornoff: Development of a cellular analysis platform featuring arrays of patterned 
microwells fabricated atop permeable supports 
(Under the direction of Nancy L. Allbritton) 
 
Many human pulmonary diseases lead to accumulation of fluid in the alveoli, the air 
sacs located in the distal lung and at which gas exchange occurs. The most serious example 
of alveolar fluid buildup is in Acute Respiratory Distress Syndrome (ARDS), in which an 
insult to the lung results in injury to the cells lining the alveolus, leading to compromise of 
the alveolar capillary barrier and impaired gas exchange. Current ARDS mortality rates lie at 
30-40%. Worsening this problem is the lack of disease-specific therapies for treating ARDS: 
the cornerstone of treatment is merely supportive respiratory care via mechanical ventilation. 
Further investigations into treating ARDS have been hampered by unresolved 
questions about the normal physiology of alveolar fluid transport. Therefore, new insights are 
needed in order to develop more effective ARDS therapies. The alveolus is lined by two 
types of cells: squamous alveolar type 1 cells that cover 98% of the alveolar surface area and 
small cuboidal alveolar type 2 cells. While studies have examined AT2 cells, the ion 
transport properties of AT1 cells remain unknown. Recent attempts to culture AT1 cells in 
bulk monolayers for ion and fluid transport studies have been unsuccessful. It was therefore 
hypothesized that a microscale device to grow single AT1 cells in conditions that mimic the 
native lung would enable study of AT1 ion transport.
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This dissertation describes the development of microfabricated devices that feature an 
array of microwells patterned atop a porous or otherwise permeable support. First, a method 
for fabricating 1002F photoresist into a freestanding microwell array is explored. Next, a 
strategy to co-fabricate freestanding 1002F films with the hydrogel chitosan to form 
microwells with a permeable support is described. Review of the literature suggests that this 
is the first reported co-fabrication of hydrogel and photoresist into a freestanding film. 
Lastly, an approach to micropattern commercially available permeable supports, etched with 
submicron-scale cylindrical pores, is presented. Together, these platforms offer potential for 
growth and analysis of not only primary alveolar cells, but a range of other cell types in a 
variety of research endeavors, pulmonary and otherwise. 
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This work, being the longest block of prose I’ve ever written, is fittingly dedicated      
to the memory of Ms. Martha Woolery. 
 
First, may this work be free of gross grammatical errors. 
 
More importantly, may it be but one of many steps I take as I strive to 
 “find a better way” for caring for the sick and afflicted. 
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Chapter 1: Introduction 
 
1.1 Airway and Alveolar Disease: States of Disordered Pulmonary Fluid 
Homeostasis  
 
1.1.1 Respiratory epithelia and luminal fluid films 
1.1.1.1 Hierarchical organization of respiratory epithelia 
The human lung is a highly complex organ system whose function is to facilitate 
exchange of CO2, a by-product of energy metabolism, for the atmospheric O2 that drives 
oxidative chemical respiration, the reaction that nearly every human cell uses to produce 
energy.
1
 
 Inhaled air is conducted through the nasopharynx and down the trachea, where it 
enters the lungs via the left and right main pulmonary bronchi. Further movement through 
the respiratory tree – the secondary and tertiary bronchi, the terminal bronchioles, and the 
respiratory bronchioles – deposits the air in the alveoli, or air sacs, located at the most distal 
part of the lung and at which gas exchange actually occurs.
1-3
 
 A key feature of the pulmonary tree is a hierarchical organization of the epithelial 
tissues lining the open-air lumen (Figure 1.1). These epithelial tissues are composed of 
different epithelial cell subtypes, organized according to their location in the respiratory tree. 
Along the trachea, bronchi, and upper parts of the respiratory bronchioles, the epithelial layer 
is mainly composed of pseudostratified epithelial cells, which are ciliated at the apical
2 
 
membrane (Figure 1.1A).
4
 As will be explained below, recent research has discovered that 
these cells, despite their lack of participation in any gas exchange, play an important role in 
pulmonary fluid homeostasis and in the innate immune system of the lung.
5-6
 The epithelial 
layer here also has a number of goblet cells and exocrine secretory glands, both of which 
serve to secrete mucus onto the luminal surface. At the more distal level of the terminal 
bronchioles, the epithelial tissue begins to transition to a layer of simple cuboidal epithelium 
that replaces ciliated pseudostratified epithelium with ciliated cuboidal cells and goblet cells 
with “club” cells that are morphologically and functionally diverse (involved in secretion of 
surfactant-like glycosaminoglycans, IgA, and lysozyme, lysosome- and cytochrome P450-
mediated metabolism of inhaled exogenous substances, and regeneration of the bronchiolar 
lining)(Figure 1.1B).
4, 7-11
 A transition again takes place as the respiratory tree further 
branches into the respiratory bronchioles, in which alveoli begin to appear in the walls. 
Alveoli are primarily located, however, at the most distal end of the respiratory bronchioles. 
Whether the alveoli lie in the walls of a respiratory bronchiole or at its distal end, a third 
transition of epithelial cell type occurs at the alveolar atrium, where cuboidal epithelium 
terminates and the epithelial layer becomes composed of two types of cells, termed alveolar 
type 1 (AT1) and alveolar type 2 (AT2) cells (Figure 1.1C).
4
 
 AT1 cells are squamous-type epithelia with large diameters – on the order of 100 µm 
– and extremely thin cytoplasms, save for a perinuclear region containing a number of 
organelles.
12
 Electron microscopy studies of alveoli reveal that AT1 cytoplasm thickness is at 
times as low as 50 nm.
13
 By combining a large cell diameter (and hence surface area) and 
low cytoplasmic thickness, AT1 cells are especially adapted to facilitating efficient gas 
exchange between the alveolar lumen and the capillary beds that underlie 70% of the alveolar 
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basement membrane.
14
 Together, AT1 cells are estimated to make up 40% of the alveolar 
cells and 97-98% of the total alveolar surface area.
13
 
 AT1 cells are thought to be terminally differentiated cells that arise from AT2 cells, 
cuboidal cells that make up the remaining 60% of alveolar cells but just 2-3% of the alveolar 
surface area.
15
 Classic experiments by Evans et al. and Adamson and Bowden, as well as 
more recent work, showed that AT2 cells function as progenitor cells that can divide and 
differentiate, eventually assuming an AT1 morphology in order to preserve the alveolar 
epithelial surface in the event an AT1 cell undergoes apoptosis or death.
16-19
 More advanced 
studies recently showed that in response to cellular injury (either AT2 cell-specific ablation 
or hyperoxic damage to AT1 cells), lineage-labeled AT2 cells clonally divide and self-renew 
in both mouse and human adult lungs, and that lipofibroblasts may help these cells form a 
specific pulmonary stem cell niche.
20-21
  
AT2 cells have further importance as the source of pulmonary surfactant, a mixture of 
secreted proteins (surfactant proteins SP-A, -B, -C, and –D) and phospholipids (mainly 
dipalmitoylphosphatidylcholine).
22
 Not only does this surfactant mixture help to opsonize 
any stray bacteria that reach the alveolus, it also accomplishes the imperative task of 
maintaining alveolar and small airway patency by reducing the surface tension of the 
epithelial surface.
23-24
 In addition, AT2 cells synthesize and secrete immune effector 
molecules such as CXC chemokines and complement proteins.
25-27
  
 Advances in our understanding of stem cell biology through gene expression profiles 
have prompted studies aimed at more clearly delineating the gene expression differences 
between the AT1 and AT2 populations, with special focus on AT2 cells undergoing 
transdifferentiation towards an AT1-like morphological and molecular phenotype.
28-31
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Gonzalez et al. analyzed freshly isolated AT1 and AT2 cells and cultured AT2 cells, finding 
over 600 genes differentially expressed in two-way comparisons between the three 
populations.
28
 Treutlein et al. recently used single-cell RNA sequencing to examine distal 
lung cells from the developing lungs of embryonic mice, and noted the presence of a 
“bipotential progenitor” cell that had expressed both AT1 and AT2 markers, potentially 
identifying a progenitor state through which transdifferentiating AT2 cells pass as they begin 
to downregulate typical AT2 gene expression patterns (typically surfactant proteins SP A-D) 
and upregulate typical AT1 patterns (such as podoplanin, aquaporin-5 (Aqp5), caveolin-1, 
and receptor for advanced glycation end products (RAGE)).
32
 One possible interpretation of 
this data, which seem to argue against the classical model of AT2-to-AT1 transdifferentiation 
is that the “bipotential progenitor” represents a population of late stage, lung-specific, stem 
cells that give rise to a small group of differentiated, functional AT1 cells for the immediate 
needs of the lung and to a group of AT2 cells to replenish the AT1 population in the adult 
organism, once the pluripotent stem cell population has decreased. However, some have also 
called into question whether AT1 cells are truly terminally differentiated: a report by 
Gonzalez et al. observes that AT1 cells can divide in vitro and stain for the proliferation 
marker OCT-4, and three other reports detail the use of keratinocyte growth factor (KGF) to 
attenuate or even reverse the AT2-to-AT1 transdifferentiation, as measured by expression of 
AT1 or AT2 markers Aqp5 and SP-A and activation of mitogen-activated protein kinase 
(MAPK) pathways.
33-36
  
In the normal state, the alveolus (though not its epithelial layer) is also home to a 
small number of immune cells, such as dendritic and plasma cells, but most notably the 
alveolar macrophage, a sentry immune cell whose function is to phagocytose any stray 
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pathogens entering the alveolus in inhaled air and any cellular debris that results from 
turnover of the epithelial layer.
4
 
1.1.1.2 Air-liquid interfaces and luminal fluid films in the pulmonary tract 
 In addition to a hierarchical organization of the cellular subtypes found in the 
epithelial layer, a second key feature of the respiratory tree is presence of a physiologic air-
liquid interface (ALI) just above the epithelial tissue, due to the open-air lumen to which the 
epithelia that line the respiratory tract face. Flow of blood through capillary beds below the 
basement membrane on which the epithelia lie ensures delivery of nutrients and removal of 
metabolic by-products, as well as ensuring proper electrolyte balance across the cell 
membrane and availability of fluid to maintain cellular hydration.
4
 While air in the lungs has 
relatively high humidity (achieved via humidification of inhaled air that takes place in the 
nasopharynx), respiratory epithelial tissue nonetheless greatly differs from other epithelial 
tissues that are bathed in large fluid volumes (large relative to the cell volume) on both sides 
of the basement membrane, basal and luminal.
14
 Importantly, the presence of an ALI appears 
to have a role in maintaining a differentiated and polarized phenotype for the epithelial layer 
and thus appears to be a key and necessary component of normal in vivo physiology, a 
concept that will be discussed further in section 1.2.4.
37-40
 
 However, rather than having an apical surface that is completely dry, epithelia at all 
levels of the respiratory tree (from the trachea to the alveolus) are known to have a thin sol-
gel laer on the luminal surface. Thus, the true location of the respiratory ALI does not lie at 
the epithelial layer, but rather just above it. Similar to the hierarchical heterogeneity of 
epithelial subtype observed along the respiratory tree, the apical fluid layer varies in 
thickness from an order of ~10 µm in the trachea and bronchi, where the fluid is termed the 
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airway surface liquid (ASL), to an estimated 0.2 µm in the alveoli, where it is known as the 
alveolar surface liquid (AvSL).
41-42
 Thinning of the fluid layer in the more distal parts of the 
lung reflects the need to minimize the diffusion distance and optimize gas exchange 
efficiency. 
The conservation of the apical fluid layer thickness within a given level of the 
respiratory tree suggests that the lung can homeostatically regulate the thickness (and hence 
the volume) of the fluid layer in both the airways and alveoli. Two opposing observations 
support this. First, because the water content of the humidified air in the lungs lacks the 
volume to match the estimated 20-30 mL that comprises the respiratory thin fluid layer over 
the surface area of the entire lung (~100 m
2
), let alone the estimated 700 mL of fluid thought 
to be lost in the proximal airways due to evaporation, the fluid layer must be generated from 
the respiratory tract itself (and not “raining out” from the air inhaled into it).41, 43 At the same 
time, the demonstration of rapid clearance of pulmonary fluid at birth, when the location of 
gas exchange moves from the placenta to the lung, and the observation that a small fluid 
bolus instilled into the lungs is cleared into the interstitium suggest that fluid clearance out of 
the respiratory lumen is a normal physiological process.
44-46
 However, as will be discussed 
below, this process of pulmonary fluid homeostasis can be disrupted by certain lung diseases. 
1.1.2 Alveolar diseases and disordered fluid homeostasis 
A number of human diseases can affect the alveolus and disrupt its normal function. 
Heart failure, for example, commonly causes edema of the pulmonary interstitium and can 
lead to an influx of fluid into the alveolus.
47
 Severe pneumonia can also fill alveoli with a 
fluid thick with necrotic debris. Alveolar hemorrhage, in which the surrounding capillaries 
bleed into the alveolar space, can result from a number of etiologies, including exposure to 
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toxic inhalants, Goodpasture’s Syndrome, Granulomatosis with Polyangiitis (GPA), and 
connective tissue and autoimmune diseases (e.g. systemic lupus erythematosus).
48-49
 
However, the most serious example of alveolar disease is Acute Respiratory Distress 
Syndrome (ARDS), in which an insult to the alveolar-capillary interface is enough to damage 
the alveolar epithelial cells, the capillary endothelial cells, and even the basement membrane 
separating the cell layers (Figure 1.2A).
50
 This compromise of the normal alveolar-capillary 
barrier (Figure 1.2B) increases its permeability, leading to the influx of a highly 
proteinaceous fluid into the alveoli that results in severe and intractable alveolar flooding and 
a severe compromise in gas exchange. Numerous etiologies (most commonly septic 
pneumonia or aspiration/inhalation injury) can cause ARDS, but the clinical pattern is the 
same: rapid onset of dyspnea and arterial hypoxemia that is refractory to O2 therapy, 
followed by worsening respiratory failure as the alveoli further fill with fluid and the alveolar 
basement membrane becomes hyalinized with thick protein deposits (Figure 1.2C).
50
  
The clinical picture reflects the two stages of ARDS pathology progression. In the 
acute or exudative stage, injury to the alveolar-capillary interface results in influx of protein-
rich edematous fluid and neutrophils, setting off localized inflammation and release of a 
variety of cytokines and chemokines, including tumor necrosis factor-alpha (TNF-α) and 
interleukins 1 and 8 (IL-1, IL-8). Damage to epithelial and endothelial cells continues and is 
accompanied by increasing deposition of fibrin-rich hyaline films along the basement 
membrane, a pathologic picture known as diffuse alveolar damage. Between days 5 and 7, 
the hyaline membrane formation begins to slow, but gas exchange remains compromised 
even as the edema resolves due to the hyalinization of the alveolar basement membrane. At 
this stage, the organizing or fibroproliferative stage, necrotic debris is removed by activated 
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macrophages, inflammation is reduced, and a slow repopulation of the alveolar and 
endothelial layers by resident progenitor cells occurs as those cells proliferate and spread 
over fresh extracellular matrix laid by down by fibroblasts activated by the inflammation.
51
 
At its onset, ARDS is a medical emergency that usually necessitates admission to an 
intensive care unit (ICU), and epidemiologic data suggest that there are close to 200,000 
cases of ARDS in the U.S. annually.
50, 52
 Up to 20% of patients in intensive care units on 
mechanical ventilation meet ARDS criteria, and current overall mortality rates of ARDS 
patients lie at 37-45%, and are as high as 50-60% for some patient groups, such as the elderly 
and those with pre-existing cardiovascular conditions.
50, 53-54
  
The most serious complication shared by all of the diseases described above is the 
persistent presence of fluid in the alveolar space. This fluid can disrupt the gas exchange 
function of alveoli, owing to a great increase in the diffusion distance without a 
corresponding increase in oxygen solubility in the fluid. Additionally, the fluid can also 
result in damage to the epithelial layer itself, further compromising gas exchange. The 
presence of intractable alveolar flooding in these disease states, but not in normal states, 
suggests a compromise of normal alveolar fluid homeostasis via an increased influx of fluid 
from the bloodstream or interstitium into the alveolus (increased rate of entry), a reduced 
clearance of fluid from the alveolar space (decreased exit rate), or both.
55-56
 
1.1.3 Alveolar diseases: therapeutic options and shortfalls 
Certain cases of alveolar flooding due to disease can be treated and resolved without 
complication. Pulmonary edema, for example, can be treated via a combination of diuretics 
(to promote alveolar fluid resorption) and appropriate management of the underlying 
etiology, e.g. cardiac failure (to prevent continued alveolar flooding).
57
 Alveolar hemorrhagic 
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diseases, namely Goodpasture’s Disease, lupus, and GPA, can be managed with 
immunosuppression, with fluid in the alveolus being gradually resorbed over time and the 
erythrocytes broken down by resident alveolar macrophages.
49
 
 ARDS, however, continues to present a treatment challenge, due to both the 
persistence of alveolar fluid (owing to basement membrane disruption and hyalinization) and 
the damage to the epithelial and endothelial cells themselves. While the triggering etiology 
(e.g. sepsis) can sometimes be treated and resolved, the patient is left in a hypoxemic state 
with flooded, fibrotic alveoli, and hence respiratory support with a mechanical ventilator is 
the mainstay of ARDS treatment.
56
 Recent clinical trials advocating a switch from traditional 
to low-tidal volume ventilation have led to some improvement in relevant patient outcomes, 
namely hospital and overall mortality and number of ventilator-free days. 
58-59
 However, low-
tidal volume ventilation is nonetheless only an improvement in supportive therapy, not a 
direct address of ARDS pathophysiology. Similarly, the FACTT Trial indicated that while 
patients who received conservative fluid management in the ICU in order to reduce alveolar 
flooding required less time on a mechanical ventilator, overall 60-day survival was not 
increased.
60
 Recently, clinical trials of both inhaled and infused β2-adrenergic receptor 
agonists that had demonstrated in vitro efficacy in potentiating fluid clearance by AT2 cell 
monolayers failed to show improvements in patient mortality.
61-62
 Other clinical trials have 
demonstrated the failure of inhaled nitric oxide, antioxidant compounds, and exogenous 
pulmonary surfactant in reducing morbidity or mortality.
63
 Even in those patients who 
survive ARDS and can be discharged from the ICU, functional morbidities remain. Herridge 
et al. found reduced exercise tolerance and diffusion capacities in ARDS patients five years 
after hospital discharge.
64
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 Considering the prevalence and variety of etiologies that can result in ARDS (notably 
sepsis from either community or nosocomial sources) and the epidemiologic data on ARDS 
mortality, ARDS presents a significant source of morbidity and mortality to the public health. 
Given the central role alveolar flooding occupies in ARDS pathophysiology, a strategic 
approach to potentiating alveolar fluid removal, especially in the early stages of ARDS 
before basement membrane hyalinization occurs, is an important and pressing biomedical 
research goal. 
 
1.2 Physiology and Pharmacology of Pulmonary Liquid Homeostasis 
1.2.1 Airway surface liquid in bronchial and bronchiolar epithelia 
In order to most efficiently develop a strategy, pharmacologic or otherwise, to 
potentiate alveolar fluid clearance, a full and complete understanding of alveolar fluid 
homeostasis mechanisms and regulation is needed. A great deal of information exists on fluid 
homeostasis in the upper airways, and so provides a useful place to begin generating a model 
of fluid clearance in the more distal lung spaces. 
 Research efforts comparing bronchial epithelia from healthy subjects and patients 
with cystic fibrosis (CF) have given great insight into fluid balance in the upper airways. 
Cystic fibrosis (CF) is a genetic disorder characterized by progressive lung disease due to the 
buildup and infection of abnormally viscous mucus in the airways.
65
 CF was classically 
thought to be due to a pathological overproduction of mucus with abnormal composition.
66
 
However, the discovery of altered transport of chloride (Cl
-
) and sodium (Na
+
) ions by CF 
epithelia have led to a model of CF not as a disease of abnormal mucus, but rather as a failure 
of mucus clearance due to dysregulated ion transport and fluid homeostasis on the airway 
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luminal surface.
5-6, 41, 67
 Discoveries of reduced chloride anion (Cl
-
) secretion to, and 
increased sodium cation (Na
+
) resorption from, the airway surface by epithelia of CF patients 
compared to healthy subjects were found in the 1980s via bioelectric measurements.
68-72
 
Subsequent functional reconstitution of the gene product shown to be mutated in CF – termed 
the cystic fibrosis transmembrane conductance regulator (CFTR) - revealed it to be a chloride 
channel.
73-76
 As further research was undertaken to better understand how CFTR loss also 
resulted in abnormally high Na
+
 resorption through the epithelial sodium channel (ENaC), 
two studies by Matsui et al. suggested that these ion transport abnormalities resulted in 
depletion of the layer of fluid approximately 10 µm thick found on the luminal surface of 
ciliated airway epithelia.
77-78
 In normal airways, this apical fluid hydrates a layer the 
approximate thickness of the respiratory cilia (hence the term ‘periciliary layer,’ PCL), and 
the mucus sol-gel layer above it (together known as the airway surface liquid ASL). The 
presence of fluid in the PCL allows efficient and coordinated beating of the cilia atop the 
cells, allowing the movement of mucus in the overlying sol-gel layer up the respiratory tree 
and out of the lung in a process termed mucociliary clearance (MCC). The dehydration 
observed in CF airways leads to ciliary stasis and a reduction in mucociliary clearance. 
Based on data comparing healthy and CF subjects, airway fluid is thought to be 
maintained via a CFTR- and ENaC-dependent transport of chloride and sodium 
(respectively) to the airway surface, creating an osmotic pressure that draws water onto the 
surface, resulting in proper ciliary function and mucociliary clearance.
41
 In CF, loss of 
CFTR-dependent Cl
-
 secretion to the apical surface and increased ENaC-mediated Na
+
 
absorption from the apical surface, reverses the osmotic pressure, leading to airway surface 
and mucus dehydration and a cessation of normal mucus clearance.
5-6, 67
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This hypothesis also describes a regulatory mechanism for airway surface ion 
transport: extracellular concentrations of the nucleotide adenosine triphosphate (ATP) and its 
metabolites. Knowledge that activation of protein kinase A (PKA) by cAMP stimulated 
chloride conductance in normal airway epithelia, but not in CF cells, suggested a role for 
cAMP-dependent PKA signaling in CFTR activation.
79-81
 Determination of CFTR’s primary 
structure identified several consensus phosphorylation sites for PKA, explaining the lack of 
response to cAMP or PKA in CF cells.
73
 Further research into the regulation of this ion 
transport system in normal airways revealed a role for constitutive release of ATP to the 
luminal surface, its subsequent metabolism by ecto-nucleotidases to adenosine, and 
activation by that adenosine of the A2b adenosine receptor, an apical membrane Gαs - 
associated GPCR.
82-83
 This activation, resulting in adenylate cyclase stimulation and 
increases in intracellular concentrations of cAMP, leads to PKA activation and 
phosphorylation of CFTR. Subsequent increases in chloride secretion and ENaC inhibition 
by CFTR generates the osmotic gradient for water flow to the airway surface, which dilutes 
surface adenosine concentrations and reduces A2b receptor activation, thus providing 
negative feedback to the regulatory pathway.
84
  
Interestingly, a second signaling pathway utilizing surface P2 purinergic receptors 
was coincidentally discovered that came to be a target for pharmacologically potentiating 
directed ion transport and correcting the disordered fluid homeostasis in CF.
85
 Early 
experiments had shown that chloride conductance in both normal and CF epithelia could be 
increased using calcium ionophores, suggesting an alternative pathway to ion transport that 
might present a druggable route to increasing airway ion transport.
86
 Further work into this 
alternative pathway showed that ion transport could be potentiated by supply of exogenous 
13 
 
ATP and uridine triphosphate (UTP) nucleotides to the extracellular surface of airway 
epithelia.
87-92
 Later data demonstrated a connection between apical P2Y purinergic receptors, 
to which ATP and UTP are agonists, and Ca
++
-dependent increases in chloride 
conductance.
93-94
 These P2Y purinoreceptors on the apical membranes of airway epithelia 
activate chloride secretion via a Gαq-mediated release of intracellular calcium that targets 
TMEM16A calcium-dependent chloride channels found in respiratory epithelia.
95
 
In summary then, the leading model for fluid homeostasis in the airway involves 
active chloride and sodium ion secretion onto the airway surface, creating an osmotic 
pressure that draws water onto the apical membrane, where it hydrates the airway surface 
with a ~10 µm-thick fluid layer that facilitates proper cilia function and mucociliary 
clearance (Figure 1.3A). Regulation of this CFTR- and ENaC-mediated chloride and sodium 
ion balance is achieved under normal conditions by the constitutive extracellular release and 
metabolism of ATP to adenosine, which fine-tunes airway surface hydration via A2b receptor 
binding and downstream cAMP-mediated activation of CFTR.
6, 96
 As will be discussed 
below, much of the same mechanistic and regulatory machinery of airway fluid homeostasis 
is also found in alveolar cells. 
Importantly, a complete understanding of the mechanisms and regulation of directed 
ion transport and fluid homeostasis in airway epithelia has led to the successful design of a 
number of pharmacologic therapies for correcting fluid homeostasis imbalance in CF. First, 
identification of CFTR as the defective protein behind CF, and many decades of focused 
drug development, has led to a new class of drugs designed to potentiate mutant forms of 
CFTR that are present at the membrane.
97-101
 Clinical tests of compounds developed by 
Vertex Pharmaceuticals, namely VX-770 and -809, have demonstrated preclinical and some 
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clinical success in improving lung function. Second, an understanding of how loss of CFTR-
mediated ion transport results in defective fluid homeostasis led to the demonstration that 
inhaled doses of hypertonic saline could provide an osmotic draw that restores proper airway 
surface hydration to normal functional levels. By doing so, Donaldson et al. reported an 
increase in sustained mucus clearance and lung function in CF patients.
102
 Third, the 
identification of accessory purinergic signaling pathways led to the development of several 
drug candidates for potentiating chloride secretion, and thus airway surface hydration, 
through non-CFTR means. Synthetic analogues of ATP were found to potentiate in vitro 
Ca
++
-dependent chloride secretion and were taken into clinical trials.
103-104
 
1.2.2 Ion and fluid transport by alveolar type 2 (AT2) epithelia 
In 1995 Bastacky et al. used scanning electron microscopy to show the presence of a 
continuous, 0.2 µm-thick apical fluid layer in alveoli.
42
 While this was the first direct 
measurement of the basal thickness of the alveolar surface liquid (AvSL), the first evidence 
that fluid homeostasis occurs in the alveolus had come a decade before, when a 
demonstration by Matthay et al. of differential clearance rates of fluid and protein instilled 
into sheep alveoli was published at the same time that the first cultures of isolated primary 
AT2 cells were shown to participate in active ion transport.
105-106
  Since that time, alveolar 
ion transport has been studied extensively using a variety of models, including animal and 
human whole perfused lungs and an innovative lung slice preparation.
107-108
 Rat models have 
been widely used due to demonstrations that total lung fluid clearance rates in rats are similar 
to those of isolated, perfused human lungs ex vivo.
107
 Despite these clinically-relevant 
models, however, a complete understanding of alveolar fluid homeostasis has proven elusive, 
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and hence there remains a crucial role for basic in vitro studies of purified primary alveolar 
cells. 
A number of published studies have specifically examined ion transport in AT2 cells. 
Early work showed that monolayers of cultured AT2 cells took up 
22
Na
+
 in an apical-to-
basolateral direction and produced measurable transepithelial potential differences when 
cultured on permeable supports.
106, 109
 Further work by a number of groups has shown that rat 
AT2 cells, both in situ and cultured on permeable supports, contain the basolateral 
Na/K/ATPase and ENaC. Bioelectric studies of rat AT2 cell monolayers and patch-clamp 
studies of individual rat AT2 cells have firmly established the functionality of these 
proteins.
40, 46, 110-112
 Studies by Fang et al. have demonstrated a role for CFTR in AT2 
cells.
113
 ENaC has been a subject of particular investigation in the alveolar biology 
community.
111, 114
 One general set of studies has focused on the balance and relative activity 
between two functional variants of ENaC. One variant, termed highly-selective (HSC) has a 
low, amiloride-sensitive conductance (approximately 6 pS, amiloride K0.5 = 37 nM) but a 
>40 fold selection of sodium over potassium cation, while the non-selective (NSC) variant is 
amiloride-insensitive (K0.5 = 2.2 µM) and cation nonselective, albeit with a higher 
conductance (21 pS).
114
 Jain et al. noted that cultured AT2 monolayers preferentially 
expressed the HSC ENaC variant when cultured under an ALI, suggesting that a shift in 
ENaC function in AT2 cells can accompany a transition from a basal to a flooded 
environment, such as that observed with alveolar disease.
40
 A second general set of studies 
has focused on potential modalities by which AT2 ENaC channels are regulated. Adrenergic, 
purinergic, and dopaminergic signaling, as well as the influence of steroid hormones, oxygen 
tension, and inflammatory chemokines have all been investigated, with particular efforts 
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trying to reconcile failed clinical trials of β2-adrenergic agonists with in vitro studies 
suggesting the efficacy of this agonist class.
115-125
 An as-yet unresolved question concerns 
whether CFTR, or at least some kind of Cl
-
 transport, is required for ENaC activation. Jiang 
et al. showed that adrenergic stimulation of Na
+
 transport in AT2 cells involved the 
activation of apical Cl
-
 channels, while Mutlu et al. showed a similar effect but demonstrated 
a role for CFTR as the intermediate in ENaC activation.
117, 119
  Interestingly, CFTR-mediated 
Cl
-
 secretion in confluent cultures of primary AT2 cells was shown to be calcium-dependent, 
a relationship not found in epithelia of the upper airways.
126
 
Striking similarities in the regulation of ion transport and fluid homeostasis were also 
recently shown between bronchial epithelial and AT2 cells at the monolayer level. Bove et 
al. used confluent monolayers of AT2 cells to show that AT2 ion transport and fluid 
movement is regulated by nucleotides via purinergic signaling pathways similar to those of 
bronchial epithelia in the larger airways.
126
 Addition of ATP and UTP to AT2 cell 
monolayers produced ion fluxes inhibited with ion transporter modulators. Similar addition 
of ATP and UTP to cell monolayers led to increases in apical fluid thickness, while addition 
of the nucleotide-scavenging enzyme apyrase produced the opposite effect. Moreover, AT2 
cells grown in monolayers expressed the P2X4 and P2Y2 purinergic receptors.
126
 The 
significance of this report was twofold. First, its study of ion transport by monolayers of 
human AT2 cells validated similar data showing functional ion transporters in rat AT2 
monolayers. Second, analysis of the role of nucleotide signaling in these monolayers 
provided the first data for a conserved apical fluid thickness regulatory mechanism between 
human airway and alveolar epithelial cells. These demonstrated similarities in ion and fluid 
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transport mechanism and regulation are made more interesting by the identification of such 
molecular machinery in AT1 cells as well. 
1.2.3 Ion transporters and purinergic receptors in alveolar type 1 (AT1) 
epithelia 
 
While bronchial and AT2 cells have been studied extensively, the physiology of AT1 
cells, which populate >98% of the alveolar surface area, remains poorly understood. For 
many years, this was due to technical difficulties in the isolation and purification of AT1 
cells, which are larger, more fragile, and lower yielding in primary cell harvests than AT2 
cells.
127
 One advance for the AT1 field came with the identification and use of antibodies to 
apical integral membrane proteins specific to AT1 cells: chiefly, RTI40 in rodents and HTI56 
in humans.
128-129
 This advance enabled positive selection strategies that allowed for the 
isolation of AT1 populations at purities of >85%, with cellular viabilities of >95%.
130-132
 
Typical isolation/purification protocols currently involve enzymatic digestion of the distal 
airspaces with elastase to liberate alveolar cells, labeling of the AT1, AT2, and macrophage 
cells with antibodies to cell-specific markers, and lastly either negative depletion by 
magnetic bead immunoselection or positive enrichment by fluorescence-activated cell sorting 
(FACS).
133
 
An early experiment implicating a role for AT1 cells in fluid transport came with the 
localization of the aquaporin-5 (Aqp5) molecular water channel to the apical membrane of 
alveolar epithelia in situ.
134
 A seminal experiment showing that the presence of Aqp5 in 
isolated AT1 cells in suspension conferred extremely high water permeability led to an early 
theory that AT1 cells played a small role in alveolar fluid homeostasis, with directed ion 
transport being achieved by the AT2 cells and water passively flowing through Aqp5 
channels in AT1 cells.
135
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However, more recent advances in AT1 cell biology have called into question the 
idea that AT1 cells play only a passive role in alveolar fluid transport. This paradigm shift 
has occurred because of the identification of similar ion transport machinery in AT1 cells 
through radionuclide uptake, electrophysiology, and mRNA and protein-level expression 
studies. First to suggest a higher role were two independent studies by Borok and Johnson 
showing that isolated rat AT1 cells immunostain for ENaC and the Na/K/ATPase.
127, 130
 
These proteins, both active in ion transport, were also shown in parallel rat alveolar tissue 
sections. Johnson also showed that isolated AT1 cells in suspension could actively take up 
22
Na
+
 in an amiloride-inhibitable fashion.
130
 Cell-attached patch clamp studies of individual, 
nonconfluent AT1 cells showed function of HSC and NSC ENaC and CFTR, as well as a 
number of other channels such as potassium and cyclic-nucleotide gated (CNG) cation 
channels and the Cl
-
/HCO3
-
 anion exchanger.
131-132
 Apart from showing electrophysiologic 
function of the ion channels previously identified by immunofluorescence, this work was 
significant in that measurements of channel density and area suggest that AT1 cells contain a 
significantly greater number of ion channels than AT2 cells. By applying the calculated 
channel density found in AT1 versus AT2 cells to the surface area of each cell type, AT1 
cells were found to have a seven-fold greater osmotic permeability, a forty-fold higher 
number of Na+ channels, and six times as many CFTR channels.
136
 While a caveat central to 
these studies is that the measured cells were grown in suspension or unpolarized on glass, the 
identification of ion channels studied in vitro with positive in situ immunostaining of alveolar 
tissue sections for those same channels supports these data. 
Based on the presence of ion- and water-transporting molecules in AT1 cells, the 
large amount of lung surface area known to be covered by AT1 cells, and the expression of 
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higher numbers of functional ion channels in AT1 versus AT2 cells, an alternative model 
theorizes that AT1 cells achieve the bulk of both ion and water transport (compared to the 
smaller AT2 cells) in the alveolus (Figure 1.3B). In this model, similar to that of the airway, 
Cl
-
 and Na
+
 are moved across the apical membrane of both AT1 and AT2 cells by specific 
ion channels (presumably CFTR and ENaC, respectively), and water follows down its 
osmotic gradient through Aqp5.
136-137
 Curiously, patients with CF who thus lack functional 
CFTR do not exhibit signs of alveolar disease, suggesting the possibility of either an 
alternative primary anion transporter as the driver of alveolar fluid homeostasis, or the 
upregulation of an alternative, secondary mechanistic pathway in CF patients that could 
present a pharmacological target in all patients with alveolar disease.
126
 
 In addition to the expression of similar ion transporters in AT1 cells as in AT2 and 
bronchial cells, evidence exists to suggest that adenosinergic and purinergic signaling 
pathways may serve to regulate AT1 ion transport in similar fashions to pathways observed 
in AT2 and bronchial cells. The same study that demonstrated purinergic regulation of AT2 
monolayer fluid homeostasis showed that AT2 cells in the process of transdifferentiating to 
an AT1-like state continued to express P2X4, P2Y2, -Y4, and Y6 receptors. Expression of the 
A2A and A2B variants of the adenosine receptor was also observed, suggesting that AT1 cells 
express these receptors as well.
126
 Any one of three additional sets of data would strengthen 
this claim: whole-cell patch-clamp electrophysiologic studies (such as those performed by 
Johnson et al. on AT1 cells grown on glass) employing adenosinergic or purinergic ligands; 
RT-PCR or immunofluorescent staining of freshly isolated AT1 cells for adenosinergic or 
purinergic receptors; and/or immunostaining of in situ alveolar tissue sections for those 
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receptors. In the latter case, however, the lack of reliable P2Y or P2X receptor antibodies 
makes this difficult to achieve. 
In summary, then, the expression of similar ion transport molecular machinery in 
bronchial, AT2, and AT1 cells, as well as apparent similarities in the pathways regulating ion 
transport in bronchial and AT2 cells, suggest conserved mechanisms and regulation of ion 
transport and fluid homeostasis in both the airway and the alveolus. Taken together, these 
similarities also provide compelling evidence that, if a detailed understanding of the 
physiology is available, successful pharmacological targets for potentiating alveolar fluid 
clearance can be identified for use in alveolar diseases.  
Given the success of in vitro cultures of bronchial and AT2 cells in replicating the in 
vivo physiology, the logical direction for subsequent research, then, would be to determine 
whether in vitro cultures of purified AT1 cells directly participate in directed ion and fluid 
transport and to elucidate the mechanisms and regulatory elements of that process. However, 
testing this theory of ion and fluid transport by AT1 cells has proven difficult due to technical 
difficulties in AT1 culture, beyond the difficulties encountered in AT1 isolation: the 
formation of intercellular gaps between AT1 cells in culture that render useless the gold 
standard methods for measuring ion and fluid transport in cultured cells. 
 
1.2.4 Current methods for studying pulmonary fluid homeostasis 
 A great deal of the data used in formulating the current model of fluid homeostasis by 
bronchial epithelia, as well as a number of studies with AT2 cells, used monolayers of 
primary cells cultured under ALI conditions. The current gold standard for ALI culture 
involves seeding primary cells on permeable supports that allow cells to polarize and 
establish high-resistance transepithelial electrical seals.
138-140
 The supports, now 
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commercially available and typically composed of either track-etched polyester or 
microwoven fluoropolymer (for more details, see Chapter 4), feature pores that permit the 
exchange of fluid, ions, and other solutes across the support. By seeding cells onto the 
support, supplying growth media to the compartment below the support, and evacuating fluid 
from the apical surface, the primary cells can be cultured across an ALI that ensures cells can 
obtain nutrients and expel metabolites from the culture medium below, while still replicating 
the ALI that characterizes their natural in vivo microenvironment. 
 The necessity for permeable supports is twofold: the maintenance of proper in vivo 
cellular physiology, and the use of bioelectric and microscopic assessment of ion and fluid 
transport. In the first case, a wealth of evidence exists showing that some kind of permeable 
support is necessary to achieve proper polarization of the cell membrane into apical and 
basolateral faces, a key feature of the respiratory epithelium.
37-38, 141-146
 Initial studies by 
Whitcutt et al. revealed a greater degree of ciliated columnar morphology and mucus 
production in vitro of tracheal cells cultured under an ALI on a permeable gelatin support.
37
 
Later work by Johnson et al. showed enhanced sodium transport and the effect of amiloride 
blockade in bronchial epithelia cultured under an ALI compared to standard immersion 
culture.
142
 In fact, the need for a culture support that closely mimics the in vivo basement 
membrane is so strict for primary bronchial epithelial cells that when the support becomes 
less or even more porous than the native basement membrane (the latter case seen in attempts 
to grow primary bronchial cells on supports with pores 3.0 µm in diameter), the epithelial 
layer fails to properly form, instead assuming a true single-cell-deep monolayer and not the 
multi-layer architecture seen of a true pseudostratified epithelium in vivo.
138
 While AT1 and 
AT2 cells exist as a pure single-cell monolayer and not a pseudostratified epithelium, at least 
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two studies have nonetheless shown that ALI conditions influence bioelectric properties in 
AT2 monolayers as well.
39-40
 
 In addition to promoting a recapitulation of both the in vivo epithelial layer 
architecture and the molecular physiology of the epithelial cells themselves, use of permeable 
supports also allows testing of tissue-scale epithelial function using bioelectric and confocal 
microscopic methods to study ion and fluid transport, respectively. In the first case, a setup 
known as an Ussing chamber is utilized to allow for real-time monitoring of voltage potential 
differences across an epithelial layer, with the capability to rapidly introduce interrogatory 
compounds such as ion transporter modulators to either the apical or basolateral faces of the 
cell.
138
 Supply of an inhibitor to a specific ion transporter present in the membranes of cells 
in the monolayer, for example, begets a reproducible and dose-dependent change in the 
transepithelial potential difference measured by the chamber apparatus. In this way, studies 
of ion channel expression can be used to guide the design of specific bioelectric experiments. 
In the second case, confocal microscopy is used to directly observe fluid movement across an 
epithelial layer. A typical protocol, pioneered by the Boucher Labs, involves labeling the 
apical surface fluid with a fluorophore-conjugated, high-molecular weight dextran and using 
a laser-scanning confocal microscope to scan through the apical fluid and epithelial cell 
layers. By measuring the thickness of the fluorescent layer above the cells, the thickness and 
volume of the surface liquid can be determined. Time course serial imaging of the fluid layer 
allows quantitation of water flux in response to perturbations of the mechanistic or regulatory 
molecular machinery (Figure 1.4).
147
 
 Both the bioelectric and confocal microscopy methods depend on the presence of 
high-resistance transepithelial electrical seals in the epithelial layer, which act to prevent 
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leakage of ions and fluid. Primary bronchial and AT2 cells readily form epithelial layers in 
culture that have transepithelial seals with resistances on the order of 500 Ω*cm2 at the 
minimum (Figure 1.5A).
126, 138, 148
  However, primary AT1 cells in culture spontaneously 
form intercellular gaps.
132, 149
 Comparison of these gaps, which reach sizes of up to 50 µm 
(Figure 1.5B), with in vivo alveolar ultrastructure led to the proposal that these gaps are the 
attempts of AT1 cells in culture to form pores of Kohn, an interalveolar gap involved in 
collateral ventilation of adjacent alveoli that prevent alveolar collapse. Regardless of their 
purpose, these gaps act to short-circuit bioelectric measurements and allow fluid leakage in 
microscopy studies, and so constitute a technical barrier that must be overcome for useful 
study of AT1 cells.
132, 149
 
 Given the imperative to directly assess ion and fluid transport by AT1 cells, and the 
problem posed by the intercellular gaps they form, I hypothesized that a novel cell culture 
platform fabricated with microscale features would enable the culture of small numbers of or 
even single primary AT1 cells while circumventing the problem posed by the AT1 
intercellular gaps. Construction of such a platform lies in the field of microfabrication. 
 
1.3 Microscale devices for analysis of discrete numbers of cells 
1.3.1 Definition and use of microscale devices 
The term ‘microfabricated’ or ‘microscale’ device refers to any of a huge number of 
devices described in the chemical and biomedical research literature, each of which possesses 
micron-scale patterned features. In a general sense, these features can be physical, chemical, 
or both.
150-151
 For example, physical features might include pedestals, channels, or wells. 
Chemical patterns could be islands of extracellular matrix protein, patterns of growth factors, 
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or gradients of substrate stiffness. Combinations of these patterning schema open 
applications such as directed or ordered cellular co-cultures, tailoring substrate stiffness for 
experiments on cellular mechanotransduction, or spatially-defined gradients of chemotactic 
factors.
152-155
 
The most common methods in use in the microfabrication field include soft 
lithography, photolithography, and injection molding, with a number of others also 
available.
156-159
 Soft lithography most commonly uses the optically clear silicone polymer 
polydimethylsiloxane (PDMS) to create structures from a master mold. By casting uncured 
PDMS onto the mold, heat curing, and later removing the polymerized PDMS, a final 
structure of negative relief from the master mold is formed.
158
 Photolithography typically 
uses photoactive polymers known as photoresists to create its structures. By exposing the 
photoresist to UV light through a mask patterned with microscale 2D features, the photoresist 
can be selectively polymerized according to the mask pattern. Injection molding, typically 
done with cyclic olefin co-polymer, a thermoset, or a thermoplastic, involves the instillation 
of a polymer in its liquid form around a mold, after which the polymer is allowed to cool and 
set, forming a negative relief of the mold. 
In addition to general classifications of device composition and construction, the 
majority of devices used in biomedical research endeavors and fabricated using these 
materials typically fall into one of several general design categories: valved or laminar flow 
microfluidics, droplet microfluidics, microwell arrays, micropedestal arrays, and 
micropatterned surfaces.
160-161
 Laminar flow microfluidic devices feature liquid flow through 
ordered microchannels, typically bordered by PDMS, at user-defined flow rates. By contrast, 
droplet microfluidics usually feature an interfaced flow of two immiscible liquids to create 
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droplets composed of one phase that are driven through the device microchannels by flow of 
the other phase. Microwell arrays feature an ordered pattern of pits into which a cells or some 
other analyte of interest is deposited. Micropedestal arrays, the opposite relief pattern of 
microwell arrays, disperse the analyte, typically cells, onto the sides or top of small physical 
posts patterned onto a surface. While microwell and micropedestal arrays are both 
patternings of physical features, micropatterned surfaces generally entail chemical 
patternings of some kind. Though a comprehensive review of the microfabrication field, 
apart from the focused survey described in sections below, is beyond the scope for this 
dissertation, there are several excellent reviews of this field, which is rapidly growing and 
becoming highly relevant for biomedical research.
162-167
 These surveys summarize recent 
advances not only in the materials and techniques of microfabricated devices, but also in the 
novel and innovative applications for which these devices are being used. 
1.3.2 Advantages of microscale devices 
A wealth of literature exists that describe in detail the advantages microscale devices 
bring to biomedical research. Chief among these advantages is the relative ease of adapting 
these devices for use with automated instrumentation and high throughput methods, which 
take advantage of the patterned nature of the devices via algorithms that not only enable 
rapid and precise analysis, but an orderly reference of assay results. Additionally, because of 
the small size of the features in these devices, a reduced consumption of reagents can be 
achieved. One unique advantage some, though not all, microscale devices have over 
traditional platforms is the ability to select for, isolate, and physically recover cells of interest 
in post-analytical stages.
160, 164, 168-169
 Review articles, such as those cited above, provide 
greater detail regarding these advantages. 
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Most relevant to this dissertation is the compelling case that microscale devices make 
as tools for analyses of single or discretely small numbers of cells. Because the design of 
these devices allows for precise engineering of the shape, size, and surface chemistry of the 
area used for cell growth, these devices allow unparalleled control of the physical and 
chemical microenvironment to which a cell or group of cells is exposed as it grows. 
150, 164, 
170-171
 By achieving such control, researchers gain the ability to create novel bio-inspired 
platforms that can precisely interrogate the mechanisms and regulation of fundamental 
cellular processes and to gather highly sensitive, cell-specific data platforms.
165, 172-175
 Be it 
due to the inherently small size of their features, or the frequent need for gathered data to 
meaningfully discern between groups of or even single cells, microscale devices are also 
uniquely suited to performing the highly sensitive measurements necessary for high 
throughput, single cell analysis.
160-161, 176
  
Thus, given their advantages and utility as single-cell analytical platforms, a research 
goal of designing and building a microscale device for the study of primary AT1 cells was 
formed. 
1.3.3 Survey of previously described microscale devices relevant to alveolar 
cell culture 
 
1.3.3.1 Microscale devices applied to respiratory biology 
Several microfabricated platforms have been developed and applied to respiratory 
biology inquiries. Reports of these platforms were consulted for their potential for use with 
primary AT1 cells. Because they can be patterned so easily and with such a high degree of 
control over their dimensions, a number of platforms utilize cell-lined microchannels to 
examine the role of shear stresses on cell attachment and vitality. Propagation of liquid plugs 
down the microchannels simulated the opening of occluded airways, providing data relevant 
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to studies of pulmonary surfactant dysfunction or depletion.
177-179
 Building on these past 
works, a study by Douville et al. created a microfluidic model of the alveolus in which sheets 
of primary murine alveolar cells or cells from the human immortalized alveolar epithelial 
A549 cell line were grown on a flexible membrane of PDMS subjected to a migrating ALI.
180
 
This study demonstrated the role of migrating ALIs in worsening the cellular damage caused 
by cyclic stretch/compression as compared to cells that were entirely submerged or air-
exposed when stretched, results relevant to research on ventilator-induced lung injury. 
 Additionally, a seminal study by the Ingber Group engineered a “lung-on-a-chip” 
device that featured a microporous membrane separating two microchannels.
181
 On one side 
of the membrane, a sheet of immortalized endothelial cells were exposed to a fluid filled 
microchannel. The opposite side of the membrane was covered with sheets of cells from 
either small airway NCI H-441 or alveolar A549 cell lines, creating an ALI across the 
membrane. A noteworthy feature of this device was the pair of microchannels that laterally 
bordered the membrane: reducing or normalizing air pressure to these side channels created 
stretch or relaxation forces that simulated the expansion of the pulmonary tissues that occurs 
during inspiration. 
Several of the studies cited above are surveyed in a review of efforts to study 
respiratory physiology on chip-based platforms.
182
 This review reiterates the need for an ALI 
in culture of pulmonary cells as a way to recapitulate true in vivo architecture. Several 
attempts to create a co-culture model of the alveolar-capillary barrier, typically via culture of 
alveolar and endothelial cell lines on opposite sides of a porous membrane, were discussed. 
Of note, this review includes coverage of chip-based research efforts at extracorporeal 
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membrane oxidation (ECMO), a direct therapeutic end goal not falling within the 
physiology- and pharmacology-oriented research goals of this dissertation.  
While useful advances, none of these devices are suited for research with primary 
AT1 cells, for at least one of a variety of reasons: incompatibility with primary cell use, 
designs that do not feature permeable supports, or designs that do not appropriately replicate 
the physicochemical features of the alveolar architecture. For example, while the “lung-on-a-
chip” represents an impressive engineering advance, its use of sheets of cells grown atop a 
membrane with large, 10 µm-diameter pores does not sufficiently replicate the alveolar 
microenvironment, which features smaller physical concavities approximately 250 µm in 
diameter whose basement membrane has submicron-scale porosity.
1, 183
 The microfluidic 
alveolar model developed by Douville et al. has similar shortfalls: sheets of cells 6 mm in 
diameter, grown on an impermeable membrane 100 µm thick, do not replicate the alveolar 
microenvironment seen by an AT1 cell. Given the shortcomings of these otherwise laudable 
devices as they relate to AT1 culture, other examples of microtechnology that utilize 
permeable membranes were explored. 
1.3.3.2 Microscale devices utilizing a permeable support 
To date there has been some success in combining microscale technologies with 
porous or otherwise permeable materials, even if they have not been used in respiratory 
biology studies. Porous membranes are used most commonly in microfluidic setups 
fabricated with PDMS, and a number of studies focused on methods in which to incorporate 
the membranes into the fabricated devices. A common design for these systems involves the 
fabrication of devices using stacked PDMS layers with a microporous membrane sandwiched 
in the middle, creating separate PDMS flow channels separated by the membrane. The 
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membranes and the PDMS layers are most commonly bonded either indirectly using a thin 
PDMS mortar layer or directly via the organosilane 3-aminopropyltriethoxysilane 
(APTES).
184-186
 However, most of the studies cited above bond only the membrane edges, at 
the macroscopic scale, to the borders of PDMS layers. A literature review did not locate any 
studies that involve bonding membranes to PDMS films with a microscale pattern, likely due 
in one part to the relative difficulty in making through-hole arrays in such films in the first 
place and due in another part to difficulty in establishing uniform seals around each 
microwell that eliminate communicating gaps between them. Indeed, the smallest area of 
membrane exposed was still 4 mm
2
.
187
 Use of “microfluidic stickers” presents an alternative 
method that is chemically distinct from the sandwich methods described above, but nearly 
identical in general concept.
188
 
Studies employing the PDMS-membrane sandwich method have used the membrane 
in a microfluidic setup in such varied applications as establishing standing chemical gradients 
to which cells can be exposed without the harsh shearing forces of high flow rates.
188-190
 In a 
general sense, seeding cells onto one side of the membrane allows for single-stream 
perfusion at relatively slow rates – or even static culture – that do not introduce shearing 
stresses to the cell. On the other side of the membrane, flows from two entering fluid 
streams, one of which carries a solute of interest, meet in the middle. This interface allows a 
standing chemical gradient of the solute to be set up along an axis orthogonal to the flow 
direction in the middle of the channel, with the extent of the gradient controlled by the flow 
rates. Because the cells are separated from these higher flow rates by the membrane, shearing 
forces are spared. A second category of applications for this kind of microfluidic setup is that 
of a plasma filter. Both Aran et al. and Son et al. describe use of the membrane for isotonic 
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and hemolysis-free filtration of plasma from whole blood.
191-192
 By using membranes with 
pores too small for red blood cells, whole blood infused into the system could be efficiently 
separated into two compartments, with one compartment retaining erythrocytes and 
leukocytes and the other containing only plasma, with low shear stress and minimal 
erythrocyte hemolysis. 
Other reports utilize the membrane to recapitulate the polarization seen in vivo of 
certain types of non-respiratory epithelial cells. For example, Jang and Suh created a 
microfluidic “kidney-on-a-chip” using PDMS bonded to a porous membrane on which sheets 
of primary rat inner medullary collecting duct (IMCD) cells were cultured.
193-194
 The 
McGuigan Group successfully patterned MDCK  and retinal epithelial cells into 
microcolonies atop commercially-available porous substrates.
195
 A device fabricated as an 
extension of “lung-on-a-chip” technology, described in the previous section, was used to 
grow cells from an immortalized colon adenocarcinoma-derived cell line, hence the term 
“gut-on-a-chip.”196 Alternatively, insertion of cylindrical electrodes on each side of the 
membrane allows measurement of the transepithelial electrical resistance (TEER) of a 
monolayer of cells cultured on the membrane.
187
 This concept was later extended in a 
microfluidic model of the blood-brain barrier that incorporated electrodes to measure TEER 
into the device.
197
 
A few devices do attempt to introduce micropatterns onto porous membranes. The 
Takayama Group developed a method to microstamp PDMS that could pattern microwells 5 
µm in height and as small as 50 µm in diameter atop a porous polyester membrane.
198
 Two 
reports – one of which used a combination of electrospun polyblend fibers and soft 
lithography, the other using a mesh-supported submicron membrane of parylene C – 
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combined microscale patterning with a unique permeable surface, but fabrication of these 
devices requires both large manpower and highly specialized equipment.
199-200
 A similar 
requirement for specialized equipment is one drawback to a recent report describing the 
ability to thermoform polyester or polycarbonate into films with 3D topographies.
201
 The 
fabricator must have ready access to not only a specialty thermoforming apparatus, but also 
to a heavy ion accelerator in order to track-etch pores into the final product.  
Despite the many examples presented, these platforms have inherent limitations that 
prevent their immediate use or adaptation for AT1 cells. Chief among these limitations is an 
inability to pattern the membranes themselves, either directly or via the enclosures of a 
microfluidic device to the specifications needed by a device for primary AT1 culture. Indeed, 
the McGuigan Group’s cell colony micropatterns and the Takayama Group’s orthogonally-
oriented microchannel array represent the works most relevant to culture of primary AT1 
cells, but each of these two methods has detractions: the McGuigan Group’s micropatterns 
appear to be limited to features larger than approximately 250 µm (comparative AT1 
diameter is 50-100 µm), and the Takayama Group’s PDMS microstamps were so thin (5 µm 
in height) that cells readily migrated out of the microwells and spread over the entire 
surface.
195, 198
 
 
1.3.4 Design guidelines for a microscale device applicable to AT1 cells  
As discussed above, a simple adaptation of previously developed technology 
platforms is unlikely to be of use in studying primary AT1 cells. Thus, there exists a need for 
a new microscale platform, designed and validated for the purpose of culturing single or 
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small or discrete numbers of primary AT1 cells in a microenvironment mimicking that of the 
native alveolus (Figure 1.6A).  
Such a platform should satisfy several design guidelines. First, its construction and 
assembly should be compatible with standard microfabrication techniques so as to minimize 
the need for designing entirely new fabrication methods. Second, the platform and its 
prototypes should be relatively rapid and inexpensive to construct, so as to ensure an efficient 
use of manpower and materials. Third, the fabrication method should allow micron-level 
precision in patterning the platform. Figure 1.6B illustrates a number of the parameters that 
should be amenable to control, including the diameter of the microwell elements, the height 
of the microwell walls, and the interwell spacing. One special consideration will have to be 
the well diameter, as it would be desirable to pattern microwells the approximate diameter of 
AT1 cells as they exist in vivo. A second consideration will have to be given to the well 
depth. While it would be ideal that wells would be deep enough to prevent the migration or 
spreading of the AT1 cells out of the wells, wells must also be shallow enough that polarized, 
differentiated AT1 cells will have the transport capacity (energetically and kinetically) to be 
able to transport fluid in the well down to a volume that reflects the thin AvSL seen in vivo. 
While optimization of well depth and diameter will be an expected step in translating a 
finished microdevice to use with primary AT1 cells, identifying early on a fabrication 
technique that allows control over these parameters to a level sufficient for use with AT1 
cells would be ideal. Fourth, the platform must incorporate some kind of microporous or 
otherwise permeable support on which the primary cells can be grown, as bioelectric and 
confocal microscopy studies will be central to the application of the platform and a wealth of 
literature has shown the effects of ALI growth on the differentiation and polarization of 
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respiratory epithelial cells. However, as has been described in Section 1.2.4, the mere 
presence of arbitrary pores in the device may not be enough, as even bronchial and primary 
AT2 cells fail to differentiate when pores are either too large or too small.
138
 Ideally, control 
over some aspects of the support, such as its thickness, can be achieved (as shown in Figure 
1.6B). Lastly, an ability to tailor the microwell, such as through surface chemistry 
modifications or ECM deposition, so as to customize the microenvironment seen by cells to 
one that closely mimics the basement membrane and other aspects of the in vivo 
microenvironment, would be optimal. Empirical evidence already exists that AT1 and AT2 
cells have different ECM preferences, and that ECM choice can guide respiratory alveolar 
differentiation.
133, 202
 
 
1.4 Scope of the Dissertation 
This dissertation describes the development and characterization of a microfabricated 
device, featuring an array of microwells patterned atop a porous or otherwise permeable 
support. The overall focus for the dissertation is on a generating a complete characterization 
of the device in an acellular state, a necessary task before the device can be used for cellular 
studies, as knowledge of the physicochemical properties of the platform is needed to 
accurately interpret observed cellular responses. Full understanding and command of these 
properties and the device’s limitations ensures maximum utility of the device for later 
cellular studies. However, certain cell-based applications, for which only minimal 
optimization was necessary, are also presented. Chapter 2 presents a method for fabricating a 
microwell array and explores the fabrication parameters and limits. Special attention is paid 
to the novelty of the method: release of the completed microwell array intact from the 
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fabrication substrate. These results have been published in the Journal of Micromechanics 
and Microengineering.
203
 Chapter 3 introduces a permeable support, composed of the 
hydrogel chitosan, to the array described in Chapter 2, with special attention to elucidating 
the support layer’s ability and limitations in allowing the diffusion of solutes across it. 
Review of the microfabrication literature suggests that this is the first reported co-fabrication 
of hydrogel and photoresist, and the first release of a freestanding film of permeable-bottom 
microwell arrays. These results are currently being prepared as a manuscript for submission 
to the journal Biomaterials. Chapter 4 describes the application of the microwell array 
fabrication method described in Chapter 2 to commercially available permeable supports, 
which feature track-etched submicron-scale cylindrical pores. Preservation of the pore 
patency after the fabrication is completed is presented, as are data showing the ability to 
pattern features as small as 25 µm atop the support layer, the smallest feature size reported to 
date for patterned commercial membranes. A manuscript describing these findings is in 
preparation for submission to the journal Lab on a Chip. Chapter 5 describes potential future 
directions for these devices, including suggested protocols for immediate translation into 
experiments with primary AT1 cells, as well as novel potential applications of these 
technologies for a range of research endeavors, pulmonary and otherwise. 
 
 
 
 
 
 
35 
 
1.5 Figures and Tables 
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Figure 1.2. Alveolar pathology in ARDS. (A) Representation of normal alveoli and 
pathologic alveoli due to ARDS, indicating the fluid-flooded and pro-inflammatory state 
characteristic of ARDS, as well as epithelial cell death and hyaline membrane formation. 
Adapted from Ware and Matthay.
56
 (B-C) Histological H&E preparations of normal (B) 
and ARDS (C) alveolar tissue. Images reprinted with permission.
206, 207
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Figure 1.3. Models of lung fluid homeostasis. (A) Fluid homeostasis in the proximal 
airways by ciliated pseudostratified epithelia is achieved by directed ion transport using 
ENaC and CFTR to create an osmotic gradient that drives water flux through aquaporin 
molecular water channels to the airway surface, a process normally regulated by signaling 
of extracellular adenosine, a metabolite of ATP.  Proper hydration of the periciliary layer 
(blue) allows efficient transport of an overlying mucus layer (green). Adapted from 
Boucher.
5
 (B) Proposed fluid homeostasis model in the alveoli, in which directed ion 
transport is thought to create similar osmotic gradients that drive water flux. Signaling of 
both extracellular adenosine, metabolized from ATP, through adenosine receptors and 
ATP and UTP directly through P2Y and P2X receptors is thought to regulate this process. 
Adapted from Dobbs et al.
136
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Figure 1.4. Real-time measurement of ASL and AvSL by confocal microscopy. Epithelial 
layers of primary human (A) bronchial epithelia (HBE) and (B) AT2 cells were cultured 
under ALI conditions. Apical surface liquid was stained by addition of a bolus of fluid 
containing 70-kDa Texas Red-conjugate dextran. AT2 (but not HBE) cell cytoplasms 
were also stained with calcein AM green. Measurement of the red fluorescent layer above 
the epithelial layer, as indicated by the double-headed arrows, allows quantification of the 
ASL or AvSL over time. Scale bars: (A) 7 µm; (B) 5 µm. Images reprinted with 
permission from the American Society for Biochemistry and Molecular Biology.
96, 126 
39 
 
 
 
 
 
 
Figure 1.5. Insufficiency of standard culture models to study primary AT1 cells. (A) 
Immunofluorescence micrograph of a monolayer of normal human bronchial epithelia 
cultured atop permeable supports and under an ALI. The tight junction protein ZO-1 is 
stained in red, while β-tubulin, a component of cilia, is stained in green. The presence of 
tight junctions indicates an intact monolayer with high TEER. Image reprinted with 
permission from Elsevier.
208
 (B) Brightfield (left) and immunofluorescent (right) 
micrographs of transdifferentiating AT2 cells grown in culture atop polystyrene. Nuclei 
are stained in blue with DAPI, while cytoplasms are stained in red with calcein AM red-
orange. Yellow arrows indicate intercellular gaps that reduce monolayer TEER values. 
Scale bars: (A) 10 µm; (B) 75 µm. 
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Figure 1.6. Design overview of a microwell array platform for culture of single AT1 cells 
under an ALI. (A) Concept illustration of several AT1 cells grown individually in 
microwells with permeable bottoms under an ALI. ALI conditions allow for cellular 
polarization and expression of relevant ion transporters and regulatory receptors, while the 
single cell format avoids the formation of intercellular gaps. (B) Design schematic for an 
array of permeable-bottomed microwells. An ideal fabrication method will allow control 
over a number of parameters for the microwell array, namely the well diameter w, the 
interwell spacing t, the depth of the well d, and the thickness h of the permeable layer. 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property AT1:AT2 whole-cell ratio Reference 
Cell surface area 43 
13
 
Osmotic water permeability 7 
135
 
Apical Na
+
 channels / cell ~ 40 
131
 
CFTR channels / cell 6 
131
 
Table 1.1. Comparison of overall ion and water transport properties between AT1 and AT2 
cells. Data taken from permeability and patch clamp studies of primary rat alveolar cells. 
Reprinted with permission from Karger Publishers.
136
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Ion channel 
Density in AT1 
cells (per µm2) 
Density in AT2 
cells (per µm
2
) 
ENaC (HSC variant) 1.49 1.63 
ENaC (NSC variant) 0.104 0.167 
K
+
 (Ba
2+
-sensitive) 0.433 0 
CNG (+/- Ca
2+
 in bath) 0.194 / 0.468 0 
CFTR (after cAMP) 0.082 0.982 
Table 1.2. Comparison of ion transporter density in AT1 and AT2 cells. Data obtained 
from patch clamp studies in primary rat alveolar cells. Reprinted with permission from ref 
131. Copyright 2006, National Academy of Sciences, U.S.A.
131
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Chapter 2: Characterization of freestanding photoresist films for 
biological and MEMS applications 
 
2.1 Introduction 
2.1.1 General approaches 
When considering a microfabricated system for culturing primary AT1 cells, several 
general design approaches were first considered. Typical strategies for plating single cells 
include limiting dilution, micropallet arrays, and arrays of microwells. Limiting dilution was 
recognized as offering no advantage for primary AT1 cell growth, as single AT1 cells seeded 
onto traditional permeable supports would not be able to spread out over a macroscopic area. 
Arrays of micropallets, pedestal-shaped structures formed atop glass substrates, have not 
been fabricated in a fashion that would allow culture under an ALI.
1
 Microcup and 
microtable variants of the micropallet format have been fabricated, and it may be possible to 
fabricate the cup or table surfaces to make them permeable, but this approach would require 
significant labor and be technically complex.
2-3
 This approach was also viewed as impractical 
due to the need to release and subsequently collect the microcup or microtable arrays for 
subsequent bioelectric analyses. Traditional microwell arrays made out of PDMS or other 
materials typically used in microfabrication do not offer a permeable support, and thus do not 
currently allow culture under an ALI. However, modification of a microwell-array format 
that allows both segregation of cells and an array of through-holes to make the microwells 
permeable presented a promising start.
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Observation that, in long-term culture of cells atop arrays of micropallets formed 
from negative photoresist, some of the micropallets would spontaneously detach from the 
glass fabrication substrate led to the hypothesis that entire films of photoresist could be 
fabricated and released intact from the glass fabrication substrate. By patterning microscale 
wells into a layer of 1002F (in the opposite relief from traditional micropallet fabrication 
strategies) and releasing the film, an array of through-holes could be achieved that would 
permit exchange of water and solutes across the photoresist film, a useful start to an AT1 
culture platform. 
2.1.2 Lab-on-a-foil devices 
A film released in this fashion could function as a lab-on-a-foil, a device type that is 
an area of emerging importance. These devices use flexible substrates less than 500 µm in 
thickness and are well-suited for a number of chemical and biological applications due to 
their rapid thermal transfer, low reagent use, laminar flow regimes, and flexibility - many of 
the same reasons that microfluidic-based lab-on-chip devices have become so attractive to 
the chemical and biological fields.
4
 Freestanding, micropatterned films have been made using 
polydimethylsiloxane (PDMS) and parylene C. PDMS is frequently used in 
microelectromechanical systems (MEMS) and is inexpensive, optically transparent, and 
easily delaminated from the fabrication surface.
5
 However, the fabrication of through-hole 
structures in PDMS is technically difficult, and thin PDMS films are mechanically fragile, 
limiting the range of useful thicknesses. Though a photopatternable PDMS-like silicone 
exists, it cannot be released from its fabrication substrate.
6
 Thick PDMS films (100 µm) have 
been patterned by filling a microfluidic mold or by using an open photoresist mold followed 
by pressure application, but these processes require pre-existing molds and an overlying 
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adhesive layer to prevent the PDMS from rising above the level of the mold surface.
7
 
Parylene C, a transparent poly(p-xylene) formulation, has also been shown to be amenable 
for forming micropatterned films and to be biocompatible, but its fabrication process is 
complex and requires multiple time-consuming steps including chemical vapor deposition, 
thermal evaporation, and reactive ion etching.
8
 Thus, an inexpensive, biocompatible material 
that can be reliably patterned and quickly released to form a freestanding film, using a 
minimum of equipment and effort, would be a significant advance for the biomaterials and 
microfabrication fields. 
2.1.3 Photoresists 
Photoresists are light-sensitive resins used in a variety of industrial, chemical, and 
biotechnological applications. Positive photoresists are polymers typically spun to a low 
thickness over a substrate. Exposure to light induces localized disruption of the polymer 
backbone, such that areas exposed to light become soluble in a developing solution.
9
 
Negative photoresists, by contrast, are high-viscosity solutions typically composed of a 
monomeric resin and a photoinitiator in an organic solvent.
9-11
 Upon exposure to light, the 
resin is converted into a high-molecular weight, insoluble form by the polymerization of 
resin monomer. This polymerization results from a change in the local chemical environment 
brought about by the light-induced generation of free radicals or strong acids from the 
photoinitiator. First used as protective layers in semiconductor patterning processes, 
photoresists have also found widespread use in recent years in a variety of applications 
outside the microelectronics industry.
9-10
 For example, patterned photoresists placed on a 
rigid substrate are often used as molds for soft lithography of PDMS and other polymers.
5, 12-
16
 They also have application as protective layers during the etching of metals and silicon, as 
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sacrificial layers to pattern silanes, polymers, and biomolecules, and as structural roles in 
microfabricated devices.
1, 17-36
 Pyrolysis of patterned photoresist films generates clear, 
microscale carbon electrodes.
37-40
 Despite the many applications illustrated above, 
photoresists generally have been relegated to use as a sacrificial layer or as a rigid structural 
component remaining on its fabrication substrate (usually glass or silicon).  
2.1.4 Photoresists as lab-on-a-foil devices 
Though freestanding photoresist films have potential as lab-on-a-foil devices, little 
about such films has been reported in the literature. One reason may be that most 
commercially-available photoresists are not ideal for use in applications requiring a 
freestanding film, since these resists are brittle and inflexible.
41-43
 Abgrall et al. detailed the 
fabrication use of freestanding films of the popular photoresist SU-8 for use in a lab-on-a-foil 
concept, but the film was laminated to a polyester support layer.
44
 Other groups have 
fabricated and released membranes made of SiN, thin single-crystal Si, or a trilayer of metal, 
photoresist, and anti-reflective coating for various stenciling applications.
45-47
 Wang and 
colleagues detailed the use of films of a negative photoresist to capture intact human colon 
crypts.
48
 These photoresist films were detached from their glass fabrication substrates after 
completion of the lithography. McPherson and Walker recently showed that 1002F 
photoresist films could be released and used as mechanical sieves.
49
 However, those reports 
did not characterize the release conditions for the films or the limits of film patterning. Thus, 
the ultimate patterning resolution and aspect ratio for such films, as well as the material 
properties, are not known.  
To have wide utility, freestanding photoresist films should have several 
characteristics. First, the resist should be easily patterned by conventional methods. Second, 
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the material must be amenable to facile release from the fabrication substrate without harsh 
solvents. Third, a material that is transparent in the visible wavelengths and possessing little 
autofluorescence would insure compatibility with light and fluorescence microscopy 
techniques. Fourth, the material used should be structurally resilient and flexible in a range of 
thicknesses. 
The photoresist 1002F meets the above criteria, possessing low autofluorescence and 
high biocompatibility.
50
 1002F is a negative photoresist whose monomer form contains 
epoxy groups, similar to the widely-used negative photoresist SU-8, that are induced to 
polymerize in a linear fashion in the presence of an acid catalyst. Mixing of 1002F monomer 
resin with triarylsulfonium hexafluoroantimonate salts, which act as a photoinitiator by 
generating acid moieties in response to activation with UV light, are mixed in the solvent γ-
butyrolactone to form a viscous photoresist that can be spin coated onto glass substrates to 
give films of uniform and predictable thickness. Compared to SU-8, 1002F offers 
comparable biocompatibility and much reduced autofluorescence.
50
 
2.1.5 Overview 
This chapter characterizes the fabrication, micropatterning, and release of 1002F 
films. The ability of various solvents to release the films from the underlying fabrication 
substrate is considered, as are the release kinetics. Fabrication parameters for a variety of 
film thicknesses, patterned with through-holes of a variety of shapes and sizes and in 
multiple layers, were measured. Properties of the films such as the patterning aspect ratio and 
resolution as well as the Young’s modulus were assessed. Lastly, two applications of the 
films, the use as stencils for achieving patterned deposition of metal onto a substrate and the 
study of single cells atop a micropore, were demonstrated. This is the first quantitative 
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description of the fabrication of freestanding films using a photoresist. These results 
established the utility of flexible, freestanding1002F photoresist films for use as an industrial, 
chemical, or biological tool.  
 
2.2 Experimental Design 
2.2.1 Materials 
EPON resin 1002F photoresist (phenol, 4,4’-(1-methylethylidene)bis-, polymer with 
2,2’-[(1-methylethylidene) bis(4,1-phenyleneoxymethylene]bis-[oxirane]) was obtained from 
Miller-Stephenson (Sylmar, CA). UVI-6976 photoinitiator (triarylsulfonium 
hexafluoroantimonate salts in propylene carbonate) was purchased from Dow Chemical 
(Torrance, CA). SU-8 photoresist was obtained from MicroChem Corp. (Newton, MA). γ-
butyrolactone (GBL) and developer (propylene glycol methylether acetate, PGMEA) were 
obtained from Sigma-Aldrich (St. Louis, MO). PDMS (Sylgard 184 silicone elastomer kit) 
was purchased from Dow Corning (Midland, MI). Chrome photolithography masks were 
designed in-house using TurboCAD software and printed by FineLine Imaging (Boulder, 
CO). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and 
penicillin/streptomycin were obtained from Invitrogen (Carlsbad, CA). H1299 cells were 
obtained from American Type Culture Collection (ATCC, Manassas, VA). 
2.2.2 Fabrication and release of single-layer films 
1002F-10, 1002F-50, and 1002F-100 negative photoresists were prepared by 
dissolving EPON 1002F resin and triarylsulfonium hexafluoroantimonate salts in GBL 
(described previously).
50
 Films of 1002F photoresist of various thicknesses (4.5-225 µm) 
were obtained by spin-coating 1002F-10, -50, or -100 on precleaned glass slides.
50
 The 
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coated slides were then soft-baked at 95
o
C in an oven to remove organic solvent. After 
cooling to room temperature, the slides were exposed to UV light from an Oriel collimated 
UV light source (1.68 mW/cm
2
, Newport Stratford, Inc., Stratford, CT) through a patterned 
chrome photomask. A two-step post-exposure bake, first at 95
 o
C and then at 120 
o
C, 
followed UV exposure. After cooling to room temperature, unpolymerized monomer was 
removed by developing the slide in propylene glycol methylether acetate (PGMEA), rinsing 
with 2-propanol, and drying under a nitrogen stream. Films were hard-baked at 120 
o
C for 2 
h. Unless stated otherwise, films were released from the glass substrate by incubated in water 
for 12 h on a laboratory shaker (60 rpm, Bellco Biotechnology, Bellco Glass, NJ) at 23
o
C. 
Films were detached from the glass slide by sliding a razor beneath the film at its corner and 
using tweezers to gently peel the film away from the glass slide. Detached films were dried 
under room air. 
2.2.3 Measurement of film properties 
Photoresist thin films were imaged with a Nikon Eclipse TE2000-U inverted 
fluorescence microscope under brightfield conditions and the image recorded with a cooled 
CCD camera (Photometrix Cool Snap fx, Roper Scientific, Tucson, AZ) controlled by NIS 
Elements software (Nikon, Melville, NY). Films were also imaged using an FEI Quanta 200 
FEG scanning electron microscope (SEM) with a Shottky field emission gun, operated under 
low-vacuum conditions (0.38 torr) (Chapel Hill Analytical and Nanofabrication Laboratory 
(CHANL)). Film thickness was determined using SEM and profilometry (KLA-Tencor P-15 
Profilometer, KLA-Tencor, San Jose, CA). Aspect ratios were measured by cutting films and 
measuring the film thickness and dimensions of through-holes using SEM. 1002F films were 
subjected to tensile strength testing using dogbone-shaped films 50 µm in thickness and 0.3 
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cm wide and 2.4 cm long using an EnduraTEC Smart Test Series tension loader. Films were 
subjected to axial stress using a 5-lb load cell and pulled at a rate of 0.01 mm/s until failure. 
The Young’s Modulus was determined to be the slope of the best-fit line in a plot of the axial 
stress versus strain, as measured photographically over the course of the tensile strength test, 
and the ultimate tensile stress determined as the axial stress in the film just prior to 
mechanical failure. 
2.2.4 Characterization of photoresist thin film release kinetics 
The release of photoresist thin films from glass substrates was assessed using 
different solvents over a 24-h time course. Twenty square-shaped photoresist thin films 50-
µm thick with dimensions of 25 x 25 mm were fabricated and immersed in either acetone, 
75% (v/v) ethanol, deionized laboratory water, or a 1% (w/v) detergent solution (Contrex 
Labware Detergent, Decon Labs, PA) (5 films per solvent dish). Films were shaken for 24 h 
in covered dishes. The dishes were observed after 1, 8, 12 and 24 h for spontaneous 
detachment of films. After 24 h, slides were removed from solvent dishes and assessed for 
the attached films assessed for their ability to be removed. Three independent trials were 
conducted, each on a separate day.  
The time needed for release of a film incubated in deionized laboratory water was 
also measured. Twenty films with dimensions identical to those described in the above 
paragraph were fabricated and immersed in water in covered laboratory dishes on a shaker 
for 1, 2, 4, 8, and 12 h. At each time point, the films in each dish (5 films per time point) 
were observed for spontaneous detachment. The ability of undetached films to be released 
from the glass substrate using a razor blade was also assessed. Three independent trials were 
conducted, each on a separate day. 
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2.2.5 Patterned deposition of metal and protein 
Patterned deposition of metal through photoresist film stencils was accomplished 
using a Cressington 108 Sputter Coater (Cressington, United Kingdom), which was 
monitored using an MTM-10 thickness monitor. Between 10 and 20 nm of Au:Pd was 
deposited on substrates under an argon gas plasma. Sputtering was performed on glass 
substrates using un-released and released films as stencils and on PDMS substrates using 
released films as stencils. Released films used as stencils were attached to the surface of new 
glass substrates using clamps or placed on PDMS using manual pressure. All substrates were 
imaged before and after deposition and after removal of the photoresist stencil by brightfield 
microscopy. 
 Additionally, patterned deposition of protein through photoresist film stencils was 
accomplished by applying a 50 µg/mL solution of rhodamine B-conjugated bovine serum 
albumin (BSA) to microarrays atop solid surfaces. Patterning was performed first on glass 
substrates using un-released films. After release, films were placed on PDMS substrates by 
applying manual pressure, or were thermobonded to glass or polystyrene substrates by 
applying pressure to the film and heating at 95
o
C. Thermobonded films could later be 
released via incubation in deionized water. All substrates were imaged before and after 
protein deposition via epifluorescence microscopy. 
2.2.6 Cell culture on a film with a single pore 
H1299 lung adenocarcinoma cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with penicillin/streptomycin and 5% fetal bovine serum. 
1002F photoresist films with a single through-hole 10 µm in diameter were fabricated, 
released, and attached to a support column so that the film separated an upper and lower fluid 
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chamber. After microscopic evaluation to ensure that films contained only one pore and were 
free of defects, films were plasma treated and the surface of the upper chamber was coated 
with 100 µg/mL collagen (type I from rat tail) for 1 h. H1299 cells were cultured in the upper 
chamber on the film until the cells were confluent on the film surface (24 h). Media in the 
basal (lower) compartment was replaced with DMEM containing calcein AM dye (10 µM). 
The film was imaged at the site of the pore after 5 min using a Nikon TE300 inverted 
epifluorescence microscope. 
2.2.7 Seeding of AT2 primary cells 
Primary human AT2 cells were obtained as a gift from Dr. Peter Bove of the Cystic 
Fibrosis Research and Treatment Center at the Univ. of North Carolina School of Medicine. 
Briefly, cells were harvested from human explant lungs obtained with patient consent under a 
protocol approved by the Univ. of North Carolina School of Medicine Institutional Review 
Board via elastase digestion of the distal airspaces as a modification of previously published 
protocols.
51
 After negative immunoselection using magnetic beads to remove contaminating 
erythrocytes and macrophages, AT2 cells were seeded into microstrainers with microwells 75 
µm in diameter and patterned with 5.0 µm pores in the lower layer. Cells were monitored via 
brightfield microscopy for their ability to spread out and assume an AT1-like morphology. 
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2.3 Results and Discussion 
2.3.1 Fabrication of 1002F films and release from glass substrates 
Films of 1002F photoresist (25 mm x 25 mm x 50 µm, ℓ x w x h) were fabricated on 
a glass substrate with a 100 x 100 array of 75-µm diameter through-holes spaced 20 µm apart 
(Figure 2.1). Process conditions for this fabrication and several others with slight variances 
are given in Table 2.1. After fabrication, the films were incubated in four different solvents: 
acetone, 75% (v/v) ethanol in water, water, and 1% (w/v) detergent in water. The ability of 
the films to be released from the substrate was then assessed over time and all released films 
were visually inspected for defects. All films incubated in acetone spontaneously detached 
from the glass substrate by 1 h, but were distorted and rigid.  At 24 h, films in ethanol, water, 
and detergent remained adhered to the glass substrate but could be detached by inserting a 
razor blade between the film and substrate. Films incubated in 75% ethanol curled upon 
release and could not be flattened. By contrast, all films placed in either water or detergent 
appeared undistorted and remained flat upon release (Figures 2.1 and 2.2). Representative 
images of films removed in each of the four solvents are shown in Figure 2.2. Since the 
highest quality films were released after incubation in water, this solvent was selected for all 
subsequent characterizations of film release. 
The time required for the release of photoresist films from fabrication substrates was 
assessed by immersing the films in water for varying times. Film releasability was then 
assessed. All films were visually inspected and characterized as “releasable without 
damage,” “released but damaged,” or “not releasable” (Table 2.2). Released films with any 
defect observed either visually or via brightfield microscopy were considered damaged. The 
most common defects observed were tearing and/or irreversible bending of the films. By 2 h 
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of water immersion, all films were releasable but 60% were damaged during the release 
process (Table 2.2, Figure 2.3). By 4 h, 87% of the films were released without damage and 
by 12 h, all of the films were released undamaged (Table 2.2). Thus the 1002F photoresist 
films were easily released without damage by 12 h using simple solvent systems and without 
the need for an underlying sacrificial or water-soluble layer.  
2.3.2 Mechanical strength of freestanding 1002F films 
To study the mechanical strength of freestanding 1002F films, the Young’s modulus 
and ultimate tensile stress were measured. Dogbone-shaped films of 1002F were fabricated, 
released, and subjected to tension testing (Figure 2.4). The Young’s modulus for 1002F films 
was determined to be 1.43 ± 0.21 GPa, and the ultimate tensile stress determined to be 54.5 ± 
3.1 MPa (final elongation 105.1 ± 0.5 %)(Table 2.3). By comparison, the Young’s modulus 
of SU-8 has been reported as 2.2 ± 0.1 GPa, and the Young’s moduli for parylene and PDMS 
were reported to be 3.2 GPa and 0.75-4 MPa, respectively, suggesting that 1002F photoresist 
is mechanically similar to parylene and SU-8 but more resilient than PDMS.
52-56
 In addition, 
1002F films were shown to be flexible (Figure 2.5) and amenable to mechanical 
manipulation without damage to the films, in contrast to films fabricated with the more brittle 
SU-8. It is hypothesized that this flexibility is due to the presence of only two epoxy residues 
in the molecular structure of the 1002F monomer unit, necessitating that 1002F 
photopolymerization occur in a linear fashion. SU-8, by contrast, has eight epoxy moieties 
per monomer and thus polymerizes largely via cross-linking reactions, which may contribute 
to its brittle nature.  
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2.3.3 Fabrication of micropatterned freestanding 1002F films 
The potential to fabricate freestanding photoresist films of a variety of thicknesses 
with features that faithfully replicated a master was assessed. 1002F photoresist films of 
varying thickness (4.5 - 225 µm) were first formed on a glass substrate and incubated in 
water for 24 h. All films, regardless of thickness, were released without damage. 
Representative electron micrographs of films with thicknesses of 4.5 µm and 225 µm are 
shown in Figure 2.6A.  To determine whether a mask pattern through which the photoresist 
was exposed with UV light could be faithfully reproduced in the free-standing films, features 
in a variety of shapes and sizes were photopatterned into the 1002F. The 1951 USAF 
Resolution Target was used as a standardized feature target. Figure 2.6B shows replication of 
level 3-3 of the 1951 USAF Resolution Target. Rectangles 247.5 µm long and 49.5 µm wide 
were recreated as rectangular through-holes 248.9 ± 2.9 µm in length and 51.0 ± 3.1 µm in 
width on the film. Areas of this standard mask that were visible to the unaided eye could also 
be fabricated, such as the features 2.5-mm in length (Figure 2.7A), without loss of film 
integrity.  
In addition to using the 1951 USAF Resolution Target, other masks, custom-designed 
in the lab, were tested. Faithful replication of the mask pattern was observed for a variety of 
designs ranging in dimensions from 645 to 25 µm in 50-µm thick films exposed to a UV 
dose of 350 mJ / cm
2
.  For example, mask circles (75 µm diameter) yielded circular through-
holes on the film of diameter 74.3 ± 2.5 µm (mean ± standard deviation) (Figure 2.1B). Mask 
spirals with a 645 µm in height and a 42 µm line width were reproduced in the film as spirals 
644.8 ± 3.0 µm in height and 42.6 ± 1.7 µm wide (Figure 2.6B). Mask squares of either 25 or 
250 µm to a side yielded square film holes of dimensions 24.4 ± 1.4 µm and 250.1 ± 3.2 µm 
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on a side, respectively (Figure 2.6C). The smallest through-hole that could be reliably 
fabricated into films 50 µm thick was 10.1 ± 0.6 µm in diameter, using a mask with circles 
10-µm in diameter (Figure 2.7C). The smallest through-hole that could be reliably fabricated 
overall was 5.1 ± 0.5 µm in diameter, fabricated in a film 4.5 µm-thick film using a mask 
with 5-µm circles (Figure 2.6C, Table 1.1).  
 The maximum ratio for the film thickness-to-hole width (aspect ratio) that could be 
fabricated in a freestanding film was also measured. The 1951 USAF Resolution Target was 
again used as a standard mask. Features with an aspect ratio of 6:1 were easily formed when 
fabricating rectangular holes into the film (Figure 2.6D). Using custom masks, the maximal 
aspect ratio for both circular and square features was shown to be 4.5:1 (Figure 2.7C-D). By 
comparison, we have previously fabricated freestanding 1002F micropillars at an aspect ratio 
of 4:1. A higher resolution mask and alignment system may further enhance the aspect ratio 
and resolution. 
2.3.4 Fabrication of multilayered, micropatterned freestanding 1002F films 
 The potential to generate photoresist films with multiple layers, each carrying a 
different pattern of features, was explored. An initial layer of 1002F photoresist was 
photopatterned onto a glass slide. After hard-baking and plasma treatment, a second layer of 
1002F was then spin-coated over the initial layer, exposed through a different mask and then 
processed as for the first layer of resist. As an example, a two-layer film was fabricated in 
which the first layer (5-µm thick) possessed circular pores 5 µm in diameter with a 10 μm 
spacing (edge-to-edge). The second layer (50-μm thick) possessed circular wells 75 µm in 
diameter with a 25-µm spacing (Figure 2.6E). All of these multilayered films (n = 8) were 
released from the substrate without damage after a 24-h incubation in water. The resulting 
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array of wells with porous bottoms is termed a microstrainer. Figure 2.6E shows scanning 
electron micrographs of released microstrainers as imaged from below (left panel) and above 
(right panel) the microwell layer, showing the pore layer and the overlying microwell pattern. 
Because of how the microwell walls attach to the underlying pore layer, this type of 
fabrication may have potential in stabilizing films containing pores with small (< 10 µm) 
diameters. Since pores this small require lower doses of UV light in order to avoid 
overexposure from diffraction effects, films with smaller pores can sometimes detach from 
the fabrication substrate during development, likely due to dissolution of thin monomer 
layers lying just above the substrate that were not adequately exposed. By creating overlying 
“wells” with relatively large diameters (on the order of 200-500 µm), large areas of pores 
with small diameters can be created, using the overlying well walls to enhance their stability 
and prevent detachment of the entire film from the substrate. Aside from this fabrication 
potential, microstrainer arrays have the potential for such uses as directed chemotaxis assays 
of individual cells, and in isolating and arraying single cells using gravity-driven flow 
through the porous well base for the subsequent analysis and tracking of cell behavior. 
 The latter application was utilized in a proof-of-principle test of AT1 culture. Primary 
rat AT2 cells, which are known to spread and assume an AT1-like morphology after several 
days in culture, were seeded onto microstrainers with wells 75 um in diameter featuring 
pores 5.0 um in diameter. Cells were seeded at low density increase the probability of 
seeding only a single cell per well. After 5 d in culture, minimal spreading was observed by 
these cells, suggesting an aversion to the relatively large pore size (Figure 2.8). 
The practical difficulty in fabricating through-holes in 1002F smaller than 5.0 µm 
presents an issue for the further development of 1002F microstrainers for use in growing 
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primary AT1 or other respiratory epithelia under ALI conditions. Anecdotal evidence 
suggests that primary cells fail to properly differentiate when grown on commercially-
available supports with pores 3.0 um in diameter; cells grown on supports with pores 0.4 um 
in diameter were consistently observed to achieve a higher degree of differentiation and 
polarization.
57
 Therefore, given the difficulty of fabricating pores on the order of 5.0 um, and 
the apparent need for primary respiratory epithelia to be grown on supports with pores 
400nm or smaller, other approaches will likely have to be pursued for generating a permeable 
layer. Microstrainers will, however, continue to present potential for growing other cell 
types. 
2.3.5 1002F films as re-usable stencils for substrate patterning 
Stencils for metal sputtering are traditionally made of stainless steel, PDMS, or 
parylene. However these materials generally possess one or more of the following 
weaknesses: high cost, complex fabrication, or mechanical instability.
7, 55, 58
  To determine 
whether micropatterned 1002F films might be employed as low-cost, re-usable stencils for 
materials deposition onto a variety of surfaces, 1002F films were fabricated with an array of 
75-µm holes. The films were released and then placed onto the substrate (glass or PDMS) to 
be coated with a metal pattern (Figure 2.9). A 20 nm-thick layer of Au:Pd mixture was then 
sputtered onto the photoresist-substrate assembly. The diameter of the metal dots patterned 
onto the substrate was 75.2 ± 3.3 µm for the glass substrate and 74.1 ± 4.2 µm for the PDMS 
substrate. Thus the 1002F stencil pattern was faithfully replicated onto the substrates. 
Furthermore the 1002F stencil was easily separated from the substrates after each use and 
could be re-used (Figure 2.10). The stencil pattern was reused up to 8 times (the greatest 
number tested) yielding a patterned spot diameter of 76.3 ± 1.9 µm. In these experiments, no 
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mechanical disruption or tearing of films was observed. Compliant membranes composed of 
SiN, thin single-crystal Si, or a trilayer of metal, photoresist, and anti-reflective coating have 
previously been used for stenciling applications.
45-47
 While resolutions as low as 1 µm could 
be achieved with these films, freestanding photoresist films are easier to fabricate and 
release. 
Additionally, released films were used as stencils for patterned deposition of protein 
onto solid supports. Application of a 50 µg/mL solution of rhodamine B-conjugated BSA to 
micropatterned 1002F films atop solid surfaces yielded spatially-specific adsorption of 
protein. This scheme was used to achieve directed protein adsorption in patterns that 
faithfully replicated the mask pattern on the glass substrate on which the 1002F film was 
fabricated (Figure 2.11A). Once released, the film could be again used for protein patterning 
by manually bonding onto PDMS substrates or thermobonding at 95
o
C onto other glass or 
polystyrene substrates. Excellent replication of the mask pattern was observed for protein 
deposition onto PDMS surfaces (Figure 2.11B), likely due to the good conformal adhesion 
PDMS offers to overlying substrates. The mask pattern was reproduced less faithfully on 
subsequent glass and polystyrene substrates (Figure 2.11C-D), likely due to inconsistencies 
in the thermobonding process needed to ensure that protein solution did not undercut the 
through-hole array in the stencil. However, further optimization of the thermobonding 
process would likely improve this application. Of note, this protein patterning method 
requires no modifications to substrate surface chemistry or use of exogenous crosslinker 
molecules. 
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2.3.6 1002F films to address a single cell within a monolayer of cells 
Films (25 mm x 25 mm x 20 μm, ℓ x w x h) with a single through-hole, 10 µm in 
diameter, were fabricated and released. A fluid reservoir was attached on either side of the 
film and H1299 cells were cultured to confluency on one side of the film. Media containing 
calcein AM dye was supplied to the compartment lacking the cells. Only the cell spanning 
the single pore should have access to the calcein AM-containing compartment. The 
nonfluorescent, membrane-permeant calcein AM is rapidly metabolized within cells to the 
fluorescent, membrane-impermeant dye calcein. Thus, living cells exposed to calcein AM 
become brightly fluorescent as the dye is metabolized and trapped within their cytosol. 
Fluorescence images of the cell-covered film demonstrated a single H1299 cell that was 
fluorescent (Figure 2.12). This cell was also observed to span the 10-µm pore. All 
surrounding cells remained nonfluorescent and so did not have access to the fluid in the 
opposite compartment. The ability to easily micropattern photoresist films with discrete 
through-holes small enough for a single cell to span is an important advantage of 1002F films 
relative to PDMS and parylene films, and to commercially-available microporous 
membranes for cell culture. By growing cells atop a freestanding film with a single through-
hole, we are able to show the delivery of an exogenous agent (here, the cytoplasmic dye 
calcein AM) to a single cell within a contiguous monolayer. 
Contemporary methods of achieving this would rely on either micropipette injection 
of the single cell or on a single-cell microelectroporator. Both of these methods suffer from 
the drawbacks of having to mechanically or electrophoretically puncture a cell membrane in 
order to load it with the compound of choice, actions that might alter the cell physiology or 
even destroy the cell. Single-pore 1002F films, by contrast, avoid the need for such harsh 
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methods and do so without the need for any additional equipment. The main drawback to 
single-pore 1002F films in relation to microinjection or electroporation, however, is an 
inability to choose a particular single cell to be loaded: the cell that will be loaded is by 
definition the cell spanning the pore, and no other. 
Nonetheless, 1002F films fabricated in this manner offer potential for such 
applications as enabling customizable study of the permeability of a single cell – even when 
a cell is part of a contiguous monolayer – to exogenous molecules (drugs, hormones, etc.) or 
for observing the permeation of a supplied agent through a monolayer through gap junctions 
in adjacent cells.  
 
2.4 Conclusions 
The photoresist 1002F can be micropatterned with good replication of a master using 
photolithography and released without damage from the fabrication substrate in a matter of 
hours, all without the need for an underlying sacrificial layer. Freestanding films have 
previously been made using PDMS and parylene. PDMS films are mechanically fragile and 
the fabrication of through-holes is technically difficult. Parylene films have high 
autofluorescence and require complex, multi-step fabrication schemes. By contrast, 1002F 
photoresist films are mechanically resilient, have low autofluorescence, require only basic 
UV photolithography to micropattern, and can be made with through-holes with dimensions 
much smaller than those of PDMS (~35 µm limit).
7
 Freestanding photoresist films can be 
used as stencils for material deposition, as patterned supports for cell culture, and as 
platforms to interrogate single cells within a monolayer. Thus, freestanding photoresist films 
have potential in future chemical and biological applications and particularly as lab-on-a-foil 
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devices. For the particular use of culturing primary AT1 cells, 1002F microstrainers are 
impractical. However, released films of micropatterned 1002F hold outstanding potential in 
forming the overall structure of freestanding microwell arrays in which to grow primary AT1 
cells, provided they can be co-fabricated and released with another material that can act as a 
permeable layer. 
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2.5 Figures and Tables 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Fabrication and release of photoresist thin films. (A) Schematic illustration of 
fabrication and release protocol: atop a clean glass substrate (i) a layer of negative photoresist 
monomer is spin-coated (ii). After exposure to UV light through a chrome mask (iii), the film is 
developed to remove unpolymerized monomer (iv). The patterned film is immersed in an aqueous 
solution (v) to reduce film adhesion to the glass substrate (vi). The intact film can be removed 
from the substrate and dried (vii). (B) Macroscopic (top row), brightfield optical (middle row) and 
SEM (bottom row) images of a 50 µm-thick film of 1002F photoresist (dimensions 25 mm x 25 
mm) with an array of 10
4
 circular wells (75 µm diameter)  before (left column) and after (right 
column) release in deionized water. Scale bars: 25 mm (top row), 75 µm (middle and bottom 
rows). 
83 
 
 
 
Figure 2.2. Removal of 1002F films with various solvents. Images of 25 mm x 25 mm films 
of 1002F photoresist (50 μm thick) with an array of 104 circular wells 75 μm in diameter 
after removal from glass using (A) acetone, (B) 75% (v/v) ethanol, (C) deionized water, and 
(D) a 1% (w/v) detergent solution. Note the distortion in the films removed by acetone or 
ethanol, compared to the intact, even films removed with aqueous solutions. Scale bars: 25 
mm. 
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Figure 2.3. Removal of 1002F films from fabrication substrate. (A) After soaking in 
deionized water for a sufficient length of time, films of micropatterned 1002F can be 
removed by applying a razor blade at the film corner and then gently lifting with laboratory 
forceps. (B) The resulting film is flat and undamaged. (C) If the soaking time is insufficient, 
films can still be removed from the substrate, but may be damaged in the removal process, 
leading to the introduction of “shear” lines (noted by the white arrows) in the films. These 
“shear” lines are permanent bends in the film and prevent the film from lying flat. Scale bars: 
25 mm. 
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Figure 2.4. Tensile testing of freestanding, released 1002F films. Dogbone-shaped, 
freestanding 1002F films were subjected to tensile testing. (A) Image time series of a 
dogbone film undergoing testing at indicated times. Yellow arrow indicates linear break in 
the film just after mechanical failure at 80.9 s. Scale bars: 3 mm.  (B) Time course load 
applied to film in (A) for calculation of its ultimate tensile strength. (C) Elastic region stress-
strain plot for film tested in (A) for determination of the film’s Young’s Modulus. Multiple 
(n=4) films were tested in this fashion to obtain mean values for the Young’s Modulus and 
ultimate tensile stress. 
 
86 
 
 
 
Figure 2.5. Flexibility of freestanding 1002F films. Freestanding 1002F photoresist films 
demonstrated flexibility and mechanical resilience. Images above show 25 mm x 25 mm 
1002F films 50 µm thick, patterned with an array of 10
4
 circular wells 75 μm in diameter, 
released from the fabrication substrate. Films would readily lie flat (A) but could be 
manipulated (B) without damage to the film. The films returned to their original flat 
orientation after manipulation. 
 
  
87 
 
 
Figure 2.6. Fabrication versatility of photoresist films. 1002F films can be fabricated with a 
variety of thicknesses (A), through-hole shapes (B), and through-holes sizes (C). The film in 
(D) demonstrates an aspect ratio of 6:1. (E) Films with multiple layers each carrying a 
different pattern could be fabricated. Scale bars (left to right, top to bottom): 20, 200, 275, 
625, 15, 250, 250, 25, 20, 50 µm. 
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Figure 2.7. Formation of high-aspect ratio through-holes in 1002F photoresist films. 1002F 
photoresist films could be fabricated with through-holes with aspect ratios as high as 6:1 for 
rectangular through-holes and 4.5:1 for square through-holes. (A) A 70 μm-thick film of 
1002F patterned with the 1951 USAF Resolution Target. The film is structurally stable even 
in areas with holes of millimeter size. (B) Scanning electron micrograph of the film shown in 
(A) illustrating the smallest size trench that was resolved (level 5-4, 11.0 μm in width), an 
aspect ratio of 6.36 : 1. (C) A 45 μm-thick film of 1002F is shown with through-holes 10 μm 
in diameter. (D) A 100 µm-thick film of 1002F is shown with through-holes 25 µm to a side, 
illustrating an aspect ratio of 4:1. Scale bars: 25mm, 100 µm, 30 µm, 100 µm. 
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Figure 2.8. Seeding of AT1-like cells into microstrainers. Primary AT2 cells were seeded 
onto microstrainers with wells 75 µm in diameter featuring pores 5.0 µm in diameter. Cells 
were seeded at low density increase the probability of seeding only a single cell per well. 
Wells from two regions of the film are shown. Scale bars: 50 µm. 
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Figure 2.9. Use of 1002F film as a stencil. Glass (top panels) and PDMS (bottom panels) 
were patterned with Au:Pd (20-nm thick layer) through a 1002F stencil. Macroscopic images 
of the sputtered substrates are shown in the left column (scale bars, 200 µm), while 
brightfield microscopic images are displayed in the right column. The macroscopic film is 25 
x 25 mm. 
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Figure 2.10. Application of photoresist thin films as inexpensive, re-usable stencils for metal 
deposition. (A) A glass substrate (25 mm x 25 mm, 50-μm thick) was sputtered with an array 
of Au:Pd circles (20 nm thick, 75 μm diameter) using a 1002F stencil. (B) Re-use of the 
same 1002F stencil to create a second Au:Pd-patterned glass slide. Scale bars: 250 µm. 
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Figure 2.11. Protein surface micropatterning using freestanding microarray 1002F films as 
stencils. 1002F arrays with 75 µm-diameter microwells and a solution of rhodamine B-
conjugated BSA (50 µg/mL) were used to micropattern BSA onto solid supports. An 
unreleased array was first used to micropattern BSA onto the glass fabrication substrate (A), 
after which the film was released. The film was subsequently bonded to PDMS (B) or other 
glass (C) or polystyrene (D) supports and for protein micropatterning on these surfaces. Scale 
bars: 150 µm. 
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Figure 2.12. 1002F films for loading exogenous molecules into single cells in a monolayer. 
(A) Schematic illustration of fabrication, cell seeding, and cell staining: a film of 1002F 
photoresist with a single through-hole, 10 µm in diameter, is fabricated and released (i-v). 
H1299 cells were seeded onto the film and allowed to grow to confluency, at which time 
media containing 10 µM calcein AM dye was supplied to the lower compartment in order to 
load only the cell spanning the through-hole (vi). The film was then imaged at the site of the 
pore under brightfield and epifluorescence conditions(vii). (B) Images of the 1002F film with 
a single through-hole. SEM micrograph shows the location of the single through-hole; 
brightfield micrograph shows a confluent layer of H1299 cells; fluorescence micrograph 
shows a single cell spanning the through-hole that has been loaded with the calcein dye; 
brightfield and fluorescence images have been merged to illustrate the single fluorescent cell 
in the monolayer. 
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Table 2.1. Process parameters for 1002F photoresist films 
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Table 2.2. Removal of 1002F films by immersion in water 
    Time (h) Undamaged (%)
a
 Damaged (%)
a
 Non-removable (%)
a
 
1 7 ± 12* 20 ± 34 73 ± 31 
2 40 ± 17 60 ± 17 0 ± 0 
4 87 ± 12 13 ± 12 0 ± 0 
8 93 ± 12 6 ± 12 0 ± 0 
12 100 ± 0 0 ± 0 0 ± 0 
a
Average ± standard deviation (n = 3 independent trials with 20 films/trial) 
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Table 2.3. Mechanical properties of 1002F films 
Replicate 
Young's Modulus 
(GPa) 
Ultimate Tensile 
Stress (MPa) 
% elongation 
1 1.53 56.8 4.36 
2 1.12 51.1 5.45 
3 1.50 57.5 5.10 
4 1.56 52.7 5.31 
Mean 1.43 54.5 5.05 
Std. Dev. 0.21 0.31 0.48 
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Chapter 3: Co-fabrication of 1002F and chitosan for freestanding 
films of permeable-bottomed microwell arrays 
 
3.1 Introduction 
3.1.1 General considerations 
 As demonstrated in Chapter 2, films of micropatterned 1002F can be reliably 
micropatterned and released from the fabrication substrate to give a freestanding film. 
However, when seeded into microstrainers patterned with 5.0 µm pores, AT2 cells failed to 
transdifferentiate and assume an AT1-like morphology, a trait they exhibit on certain other 
surfaces when seeded at low-density. Therefore, a different approach is needed for creating a 
permeable bottom to the microwell onto which primary AT1 cells are to be seeded and 
grown under ALI conditions. This chapter presents a method to co-fabricate a micropatterned 
and freestanding 1002F photoresist film with a film of the hydrogel chitosan to create a 
freestanding array of permeable, hydrogel-bottomed microwells. In addition to its potential 
for growing cells under an ALI, a microwell platform that incorporates a permeable support 
presents an additional utility: the analysis of cellular heterogeneity. 
3.1.2 Analysis of cellular heterogeneity 
Heterogeneity among the various cells in a biological system is emerging as an 
important subject area of biomedical research, with applications in cancer biology, 
immunology, stem cell biology and regenerative medicine.
1-8
. The end goal of such
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studies is to translate data describing biochemical or genetic differences between cells, even 
cells with similar physiologic roles and lineages, into models that explain how those 
differences affect the overall cellular phenotype and function. In order to detect differences 
between cells in a representative population, the analytical method must easily identify and 
differentiate between physically similar but nonetheless biochemically different cells within a 
population. If the analytical method lacks sufficient power to achieve this, however, then the 
cells must be separated to a degree that differences can be detected while preserving as much 
of the in vivo physiology as possible.  
While a number of methods are currently available for analyzing cellular 
heterogeneity, limitations in each method exist.
9-11
 Limiting dilution, such as on 384-well 
plates, is a well-established method for the isolation, clonal expansion, and analysis of 
different cells from a population. While this method can be used to isolate even single cells, 
there is significant labor and cost involved in this, resulting in low overall throughput. Flow 
cytometry, another widely used approach, can generate a large amount of data, but is limited 
to a single interrogation step, unless the cells are sorted via the accompanying fluorescence-
activated cell sorting (FACS) technology. Even so, this approach demands that cells be 
dislodged, a preparatory step that can alter the physiology of the cells and possibly induce 
cellular apoptosis, creating the need for large numbers of cells to achieve a sufficient 
recovery of cells.
12-15
 FACS can also lead to cell physiology changes due to the charged 
nature of the sorting apparatus. Furthermore, this approach cannot differentiate between 
individual cells once they have been sorted. While certain high-throughput technologies, 
namely microtiter plates that reduce the number of cells studied per well, have led to 
improved understanding of cellular heterogeneity, very often these platforms simply increase 
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the number of compartments analyzed per unit area and do not offer advances in the ability to 
discriminate between different cells – only different responses from different wells.  
3.1.3 Microfabricated platforms for analyzing cellular heterogeneity 
Microfabricated platforms allow the study of biological systems with unparalleled 
control of the physical and chemical microenvironment to which a cell or group of cells is 
exposed. Such technology permits precise customization of the shape, size, and surface 
chemistry of the area used for cell growth. 
16-19
 By achieving such control, researchers gain 
the ability to interrogate the mechanisms and regulation of fundamental cellular processes 
and to create novel bio-inspired platforms. 
20-24
 
In addition to the approaches described above, some types of microfabricated devices 
have been used to study cellular heterogeneity. Microwell arrays, typically constructed from 
polydimethylsiloxane (PDMS), can be used to array cells at low density into physically 
separate wells. However, biochemical crosstalk (in the form of secreted paracrine signaling 
molecules distributed by the culture media solution over the entire area of cell growth) and 
cell migration from one well to another can lead to confounded data, as readouts from 
different groups of cells are not guaranteed to constitute independent measurements.
11, 25
 
While certain methods, such as overlaying a physical barrier onto microwells seeded with 
cells, can reduce such confounding, cell survival and viability can be compromised over the 
long term as cells consume the small quantities of culture media with which they are 
seeded.
26
 Micropallet or microraft arrays, consisting of a large number of individual pedestal 
elements onto which cells can be seeded, can sometimes prevent physical migration of cells, 
but nonetheless do not eliminate biochemical crosstalk from distributed paracrine signals. 
Additionally, such platforms are ill-suited for nonadherent cells.
11, 27-28
 Droplet microfluidics, 
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another approach for high-throughput cellular analysis, can rapidly assay large numbers of 
isolated cells, but long-term culture of cells in droplets is difficult due to reduced delivery of 
oxygen and nutrients.
11, 29
 In addition, analytical reagents must be pre-loaded into the droplet 
with the cells and subsequent analyses based on data obtained in the initial screening are 
technically difficult to set up.
30
 
Therefore, a platform that allows for user-customized interrogation of discrete 
numbers of cells, grown in a microenvironment tailored to mimic in vivo conditions,  and yet 
isolated so as to improve the independence of measured responses, and yet still arrayed in a 
fashion that permits high-throughput analysis, would be a useful tool for analysis of cellular 
heterogeneity. It was recognized that the most common methods and materials in use in the 
microfabrication field – including soft lithography using polydimethylsiloxane (PDMS), 
photolithography using photoresists, injection molding using cyclic olefin co-polymer, 
among others – grow cells atop impermeable supports.31-34 This led to the hypothesis that by 
incorporating a permable layer into a microwell array, cells could be seeded and then 
physically confined in a permanent or semi-permanent fashion to the wells. The permeable 
layer would not only allow the cells to be maintained in culture long term, but would also 
allow analyses to be performed at times chosen by the user. 
3.1.4 Chitosan 
Chitosan is a cationic polysaccharide composed of D-glucosamine and N-acetyl D-
glucosamine derived from the chemical de-acetylation of chitin that has begun to see 
increased use in a number of biological applications.
35-38
 Many of the chemical and physical 
properties of chitosan – including the tensile strength, moisture absorption, and degradability 
– have been well characterized.39-49 Of note, the molecular structure of chitosan features a 
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free amine group in those saccharide units that have been deacetylated. This free amine 
group not only is responsible for chitosan’s pH-dependent solubility, but also allows the 
conjugation of exogenous molecules to the polysaccharide chain.
37, 50-51
 Chitosan has been 
shown to be biocompatible to a number of cell types, including endothelial, hepatic, and 
peripheral nerve cells and orthopedic tissues.
52-56
 Chitosan can be manipulated to form 
hydrogels, porous scaffolds, and dry films.
38, 47, 57
 Of particular interest were studies showing 
that drugs could freely diffuse across chitosan layers, suggesting that chitosan capsules and 
films are permeable at the nanoscale and therefore giving chitosan a potential role in drug 
and gene delivery systems.
58-62
 A key feature of chitosan employed by some of these studies 
is the amine group, which protonates in a pH-dependent manner and induces swelling of the 
chitosan matrix, increasing its network pore size and permitting diffusion of drugs entrapped 
within. Recently, a microfluidic setup was utilized for the in situ generation of a semi-
permeable chitosan microscaffold for the formation of bacterial biofilms.
63-64
 Flowing liquid 
streams of chitosan (dissolved in pH 5 solution) and buffer (pH 10) were merged in a 
microfluidic channel, leading to precipitation of chitosan and the interface that created a 
hydrogel window at the convergence of the two fluid streams. Analysis of the film showed 
that it was semi-permeable, and subsequent modification with alginate allowed the deposition 
and culture of bacterial biofilms.  
Due to its biocompatibility and pH-dependent solubility and swelling, chitosan 
presented potential for incorporation into a hybrid freestanding film with 1002F. Notably, 
pH-dependent protonation of the chitosan amine group allows tailoring of chitosan solution 
densities to viscosities that permit spin coating. Thus, the ability to co-fabricate chitosan and 
UV-micropatterned photoresist films to form a hybrid platform was investigated. 
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3.1.5 Overview 
This chapter presents a method to co-fabricate a micropatterned and freestanding 
1002F photoresist film with a film of the hydrogel chitosan to create a freestanding array of 
hydrogel-bottomed microwells. These films are shown to have optical properties ideal for 
microscopy applications, and the chitosan layers are shown to be semi-permeable with a 
molecular exclusion of 16.2 ± 6.3 kDa. By seeding cells into the microwells, overlaying a 
layer of inert mineral oil, and supplying media on the bottom surface, cells could be 
physically isolated from one another but maintained in culture for at least 5 days. Use of this 
method, which reduces confounding biochemical crosstalk between cells and eliminates 
mixing of different clonal populations, will enable high-throughput studies of cellular 
heterogeneity with increased ability to customize dynamic interrogations compared to 
currently available technologies. 
 
3.2 Experimental design 
3.2.1 Materials 
Chitosan (medium molecular weight), γ-Butyrolactone (GBL), photoresist developer 
(propylene glycol methyl ether acetate, PGMEA), toluidine blue, FITC-dextrans (average 
molecular weights 4, 10, 20, 40, and 70 kDa), and mineral oil were purchased from Sigma-
Aldrich (St. Louis, MO). EPON resin 1002F photoresist was obtained from Miller-
Stephenson (Sylmar, CA). UVI-6976 photoinitiator (triarylsulfonium hexafluoroantimonate 
salts in propylene carbonate) was purchased from Dow Chemical (Torrance, CA). 
Polydimethylsiloxane (PDMS, Sylgard 184 elastomer kit) was obtained from Dow Corning 
(Midland, MI). Sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate (sulfo-
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SMCC) was obtained from Thermo Scientific (Rockford, IL). Chrome photolithography 
masks were designed in-house using TurboCAD software and printed by FineLine Imaging 
(Boulder, CO). RPMI 1640 medium, fetal bovine serum (FBS), penicillin/streptomycin, 
tetramethylrhodamine-conjugated BSA, and calcein AM red-orange were obtained from Life 
Technologies (Grand Island, NY). Wild type Ba/F3 cells were obtained from American Type 
Culture Collection (Manassas, VA). Transwell
™
 polystyrene cassettes, 12- and 24-mm in 
diameter and hereafter referred to as “cassettes,” were kind gifts from Dr. Brian Button at the 
Univ. of North Carolina School of Medicine. 
3.2.2 Co-fabrication of freestanding 1002F:chitosan films 
Medium molecular weight chitosan was dissolved in 0.5% (w/w) acetic acid to a 
concentration of 2% (w/w). Dry films of chitosan were obtained by spin coating dissolved 
chitosan onto pre-cleaned, air plasma oxidized glass slides and baked at 95
o
C for 1 h. 
Following a 2-min air plasma treatment, micropatterned films of 1002F negative photoresist 
were fabricated atop the dry chitosan films as described previously.
65
 Briefly, EPON resin 
1002F negative photoresist, dissolved in GBL and mixed with UVI-6076 photoinitiator, was 
spin-coated atop the dry chitosan films to a desired thickness of 50 m and soft-baked at 
95
o
C to remove organic solvent. After exposure to UV light through a patterned chrome 
photomask, the hybrid film was given a post-exposure bake, first at 95
o
C and then at 120
o
C, 
and then developed in PGMEA to remove unpolymerized photoresist monomer. The 
resulting micropatterned hybrid film was hard-baked, first at 95
o
C and then at 120
o
C, to 
solidify the photoresist layer. After affixing a polystyrene cassette using a thin PDMS mortar 
layer, the chitosan layer was neutralized and the hybrid film released via incubation in a 
0.1% (w/w) aqueous solution of sodium hydroxide. Precise process conditions for hybrid 
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films with a photoresist layer 50 m thick are identical to those previously reported, with the 
exception that the hybrid films were incubated in 0.1% (w/w) NaOH for 48 h before 
release.
65
 Immediately after release, the hybrid films were gently washed with deionized 
water and the chitosan hydrogel layer was rehydrated by immersion in phosphate buffered 
saline (PBS) pH 7.4 for at least 12 hours before use. 
3.2.3 Imaging 
Hybrid films were imaged using an FEI Quanta 200 FEG scanning electron 
microscope (SEM) with a shottky field emission gun, operated under low-vacuum conditions 
(0.38 torr) (Chapel Hill Analytical and Nanofabrication Laboratory (CHANL)). High-
resolution images of the chitosan layer at the bottom of microwells in critical point-dried 
hybrid films were also obtained using a Hitachi S-4700 Cold Cathode Field Emission 
scanning electron microscope (CHANL). A Nikon Eclipse TE2000-U inverted fluorescence 
microscope was used to image films during diffusion and protein conjugation experiments 
and for all cellular analyses. Brightfield and fluorescence micrographs recorded with a 
cooled CCD camera (Photometrix Cool Snap fx, Roper Scientific, Tucson, AZ) controlled by 
NIS Elements software (Nikon, Melville, NY). Fluorescence micrographs were analyzed 
using Image J (NIH, Bethesda, MD). 
3.2.4 Multi-layer fabrication 
 Multi-layer 1002F:chitosan:1002F sandwich films were fabricated using a layer-by-
layer approach. First, 1002F photoresist was spin-coated to a thickness of 25 µm onto a clean 
glass slide. After UV exposure and post-exposure bake (see above section 3.2.1), the film 
was spin coated with chitosan hydrogel without developing away unpolymerized 1002F 
monomer. After a brief bake to remove chitosan aqueous solvent, the film was again spin 
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coated with 1002F to a thickness of 50 µm, soft-baked, and UV exposed through a hexagonal 
photomask 0.38 cm to a side. After a post-exposure bake, the 3-layer sandwich film was 
incubated overnight in 0.1% (w/w) NaOH, and then gently released using laboratory forceps. 
The film was then subjected to a two-sided development to remove unpolymerized 
photoresist monomer. The sandwich films were then baked to remove lingering solvent and 
imaged by scanning electron microscopy. 
3.2.5 Measurement of chitosan dry film thickness 
The thicknesses of dry chitosan films were determined via profilometry. After spin-
coating chitosan solution onto clean glass slides and baking at 95
o
C for 1 h, dry films were 
scored with a razor to produce trenches in the dry films. Film thickness was determined by 
using a profilometer (KLA-Tencor P-15 Profilometer, KLA-Tencor, San Jose, CA) to 
measure the height difference between the dry film surface and the glass surface in the 
trenches. 
3.2.6 Measurement of 1002F:chitosan film optical properties 
Glass coverslips were deposited into the wells of a 6-well polystyrene plate, and 
background absorbance spectra from 300-800 nm were obtained using a SpectraMax M5 
microplate reader (Molecular Devices, Sunnyvale, CA). Dry films of chitosan were prepared 
above the same coverslips by spin-coating chitosan solution at 500 rpm and baking for 1 h at 
95
o
C. Coverslips were then neutralized in 0.1% (w/w) NaOH for 30 min and rehydrated in 
1X PBS at pH 7.4 for 1 h. Absorbance spectra from 300-800 nm for the dry films were 
obtained by measuring absorbance for the spin-coated coverslips and subtracting out the 
absorbance values obtained before spin coating. Six replicates were tested and replicates 
were averaged to give an average absorbance spectrum. 
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Measurement of fluorescence values for chitosan co-fabricated with 1002F was 
achieved using films fabricated as described above using chitosan spin coated at 500 rpm. 
After the baking step, either 1002F or the negative photoresist SU-8 was then spin-coated to 
a thickness of 50 µm, and UV-micropatterned with 100 µm-diameter wells as described 
above. After the fabrication process was complete, films were imaged using an inverted 
epifluorescence microscope equipped with UV (ex 340-380 nm / em 435-485 nm), GFP (ex 
465-495 nm / em 515-555 nm), Texas Red (ex 522-592 nm / em 584-664 nm), and Cy5 (ex 
588-668 nm / em 652-732 nm) Nikon filter sets. Quantitative fluorescence of the chitosan 
and photoresist layers in each wavelength set was measured using ImageJ to calculate the 
mean pixel intensity in the microwell spaces (for chitosan) and in the wall spaces (for the 
photoresists). Two films were measured for each of the two photoresists, and chitosan layers 
in all four hybrid films were measured. Two regions per film were analyzed in each 
wavelength set. 
3.2.7 Diffusion testing 
1002F:chitosan hybrid films micropatterned with 900 100-m diameter wells were 
fabricated, affixed to 12-mm diameter polystyrene cassettes, oxidized for 2 min with an air 
plasma, and released as described above. The films where then placed into the macro-scale 
wells of a 12-well plate, suspended by the cassette approximately 1 mm from the well 
bottom. PBS was supplied into the cassette (upper) and the dish (lower) compartments at 
volumes (0.5 and 1.5 mL, respectively) recommended by the plate manufacturer to give an 
equal height between the two compartments. Either toluidine blue dye (MW 270 Da) or one 
of several FITC-dextrans (average molecular weights 4, 10, 20, and 40 kDa) was supplied 
into the upper fluid compartment as bolus solutions in PBS to a final concentration of either 
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0.01% (w/w)(toluidine blue) or 200 µg/mL (FITC-dextrans). Rhodamine B-conjugate 
dextran (70 kDa) at a concentration of 200 µg/mL was supplied as a high-MW, slow-transit 
negative control across the several experiments. Plates were covered to prevent evaporation, 
and incubated at room temperature. At regular time points, 60 and 15 L samples were taken 
from both the bottom and top (respectively) fluid compartments for analysis using a 
SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale, CA). Seven different 
devices, representing four different fabrication batches of films, were tested in this manner. 
Commercially-available track-etch membranes with pores 400 nm in diameter (Corning Life 
Sciences, Tewksbury MA) was also tested as positive controls for dye diffusion. Toluidine 
blue concentrations were measured via absorbance at 633 nm, while FITC-dextran 
concentrations were measured via fluorescence (excitation 490 nm / emission 520 nm). 
Rhodamine B-dextran fluorescence was measured as well (excitation 545 nm / emission 580 
nm). 
Additional 1002F:chitosan hybrid films were micropatterned, affixed to polystyrene 
cassettes, and released as described above. The cassette (upper) compartment was then 
supplied with a solution containing 200 g/mL of both rhodamine B-dextran (a 70 kDa, 
negative diffusion control) and of one of several FITC-dextrans (molecular weights 10, 20, or 
40 kDa). After incubating for 1 min, the dextran mixture was carefully aspirated off so as to 
leave droplets of the dextran solution remaining in the hydrogel-bottomed microwells. After 
depositing 500 L of mineral oil into the cassette compartment to cover the microwell array 
and prevent evaporation, the cassette was placed into a well in a 12-well plate containing 1.5 
mL of 1X PBS. At regular time intervals, fluorescence images of the microwell array were 
obtained with an inverted fluorescence microscope. Fluorescence micrographs were analyzed 
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using Image J to generate quantitative fluorescence values for each microwell. Hybrid films 
that had not been released and whose microwells were thus blind-ended were used as 
negative diffusion controls to correct for any photobleaching. Fluorescence values, averaged 
for each microwell, were used to construct a time course of dextran diffusion across the 
chitosan membrane and out of the well. Fluorescence of the negative control solute 
rhodamine B-conjugated dextran 70 kDa was measured independently of FITC-dextran 
fluorescence; microwells exhibiting diffusion of this negative control solute were counted as 
artifacts. Six microwell arrays were used for each molecular weight of FITC-dextran tested. 
3.2.8 Calculation of diffusivity constant for chitosan membranes in 1002F:chitosan 
hybrid films 
 
Calculation of the diffusion constant (also known as the diffusivity) was achieved by 
modeling the plate wells in which the 1002F:chitosan hybrid films were incubated during 
each diffusion experiment as a closed, two-compartment system, separated by a membrane of 
fixed thickness h and permeable area A. similar to a model described by Lee et al.
66
 The 
upper compartment, assigned the arbitrary designation “1” in this model, has a fixed volume 
V1 of 0.5 mL and serves as the “source” of the diffusing solute. The lower compartment 
(designated “2”), whose volume V2 is fixed at 1.5 mL of fluid, serves as the “sink” 
compartment into which the solute diffuses via movement through and across the chitosan 
membrane of fixed thickness h and area A in the hybrid film. Volumes of each compartment 
are based on the volumes of fluid supplied to them at the initiation of the diffusion 
experiment. The source compartment is supplied with diffusing solute to an initial 
concentration of C1
o 
, while the sink compartment starting concentration, C2
o 
, is assumed to 
be zero. The thickness of the membrane in the model, termed h, is the thickness of the 
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chitosan layer only, as diffusion is assumed to only occur through the chitosan layer, and not 
the 1002F layer, an assumption supported by early experiments (data not shown). 
This diffusion model has two characteristics: first, compartments have finite and fixed 
volumes; and second, there is a finite amount of solute that is supplied to the source 
compartment. Hence, the amount of solute in the total system is fixed. 
Furthermore, a number of assumptions are made regarding this system. The first 
assumption is that diffusion of solute through and across the membrane takes more time than 
diffusion of the solute within the liquid in each compartment (i.e. that the diffusion 
coefficient for the solute in the liquid is far greater than that of the coefficient for the same 
solute through the membrane). Hence, solutions in the compartments are assumed to be well-
mixed and thus no concentration gradient exists within either compartment. Second, it is 
assumed that within the membrane itself, any gradient of solute concentration exists only in 
the z-direction (perpendicular to the membrane). Third, quasi-steady state is assumed for the 
membrane, postulating that the time for the solute concentration to stabilize to a linear profile 
in the z-direction is much shorter than the diffusion time through the membrane. Fourth, it is 
assumed that the diffusion coefficient for the solute in the membrane is not a function of its 
concentration. The fifth and final assumption is that there is no accumulation of solute at 
either membrane interface; hence the number of moles that enter the membrane from the 
source interface during any particular time period equals the number of moles that leave the 
membrane at the sink interface. 
Assuming a linear profile for the gradient within the membrane under the quasi-
steady state assumption, the concentration of solute within the membrane in the z-direction 
varies with z and can be written as: 
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Equation 3.1: 
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By applying Fick’s First Law and the equation above to the membrane layer, the flux J can 
be written as: 
Equation 3.2: 
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Because the system is closed, the total number of moles of solute, N is fixed and is: 
Equation 3.3: 
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By combining Equation 3.3 with Equation 3.1, the total number of moles can be re-written 
as: 
Equation 3.4 
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By differentiating both sides with respect to time, the molar velocity is obtained: 
Equation 3.5: 
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By expressing the molar velocity as a product of the molar flux and the area A, and applying 
the assumption about no accumulation of solute at either membrane interface, the molar 
velocity can be described as: 
Equation 3.6: 
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Note that Equation 3.3 can be re-arranged to give either of the following two equations: 
 
Equation 3.7: 
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Equation 3.8: 
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By combining Equation 3.4 above with Equations 3.6 (molar velocity) and 3.2 (Fick’s Law), 
a differential equation for C2 can be obtained: 
Equation 3.9: 
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This derivation introduces a new term, V, where 
Equation 3.10: 
            
Similarly, Equations 3.2, 3.4, and 3.6 can be combined to give a differential equation  for C1: 
Equation 3.11 
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The similarities between the final differential equations for C1 and C2 make sense in 
light of Fick’s First Law, which relates the flux to the first derivative of the concentration. 
Viewed from the sink compartment, the concentration of solute diffusing into the 
compartment begins low and rises rapidly before tapering off; thus, the first derivative of the 
concentration is initially strongly positive and levels off to become weakly positive at later 
time. Similarly, when viewed from the perspective of the source compartment, the 
concentration of solute diffusing out of the compartment begins high and rapidly decreases 
before tapering off as equilibrium is approached; thus, the first derivative of the 
concentration is initially strongly negative and levels off to become weakly negative at later 
time. This transition of the first derivative from a high magnitude (either positive or negative 
in sign) to a lower magnitude (again, either positive or negative in sign) is identical in both 
the source and sink compartments, and thus the differential equations describing the flux will 
appear similar. The only difference between them will therefore be the sign (positive or 
negative), and this is supplied by the direction in which the concentration (C1 or C2) changes. 
Solving the differential equations for C1 or C2 by integration over time gives an 
expression for C1 or C2 that has only one unknown variable, D. Integrating the expression for 
C2 and applying initial conditions gives: 
Equation 3.12: 
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where the term τ (Greek tau, not to be confused with t, for time) is: 
Equation 3.13: 
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Using natural logarithms on Equation 3.12  linearizes it in terms of the time parameter t: 
Equation 3.14: 
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Equation 3.14 allows determination of the diffusion coefficient D, since values for all other 
variables are known: τ and h depend on the membrane parameters, C2
o 
and N are given by the 
experimental setup, and C2 is measured for a certain timepoint t. By plotting the natural 
logarithm value depicted at the right in Equation 3.14 against time adjusted for the tau term 
(e.g. t/tau), the slope of the now-linearized data curve can be used to calculate the diffusion 
coefficient D: 
Equation 3.15: 
      
 
 
 
Application of the above operations to the C1 equations gives an expression similar to 
Equation 3.14: 
Equation 3.16: 
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] 
and a similar plot of the natural logarithm term on the right side of Equation 3.16 against 
t/tau will give Equation 3.15. 
3.2.9 Spatially controlled protein conjugation 
1002F:chitosan hybrid films micropatterned with 100-m diameter wells were 
fabricated, affixed to polystyrene cassettes as described above, and treated with an air plasma 
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for 2 min. Films were patterned with protein via a covalent coupling strategy using the 
reagent sulfo-SMCC. A sulfo-SMCC solution was prepared by dissolving 2 mg of sulfo-
SMCC in 1.5 mL of 50 mM sodium phosphate, pH 7.4. The cassette compartment of the film 
was then supplied with 500 L of the sulfo-SMCC solution and incubated at room 
temperature for 40 minutes. After removing sulfo-SMCC solution and washing three times 
with PBS, activated films were imaged to measure fluorescence background and then 
incubated with 250 L of BSA-tetramethylrhodamine (0.1 mg/mL) for 40 minutes at room 
temperature in the dark. After aspirating away the protein solution and washing three times 
with PBS, films were imaged via fluorescence microscopy and the fluorescence within the 
microwell spaces was quantified. Unactivated 1002F:chitosan films were used as controls, 
and three films were used for each experimental group. 
3.2.10 Isolated clonal expansion and analysis of heterogeneity of cell proliferation in 
entrapped, nonadherent cells 
 
Wild-type Ba/F3 cells were cultured in RPMI 1640 medium supplemented with 
penicillin/streptomycin and 10% fetal bovine serum. 1002F:chitosan hybrid films 
micropatterned with 100-m diameter wells were fabricated, affixed to 12 mm-diameter 
polystyrene cassettes, and released as described above. After ethanol sterilization, films were 
placed into 12-well plates filled in the bottom compartments with RPMI 1640 medium either 
containing or lacking 10% FBS. Ba/F3 cells were deposited into the cassette compartment at 
a density of 1.5 x 10
4
 cells / cm
2
. After 20 minutes, microarrays were inspected via 
brightfield microscopy to confirm that cells had settled into the chitosan-bottomed 
microwells, at which point the media in the cassette (upper) compartment was carefully 
aspirated away and 200 L of filter-sterilized mineral oil was overlaid in order to trap the 
cells in medium droplets in the microwells. Cells were also seeded at the same density into 
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two additional sets of chitosan-bottomed microwell arrays fabricated with a design identical 
to that described above but not released (so as to yield blind-ended microwells). After cell 
seeding, one array set was left to incubate without removing the cell seeding media, while a 
second array set had its media removed and was overlaid with 200 L of sterile mineral oil. 
All arrays were imaged daily with brightfield microscopy to assess cell survival and/or 
proliferation. The number of cells present in each well as manually counted and recorded at 
daily time points.  
3.2.11 Growth of AT1-like cells 
 Primary human AT2 cells were obtained as a gift from Dr. Peter Bove of the Cystic 
Fibrosis Research and Treatment Center at the Univ. of North Carolina School of Medicine. 
Briefly, cells were harvested from human explant lungs obtained with patient consent under a 
protocol approved by the Univ. of North Carolina School of Medicine Institutional Review 
Board via elastase digestion of the distal airspaces as a modification of previously published 
protocols.
67
 After negative immunoselection using magnetic beads to remove contaminating 
erythrocytes and macrophages, AT2 cells were seeded into arrays of chitosan-bottomed 
microwells 75 µm in diameter at a density of 1 x 10
4
 cells per cm
2
. Cells were monitored via 
brightfield microscopy for their ability to spread out and assume an AT1-like morphology. At 
day 9 of culture, cells were stained for 2 h with Hoescht 33342 (1 µg/mL) and calcein AM 
red-orange (10 µM) and imaged by brightfield and fluorescence microscopy. 
3.2.12 Statistical testing 
Unless otherwise stated, all statistical analyses performed utilized the student t-test. 
Statistical significance was defined as p < 0.05. 
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3.3 Results and Discussion 
3.3.1 Co-fabrication of freestanding 1002F:chitosan films 
Freestanding 1002F:chitosan hybrid films were fabricated and micropatterned using 
the strategy depicted in Figure 3.1A. Briefly, the viscous chitosan solution was spin-coated 
onto plasma oxidized glass slides and baked to give dry chitosan films. After a second air 
plasma treatment, 1002F negative photoresist was spin-coated atop the dry chitosan films and 
soft-baked to remove organic solvent. After exposure to UV light through a patterned chrome 
photomask and chemical development to remove unpolymerized photoresist monomer, the 
hybrid films were hard-baked to solidify the photoresist layer. The resulting hybrid films, 
featuring an array of microwells patterned into the 1002F film and bottomed by a layer of 
chitosan, were released from the glass substrate by immersion in dilute aqueous NaOH. By 
affixing a polystyrene cassette and placing into a 6- or 12-well plate the films adopted a setup 
similar to commercially available Transwell™ permeable supports, in which a membrane 
(here, the chitosan layer) separates two compartments: an “upper” compartment that 
interfaced with the photoresist film and the microwells patterned into it, and the “lower” 
compartment that lay beneath the chitosan layer. Figure 3.1B depicts how the addition of the 
cassette established these compartments.   
Scanning electron micrographs of the resulting released hybrid film, shown in Figure 
3.2, illustrated how the thin chitosan layer forms a bottom to the microwells that are 
patterned from the photoresist layer. High-resolution scanning electron micrographs of the 
chitosan layer, shown in Figure 3.2C, revealed a uniform film approximately 400 nm thick 
composed of entangled chitosan polysaccharide chains with tortuous pores of irregular shape 
and diameters on the order of tens of nanometers. Figure 3.2D reveals the chitosan layer to 
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have a pebbled, irregular surface, again showing pores of irregular shape and diameters on 
the orders of tens of nanometers. 
3.3.2 Multi-layer 1002:chitosan:1002F sandwich films 
Early experiments with fabricating 1002F:chitosan hybrid films revealed that, when 
1002F wells >500 µm in diameter were fabricated atop chitosan films, the chitosan had a 
tendency to tear away from the well walls during release and remain on the glass fabrication 
substrate. Predicting that an underlying layer of micropatterned 1002F would enhance the 
structural stability of the chitosan layer when a larger well was patterned above, the ability to 
generate 1002F:chitosan:1002F sandwich films by delaying development of the patterned 
1002F until after the film had been released was assessed. Figure 3.3A illustrates the 
fabrication scheme, in which a layer of 1002F spin coated atop a glass slide was UV-exposed 
and post-exposure baked but a development step to remove unpolymerized monomer was 
withheld. Chitosan hydrogel solution was then spin coated atop this layer. 
Withholding the development step in the fabrication of the lower 1002F layer was 
based on the reasoning that subsequent baking steps would cause evaporation of the chitosan 
aqueous solvent and led to deposition of a thin, 400 nm-thick film of chitosan that would coat 
the microwell walls but neither fill the microwell space nor span it. This prediction was 
confirmed in trials in which a development step was included in the fabrication of the first 
1002F layer. 
After spin coating the chitosan layer and baking to remove its solvent, a second layer 
of 1002F was spin coated atop the dry chitosan film. UV exposure of this film through a 
mask with features of larger or equal, but not smaller, size than the first 1002F layer was 
followed by a post-exposure bake. Again development was withheld. Instead, the 2-layer 
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sandwich film was released after an overnight soaking in dilute NaOH, and unpolymerized 
1002F monomer was removed from both sides of the sandwich film simultaneously by 
immersing in developer. Figure 3.3B shows scanning electron micrographs of the resulting 
sandwich film: the upper panel of micrographs shows the edge of a large hexagonal well 0.38 
cm to a side, inside of which a chitosan layer of submicron thickness was visible. The 
underlying microwell pattern was faintly visible, similar to results shown in Figure 3.2B 
(chitosan-bottomed microwell arrays imaged from the lower compartment revealed the 
microwell pattern). When imaged from the opposite face, the microwell pattern of the first 
1002F layer was clearly visible (Figure 3.2B, lower panel). In future endeavors, it might be 
expected that, due to the multiple baking steps involved after processing of the first 1002F 
layer, the sizes of the features in the lower layer of 1002F are likely to be reduced in 
comparison to the sizes of features in the mask, due to local diffusion of photoacid generator 
in the first 1002F layer. However, careful control of processing conditions can likely 
minimize these effects, which are expected to be less when features of the lower layer are 
larger in size. This application has the potential for generating sandwich films for patterned 
co-culture of two different cell types, one on each side of the chitosan membrane and able to 
be grown in two different patterns. An extension of this concept will be to create sandwich 
films that have the same pattern on both sides of the chitosan membrane using only a single 
mask and UV exposure step. 
3.3.3 Chitosan hydrogel thickness measurements 
Several properties of the chitosan films prepared in this fabrication protocol were 
evaluated. First, the thicknesses of dry films spin-coated at various speeds were measured 
using profilometry. Figure 3.4 shows the thickness of dry films resulting from spin coating 
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chitosan at various speeds, suggesting that varied thicknesses of the chitosan layer (for such 
considerations as mechanical strength) can be achieved simply by varying the spin coating 
speed. Table 3.1 gives the thickness measurements of dry films generated from several spin 
coat speeds. Additional formulations of the chitosan solution with higher or lower 
concentrations of chitosan would be expected to give thicker or thinner films, respectively, 
based on identical spin coat speeds. 
These results show that the thickness of a dry chitosan film fabricated by spin coating 
at the speed typically used in the co-fabrication protocol (2000 rpm) was 349 ± 24 nm. 
Comparison of this thickness to the measured thickness of the chitosan layer in hybrid films 
that had been imaged after being released and rehydrated (see Figure 3.2C) reveals that 
released and rehydrated films are 12.5% thicker than dry films. This increase in thickness is 
likely due to slight osmotic swelling of the chitosan hydrogel layer that occurs in a pH-
dependent manner 
68
. Because the pH of the rehydrating solution is 7.4 (the pH requirement 
of cultured cells, for which these films will be used) and the amine groups on the chitosan 
become neutralized at higher pH (pKa 6.3), hydrogel theory predicts only slight equilibrium 
swelling at this pH, consistent with the results shown here. 
It is worth pointing out that, given the submicron thickness of the alveolar basement 
membrane in vivo, thin hydrogel surfaces such as that of the chitosan layers used in this study 
may offer a more realistic replication of the alveolar basement membrane than commercially- 
available microporous supports used for cell culture, which are typically at least 10 µm 
thick.
69
 This feature of chitosan films may be useful for future studies of AT1 cells. 
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3.3.4 Optical properties 
Because brightfield and especially fluorescence microscopy is anticipated to be a 
chief means of analyzing cells cultured on the 1002F: chitosan hybrid films, the absorption 
and autofluorescence of chitosan films were measured. Absorbance spectra of glass 
coverslips spin coated with chitosan at 500 rpm to a thickness of ~800 µm, shown in Figure 
3.5A, revealed absorbance below 0.02 (>95.5% transmittance) for hydrated chitosan films at 
wavelengths above 400 nm. Because these films were thicker by a factor of ~2 than chitosan 
layers in typically fabricated 1002F:chitosan hybrid films, absorbance of chitosan layers 
fabricated with the typical protocol is likely to be even less. 
Fluorescence measurements of chitosan films ~800 µm in thickness similarly 
revealed that chitosan films had very low autofluorescence, compared to 1002F and 
especially SU-8 photoresists. The green wavelengths had the highest autofluorescence 
values: mean pixel intensity for chitosan films was 63.8 ± 2.6, whereas the 1002F layer (45 
µm thick) had pixel intensities of 840.5 ± 126.6  and the SU-8 layer (45 µm thick) had pixel 
intensities of 4046.3 ± 292.4. Figure 3.5B shows fluorescence values in four different filter 
sets commonly used in fluorescence microscopy for chitosan, 1002F, and SU-8. While there 
are significant differences in thickness between the chitosan and photoresist layers tested, the 
thickness of each layer reflects a typical thickness used in the hybrid photoresist:chitosan 
film, and so provides a useful comparison. Overall, the low absorption and autofluorescence 
of chitosan across the visible wavelengths suggest that microscopy-based methods for 
cellular analysis will be quite compatible with 1002F:chitosan hybrid films. 
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3.3.5 Diffusion testing of micropatterned 1002F: chitosan hybrid films 
In order to determine whether solutes could diffuse across the chitosan layer at the 
bottom of the microwells in the 1002F:chitosan films, the permeability of the chitosan layer 
to small-molecule solute diffusion was first measured. A general diffusion scheme is 
depicted in Figure 3.6A. Freestanding chitosan:1002F hybrid films affixed to polystyrene 
cassettes were placed in a 12-well plate and PBS was supplied to the upper and lower 
compartments. Commercially-available Transwell™ track-etch membranes were used as 
positive controls. Addition of a bolus of concentrated dye to the upper compartment created a 
gradient to drive solute diffusion from the “source” compartment, across the chitosan 
membrane, and into the lower “sink” compartment. 
Toluidine blue dye (MW 270 Da) seeded into the upper compartment was visually 
observed to enter and disperse throughout the lower compartment (Figure 3.6B). Quantitation 
of toluidine blue concentration in the lower compartment over time revealed that after 8 h, 
toluidine blue concentration was 41.5 ± 1.5 % of its later maximal value in wells with 
1002F:chitosan films and 16.3 ± 0.6% of the concentration in the top compartment, whereas 
the concentration in the positive control wells was 51.4 ± 0.1% of its maximal value and 23.8 
± 0.0% of the concentration in the top compartment. By 48 hr, toluidine blue concentration in 
wells with 1002F:chitosan membranes had reached 90.8 ± 3.2% maximal value and 88.9 ± 
1.3% of the top compartment concentration, compared with 90.9 ± 0.9% and 98.2 ± 13.4% 
(respectively) for the positive control. Figure 3.6C illustrates the time course of absolute 
toluidine blue concentration in the lower compartment for 1002F:chitosan membranes and 
the Transwell™ positive control membranes. These data suggest that chitosan membranes 
have comparable permeability to small molecules as membranes with cylindrical track-etch 
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micropores, indicating that the chitosan hydrogel layer remained permeable to small 
molecules after the fabrication process was completed. Employing this same method with a 
high-MW FITC-conjugated dextran (MW 70 kDa) instead of toluidine blue dye, however, 
revealed that after 48 hours of incubation, the concentration of solute in the bottom 
compartment was only 0.2 ± 0.1% of that in the top compartment, compared to a value of 
31.6 ± 2.2% for a positive control. 
Given the possibility that the chitosan layer had a molecular exclusion limit, wherein 
solutes with molecular weights above the limit were unable to diffuse through the chitosan 
film, diffusion of solutes in a range of molecular weights was investigated. Fluorophore-
conjugated dextrans are commercially available in several molecular weights and have been 
used in permeability studies of other membranes.
66, 70
 Using the method described above, 
diffusion of FITC-conjugated dextrans of molecular weights 4, 10, 20, and 40 kDa were 
investigated. Figure 3.7 shows the concentration of each dextran, relative to its theoretical 
equilibrium concentration Ceq, over the course of time. Transwell™ membranes were used as 
positive controls in all experiments. Dextrans with molecular weights 4 and 10 kDa were 
shown to diffuse through chitosan membranes, reaching half-theoretical maximum values by 
48 and 120 hr, respectively (Figure 3.7). Compared to those dextrans, diffusion of dextran 
with MW 20 kDa was greatly reduced, reaching C / Ceq value of only 0.2 after 5 days of 
incubation, and dextran with MW 40 kDa did not exhibit appreciable diffusion at all, 
consistent with earlier data that FITC-dextran with a higher MW of 70 kDa exhibited 
virtually no diffusion across the membrane. In all experiments except the positive controls, 
diffusion of 70 kDa rhodamine B-conjugated dextran was not observed, consistent with 
earlier results. 
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In order to further validate the above data, a method to track and measure molecular 
diffusion in individual wells in an ensemble fashion was devised. Depositing a solution 
containing FITC-conjugated dextran of a given molecular weight into the top compartment 
and then aspirating the solution away was found to cause the film surface to discontinuously 
de-wet, leading to the entrapment of droplets containing fluorescent dextran in the chitosan-
bottomed microwells. Overlay of a layer of mineral oil to prevent water evaporation and 
immediately supplying an aqueous solution to the bottom compartment allowed the entire 
chitosan hydrogel layer and the microwells they bordered to remain hydrated. Via serial 
imaging of the well array, quantitative fluorescence values and hence dye concentration in 
each microwell were obtained, and time courses of dextran diffusion across the chitosan 
membrane and out of the well were generated. Because fluorophore-conjugated dextran with 
a molecular weight of 70 kDa was found to exhibit very slow transit across the chitosan layer 
(see above), rhodamine B-conjugated dextran (MW 70 kDa) was employed to identify 
microwells whose chitosan bottoms happened to contain a fabrication defect that would 
leakage of dye through the defect. Any microwell that exhibited movement of the 70 kDa 
rhodamine B-conjugated dextran across the chitosan layer and out of the microwell would be 
classified as an artifact and ignored.  
Data generated in this fashion, shown in Figure 3.8, revealed that the chitosan films 
had defects at a rate of less than 0.1% of microwells observed, and were permeable to 
fluorescein and FITC-dextrans of molecular weights 4, 10, and 20 kDa. While fluorescein 
and FITC-dextran 4 kDa were qualitatively observed to traverse the membrane, quantitative 
data on their diffusion across the chitosan membrane could not be obtained, as these solutes 
diffused through the chitosan layer extremely rapidly, exiting the well within 60 seconds of 
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being loaded. Dextrans of average molecular weights 10 and 20 kDa reached half of their 
equilibrium values by 2 and 5 hours, respectively (Figure 3.8, first and second rows). By 
contrast, FITC-dextran 40 kDa exhibited no decline in fluorescence values (Figure 3.8, third 
row), consistent with data in Figure 3.7 showing no appreciable diffusion of FITC-dextran 40 
kDa. 
3.3.6 Calculation of diffusion coefficients and MW cutoffs for chitosan membranes in 
1002F:chitosan hybrid films 
 
A mathematical model based on Fick’s First Law and reported by Lee et al. 66 was 
used to calculate the diffusion coefficient, D, for dextrans of various molecular weights that 
exhibited diffusion through the chitosan membrane. Mathematical details are described in 
Section 3.2.8 above. Figure 3.9A illustrates the closed, two-compartment model used in these 
calculations, which resembles the overall layout of the Transwell™-type experimental setup 
employed here to test diffusion. Figure 3.9B shows a plot of diffusion coefficients 
determined using this model versus log(MW). These values, which range in order of 
magnitude from 10
-9
 to 10
-12
 cm
2
 / s and are reported in Table 3.2, fall within the range of 
previously reported values for slow solute diffusion within a solid.
71
 Lower molecular weight 
dextrans predictably had higher diffusion coefficients, and 40 kDa dextran was found to have 
a diffusivity a full order of magnitude less than that of 20kDa dextran. Fitting a line to the 
linear region of diffusion coefficients in this plot allows extrapolation to find the molecular 
weight that would give a zero-value diffusion coefficient, which is the theoretical molecular 
exclusion limit. Using this method, a theoretical molecular exclusion limit of 16.2 ± 6.3 kDa 
was determined for the chitosan membrane in the 1002F:chitosan hybrid films. This value 
and range, at its minimum, agrees with the diffusion of 10 kDa-MW FITC-dextran observed 
here, and at its maximum, also agrees with observed diffusion of 20 kDa-MW FITC-dextran. 
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Additionally, the value appears to be in agreement with the failure to observe diffusion of 40- 
and 70 kDa MW dextrans through the membrane. 
Two points are worth noting. First, the calculated molecular exclusion limit is a 
theoretical value based on a linear extrapolation, and so solutes with molecular weights 
higher than the theoretical cutoff can still exhibit measurable diffusion, a case also found in 
the data of Lee et al.
66
  Second, it should be remembered that commercially-available FITC-
dextrans, while nonetheless useful, include a range of molecular weights classified by their 
average. Therefore, it is entirely possible to observe diffusion of samples with an average 
molecular weight higher than the theoretical exclusion limit, as the observed diffusion may 
be due to solute molecules with weights on the lower end of the range (below the average). 
However, this theoretical molecular exclusion limit, and the failure to observe 
diffusion of  dextrans > 40 kDa, might seem at odds with previous reports describing the size 
of pores in chitosan microparticles or capsules as being 10 m or higher. 38, 56 Additionally, 
the Bentley Group reported that antibodies with a molecular weight greater than 150 kDa 
could permeate through chitosan membranes fabricated in situ on a microfluidic device.
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However, the processing conditions under which chitosan membrane was formed in these 
other reports differ greatly from those reported here, in which chitosan membranes were 
required to be prepared as dry films in order to facilitate photoresist spin coating and UV 
photolithography. It is hypothesized that the processing steps employed in the fabrication 
process described here, especially the baking steps necessary for proper polymerization of 
the photoresist, lead to a high degree of entanglement and possibly even chemical 
crosslinking that reduce the network pore size and therefore lower the molecular exclusion 
size limit. While no reports of permeability through chitosan films that had been baked at 
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high temperatures could be found, two early reports describing permeability through chitosan 
films that had been dried reported the exclusion of solutes with molecular weights above 13 
kDa, while permitting passage of solutes 2.9 kDa and lighter.
72-73
 These early reports support 
the findings described here. It has not escaped notice that these results suggest two further 
applications for this platform. First, numerous possibilities exist to chemically modify the 
chitosan films in ways that may permit adjustment of the permeability. Second, the molecular 
exclusion limit presents opportunities for the selective entrapment of molecules with high 
molecular weights, such as growth factors, secreted reporters, or antibodies in the wells. 
Exploration of these questions is the subject of future research in this area. 
3.3.7 Spatially controlled protein conjugation 
The free amine group in the molecular structure of chitosan has been used in 
numerous applications for conjugating exogenous molecules to chitosan surfaces 
37, 50-51
. 
Hence, the potential to utilize the amine group to achieve spatially controlled molecular 
patterning was explored. Chitosan:1002F hybrid films micropatterned with 100-m diameter 
wells were patterned with protein via a covalent coupling strategy using the 
heterobifunctional crosslinker sulfo-SMCC, which allows conjugation of molecules with free 
amine moieties to molecules with free sulfhydryl moieties. Sulfo-SMCC supplied to the top 
compartment of released films was used to activate the chitosan surface lining the bottoms of 
the microwells, after which tetramethylrhodamine-conjugated BSA was supplied to the top 
compartment. Compared with unactivated films, sulfo-SMCC treated films exhibited a fold 
increase of 2.2 in average fluorescence within the microwells, suggesting that activation of 
the chitosan surface resulted in higher deposition of protein onto the microwell bottoms as 
compared to protein adsorption onto the same surface. It is noteworthy that this covalent 
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conjugation scheme, which uses the amine-to-sulfhydryl linker reagent sulfo-SMCC, can 
likely be adapted to utilize other crosslinkers, heterobifunctional or otherwise, or amine-
reactive silanes in order to allow user-defined and spatially-controlled surface 
functionalizations that are selective for the chitosan layer at the bottom of the microwells. 
Additionally, because the conjugation scheme described here can be carried out either before 
or after film release, the potential exists to generate a heterofunctionalized chitosan 
membrane – with one set of exogenous molecules conjugated to the chitosan facing the upper 
compartment and another set of exogenous molecules conjugated to the chitosan facing the 
bottom compartment. Additionally, given the molecular weight cutoff for the chitosan films 
(see section above), it is possible that crosslinker reagents and conjugation molecules will 
diffuse throughout the film thickness, resulting in a film impregnated with covalently-bound 
exogenous molecules. 
3.3.8 Survival and proliferation of nonadherent cells entrapped in chitosan-bottomed 
microwells 
 
Inspired by the success of the well-by-well diffusion monitoring tactic described 
above (see Figure 3.8), it was hypothesized that a similar setup, depicted in Figure 3.11A, 
would enable physical isolation of clonal cell populations without a loss of cell viability. By 
applying cells onto a microwell array at low density, microwells would be seeded with 
discrete numbers of cells. Subsequent aspiration of seeding medium would discontinuously 
de-wet the film surface, leaving discrete medium pockets containing cells in each microwell. 
Application of a mineral oil layer atop the array would physically entrap those cells within 
the well spaces. By also supplying culture medium to the compartment below the chitosan 
membrane, nutrients could be exchanged across the permeable chitosan film and cells could 
be maintained and clonally expanded within each microwell. 
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To first evaluate the ability of cells to survive when isolated into discrete medium 
pockets found within microwells, wild-type Ba/F3 cells, an immortalized non-adherent 
murine pro-B cell line derived from the marrow of C3H mice, were seeded onto patterned 
1002F:chitosan hybrid films. After removal of seeding media and mineral oil overlay, media 
either containing or lacking FBS was supplied to the bottom compartment, and the arrays 
were imaged daily for the next three days. At 72 h in culture, cells entrapped within 
microwell arrays supplied with serum-positive media to the lower compartment remained 
viable and had begun to proliferate (Figure 3.11B). By contrast, cells entrapped within 
microwell arrays supplied with serum-free media to the lower compartment failed to 
proliferate and adopted a shrunken morphologic appearance consistent with apoptosis. These 
data are consistent with previous reports that the Ba/F3 cell line is dependent on serum 
growth factors or the cytokine IL-3 cytokine for survival, undergoing apoptosis upon serum 
or cytokine removal.
74-75
 Therefore, the observed proliferation of cells in the presence of 
serum-positive media on the opposite side of the chitosan film and the failure of cells to 
proliferate when media was serum-free suggest that the chitosan membranes were 
functionally permeable to serum growth factors necessary for proliferation of the cells. 
3.3.9 Isolation and expansion of clonal populations in discrete medium pockets 
To further demonstrate utility of this platform in isolating clonal populations of cells, 
wild type Ba/F3 cells were seeded onto the hybrid platform and isolated via oil overlay as 
described above. Clonal expansion of cells was monitored in comparison to cells seeded onto 
two control platforms. Each control platform was a 1002F:chitosan hybrid film that had not 
been released from the substrate and whose microwells were therefore blind-ended. In one 
control, cells were seeded and overlaid with mineral oil as on the test platform; in the second 
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control, cells were seeded and grown in media without any oil overlay. The first (oil-overlay) 
control exhibited no clonal expansion of cells (presumably due to either rapid depletion of 
nutrients from the ~400-pL microwell volume or poor delivery of oxygen)(Figure 3.12A). 
This was in sharp contrast to the second control, in which clonal expansion was observed. 
However, on this control, 0% (n = 62) of wells empty after the initial cell seeding remained 
empty by 48 hours (Figure 3.12B), suggesting that mixing of clonal populations was 
occurring. By comparison, cells grown on the released 1002F:chitosan hybrid platform and 
supplied with media also exhibited heterogeneous clonal expansion (Figure 3.12C). At the 
same time, however, there was no observed migration of cells into microwells that were 
empty after the initial cell seeding, unlike that observed in Figure 3.12B. These results 
confirm the hypothesis that this platform could be used to clonally expand cells but keep 
different clonal populations separate, all the while permitting each of those populations to be 
interrogated en masse. 
3.3.10 Analysis of cell division heterogeneity in entrapped, nonadherent cells 
In order to demonstrate a proof-of-principle application for analyzing cellular 
heterogeneity, the proliferation of discrete numbers of Ba/F3 cells into clonal populations 
was quantified in 47 separate microwells containing cells. As shown in Figure 3.13A, cells 
heterogeneously proliferated and expanded while on the microwell array. Figure 3.13B 
shows that the average number of cells per well increased to 1.6 ± 0.6 at 24 hours, 2.3 ± 1.1 
at 48 hours, and finally to 5.2 ± 4.2 at 72 hours for wells initially seeded with a single cell. 
Cells in wells with 2 cells initially expanded to 3.2 ± 0.9, 4.9 ± 2.3, and 11.1 ± 6.5 cells by 
24, 48, and 72 hours respectively. The high variability in the number of cells per well, 
especially by day 3 in culture, suggests that some cells were proliferating faster than others, 
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generating greater numbers of daughter clone cells. Average cell doubling times were 
determined to be 31.4 ± 3.9 and 29.8 ± 3.4 hours for wells with 1 and 2 cells per well initial 
seeding, respectively. However, suspecting that there was a large range of doubling times, a 
histogram of cell doubling time was constructed by calculating the doubling times of cells in 
47 microwells. Figure 3.13C shows that cell doubling time ranged from <20 to slightly over 
80 hr. While 45% of cells had doubling times between 22 and 34 hr (i.e. there were not two 
wholly separate populations of “fast” and “slow” dividers that drove the average to a middle 
value), the presence of some apparent fast  and slow dividers (doubling times < 20 and >60 
hr) was appreciated. 
These results compare favorably with the growing realization that small sets within a 
population of cells act to maintain the entire population, either through rapid proliferation to 
offset the effects of other cells dying off, or through the secretion of paracrine factors that 
induce nearby cells to divide. One recent report examined proliferation of hematopoietic 
stem cells grown in a novel microfluidic device featuring nanoliter-scale growth chambers.
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By continuously perfusing media to the chamber apertures, clonal cell populations within the 
chambers could be maintained for up to 72 hr. While that device and the platform described 
here offer better and longer culture of cells than other currently available technologies 
(including many microscale approaches), the 1002F:chitosan hybrid films described here 
have the additional advantage of requiring no other specialty equipment, namely continuous 
perfusion devices, for growing cells after the devices are fabricated.  
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3.3.11 Growth of primary human AT2 cells as AT1 surrogates 
Finally, in order to begin direct evaluation of the 1002F:chitosan films were use in 
growing primary AT1 cells under an ALI, primary human AT2 cells seeded into chitosan-
bottomed microwell arrays 100 µm in diameter that had been coated with the ECM protein 
laminin, a known component of the alveolar basement membrane.
77
 Cells were seeded at a 
low density (1 x 104 cells/cm
2
) to as to increase the probability of obtaining a single cell per 
well (Poisson probabilities for n = 0, 1, 2, 3 cells per well are 0.456, 0.358, 0.141, and 0.037 
respectively). After 9 days in culture, cells were stained with Hoescht 33342 and calcein AM 
red-orange to label cell nuclei and cytoplasms, respectively. A small number of cells (~1%) 
were observed to have spread out over the microwell bottom area and adopted an AT1-like 
squamous morphology (Figure 3.14).  These finding suggest that, with further optimization, 
this platform holds potential for use in direct study of primary AT1 cell ion and fluid 
transport. Further work will focus on tailoring ECM and microwell dimensions to promote 
reproducible cell spreading over the entire microwell bottom area. 
 
3.4 Conclusions 
 Here, the development of a microfabricated cellular analysis platform that will 
enable high-throughput study of cellular heterogeneity in response to user-defined and 
dynamically controlled stimulations is described. This platform features an array of 
microscale wells, formed via the first reported co-fabrication of a photoresist film with 
chitosan to form a freestanding array of microwells bound by a semi-permeable hydrogel 
layer. Deposition of a layer of inert mineral oil above the well layer allows cells lying in the 
wells to be physically isolated from other wells, preventing cellular migration and reducing 
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biochemical crosstalk that might confound results. The chitosan layer at the bottom of the 
microwells maintains chemical access to the cells for exchange of nutrients and small 
molecules supplied by the user for cellular interrogation. Use of this platform will enable 
future high-throughput studies of the diversity in cellular biochemistry and genetics. In 
addition, the observation of a limited number of primary AT2 cells spreading out over the 
microwell surface and adopting an AT1-like molecular phenotype were observed, suggesting 
potential of this platform, after optimizations are conducted, for growth of primary AT1 cells. 
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3.5 Figures and Tables 
 
 
 
 
 
 
 
 
 
Figure 3.1. Fabrication and release of hydrogel-bottomed microwell array films. (A) 
Fabrication and release protocol. Atop a clean glass slide (i), the chitosan hydrogel layer is 
deposited via spin-coating (ii). 1002F negative photoresist is then spin-coated atop 
chitosan hydrogel layer (iii). UV exposure through a patterned photomask (iv) and 
subsequent development yields a microwell array with chitosan hydrogel bottoms (v). 
Soaking in dilute NaOH allows release from the glass substrate, yielding a freestanding 
chitosan:1002F hybrid film (vi). (B) Attachment of a polystyrene cassette to the film 
creates a two-compartment cell culture system. The apical and basolateral compartments 
are separated by the chitosan hydrogel layer (note the purple sheen of the submicron 
chitosan layer). 
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Figure 3.2. Imaging of released chitosan-bottomed microwell array films. (A-B) Scanning 
electron micrographs of released, freestanding 1002F:chitosan films imaged from above 
(A) and below (B) the 1002F layer. Each film features an array of 10
4
 75 μm-diameter 
circular wells 50 µm deep. (C-D) Scanning electron micrograph of chitosan hydrogel 
layer cross-section (C) and surface (D). (C) shows the area marked by the blue box in (A), 
while (D) shows the area marked by the blue box in (C). Scale bars: (A) 100 µm; (B) 400 
µm; (C) 1 µm; (D) 500 nm. 
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Figure 3.3. Fabrication of multi-layer 1002F:chitosan:1002F films. (A) Strategy for 
fabricating 1002F:chitosan:1002F sandwich films. By delaying the removal of 
unpolymerized 1002F monomer until after the release of the hybrid film, a single 
development step allows for creation of a three-layer film with chitosan hydrogel in the 
middle. (B) Scanning electron micrographs of a 1002F:chitosan:1002F sandwich film. The 
top layer contains a single large, hexagonal well, while the bottom layer contains an array 
of 25-µm square microwells. Scale bars: 500 µm (left column), 250 µm (right column). 
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Figure 3.4. Dependency of chitosan film thickness on spin coating speed. Chitosan 
hydrogel was spin coated at the indicated speeds atop glass slides. Films were dried by 
baking, after which film thicknesses were measured by profilometry. Data are from n > 3 
replicates per spin coating speed. Data shown are mean ± SD. 
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Figure 3.5. Optical properties  of chitosan films. (A) Absorbance spectrum of hydrated 
chitosan films 800 µm in thickness. Spectrum is based on mean absorbance from n = 6 
films. (B) Autofluorescence of chitosan, 1002F, and SU-8 layers in chitosan films co-
fabricated and micropatterned with either 1002F or SU-8. Data presented are as mean ± 
SD, n > 2 films each. 
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Figure 3.6. Permeability of micropatterned 1002F:chitosan films. (A) Workflow diagram 
for testing solute diffusion through chitosan-bottomed microwell arrays. After seeding 
concentrated dye into the upper compartment, dye solute will diffuse across the film and 
into the bottom compartment. Samples are taken at regular intervals from each 
compartment to determine solute concentration in the compartments. (B) Photographs 
illustrating diffusion of toluidine blue dye across a chitosan-bottomed 1002F microwell 
array into the bottom compartment over a 24 hour period. (C) Quantitation of toluidine 
blue concentration in the bottom compartment. A polyester Transwell™ membrane with 
pores 0.4 µm in diameter was used as a positive control. Data are presented as mean ± SD 
for n = 7 films. 
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Figure 3.7. Diffusion of FITC-conjugated dextrans through chitosan membranes in 
micropatterned 1002F:chitosan films. Quantitation of ratio of FITC-dextran concentration 
C to its theoretical equilibrium value C
eq
  for four different molecular weights of dextran 
diffusing across a chitosan-bottomed 1002F microwell array. A polyester Transwell™ 
membrane with pores 0.4 µm in diameter was used as a positive control. Data are 
presented as mean ± SD for each time point, n = 7 films. 
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Figure 3.8. Visualization of FITC-dextran diffusion through chitosan membranes in 
individual microwells. Chitosan-bottomed microwell arrays are supplied with FITC-
dextran with average molecular weights of 10, 20, or 40 kDa and a 70 kDa rhodamine B-
dextran negative control. Dye is confined to the microwells by a discontinuous de-wetting 
process and a layer of mineral oil is overlaid to prevent evaporation. Serial imaging of the 
arrays, as well as a blind-ended array to control for photobleaching, allows quantitation of 
[FITC-dextran] over time. Left and middle columns show arrays just after dye seeding and 
at termination of experiment, respectively. Plots in right column show quantitation of 
relative fluorescence over time for both FITC-dextran and the rhodamine B-dextran 
control. Data are presented as mean ± SD for n = 6 films per weight of FITC-dextran 
tested. All fluorescence micrographs show wells 100 µm in diameter. Scale bar (upper 
right): 100 µm. 
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Figure 3.9. Determination of diffusion constants and molecular weight cut-off for 
chitosan membranes in micropatterned 1002F:chitosan films. (A) Diffusion model 
employed in this study, based on Lee et al. Supply of dye to the upper source 
compartment creates a gradient that drives diffusion of the dye across the membrane and 
into the sink compartment below. Each compartment has a volume V, throughout which 
dye exists at some concentration C. (B) Determination of the theoretical molecular 
exclusion limit of chitosan films in the 1002F:chitosan hybrid devices via extrapolation in 
a plot of diffusivity vs log(MW). Data are presented as mean ± SD for the diffusion 
coefficient calculated for each MW shown. The theoretical molecular weight exclusion 
limit is the extrapolated x-intercept of a line fitted to the linear region of the D vs 
log(MW) plot. 
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Figure 3.10. Selective and covalent modification of chitosan film surfaces. (A) Covalent 
conjugation scheme. Use of the heterobifunctional linker sulfo-SMCC allows 
functionalization of the chitosan surface via its amine moiety to covalently attach 
macromolecules with sulfhydryl groups to the surface. (B) Fluorescence of chitosan-
bottomed microwell arrays comparing adsorption versus covalent attachment of BSA-
tetramethylrhodamine. * p < 0.05. (C-D) Fluorescence micrographs of chitosan-bottomed 
microwell arrays comparing adsorption (C)  versus covalent attachment (D) of BSA-
tetramethylrhodamine. Scale bars: 75 µm. 
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Figure 3.11. Entrapment of non-adherent cells in culture medium micropockets. (A) 
Design schematic for entrapping and maintaining nonadherent cells within micropockets 
of culture medium. Seeding cells into chitosan-bottomed microwells and aspirating excess 
media off discontinuously de-wets the upper compartment. Overlay of mineral oil entraps 
cells in the microwells. (B) Functional permeability of chitosan membranes to serum 
growth factors. Wild-type Ba/F3 cells were seeded into medium micropockets and media 
either containing or lacking serum was supplied to the lower compartment. Cells were 
monitored daily over the next three days to monitor for cell survival and/or proliferation. 
Scale bar (lower right): 100 µm. 
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Figure 3.12. Physical isolation of clonal cell populations in microwell medium pockets. 
Wild-type Ba/F3 cells were seeded into unreleased (blind-end) (A-B) or  released (C) 
1002F:chitosan microwell arrays and imaged daily over 48 hours. Blind-end microwell 
arrays were either overlaid with mineral oil (A) or culture medium (B). Freestanding 
microwell arrays were overlaid with mineral oil in the upper compartment, while culture 
medium was supplied to the bottom compartment. Scale bar (lower right): 100 µm. 
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Figure 3.13. Quantitation of cell proliferation in microwell medium pockets. (A) Several 
adjacent wells illustrate the heterogeneity of cell proliferation within a population of wild-
type Ba/F3 cells. (B) Measurement of number of cells per microwell, segregated by the 
initial number of cells in each microwell. Data are shown as mean ± SD for 47 
microwells. (C) Cell doubling time, calculated and aggregated based on all cells present 
within a given microwell, was determined for 47 separate microwells. The histogram 
shows relative frequencies of cell doubling times. 
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Figure 3.14. Growth of primary AT1-like cells in laminin-coated 1002F:chitosan 
microwells. Two examples of primary AT2 cells, seeded at low density into chitosan-
bottomed microwell arrays coated with laminin, are shown. Brightfield and fluorescence 
micrographs were taken of cells grown for three days in culture and then stained with 
Hoescht 33342 and calcein AM red-orange to label nuclei and cytoplasms, respectively.  
Cytoplasmic labeling was performed to identify cells that had spread out over the coated 
chitosan in the bottoms of the microwells and adopted an AT1-like morphology. Scale bar 
(upper left): 75 µm. 
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Table 3.1 Spin coat speed determination of chitosan film thickness. Chitosan hydrogel was 
spin coated atop glass slides at the spin coat speeds indicated below. The thickness of the 
resulting dry film was determined by profilometry. 
 
Speed (rpm) Thickness (nm) 
500 798.8 ± 35.3 
1000 549.8 ± 20.3 
2000 348.9 ± 24.2 
3000 291.4 ± 21.5 
4000 279.1 ± 0.4 
6000 191.8 ± 4.0 
8000 179.2 ± 1.9 
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Table 3.2 Comparison of diffusion constants to solute molecular weight for chitosan 
membranes in 1002F:chitosan hybrid films. Diffusion coefficients were determined from the 
slopes of plots generated based on Equation 3.14, as described in text. 
 
MW (Da) log MW D (cm
2
 / s) Error in D 
270 2.431364 3.28 x 10
-9
 2.58 x 10
-10
 
4000 3.60206 7.36 x 10
-10
 3.54 x 10
-11
 
10000 4 2.81 x 10
-10
 1.02 x 10
-11
 
20000 4.30103 9.68 x 10
-11
 2.27 x 10
-12
 
40000 4.60206 3.42 x 10
-12
 1.36 x 10
-13
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Chapter 4: Micropatterning of 1002F photoresist atop track-etch 
membranes 
 
4.1 Introduction 
4.1.1 Cellular polarization in epithelial tissues 
In vivo, a number of epithelial cell lineages, such as bronchial, renal, or 
gastrointestinal cells, have a polarized orientation relative to the basement membrane on 
which they sit and across which they exchange nutrients, oxygen, and metabolites.
1
 The 
polarization process involves the cell establishing and segregating membrane faces with 
distinct molecular organizations: an apical membrane that faces some kind of lumen, and the 
basolateral membrane, which interfaces with ECM on the basement membrane and with 
adjacent cells.
2-3
 The proper organization of these membrane faces is often essential to 
epithelial cell function. For example, airway cells establish cilia on the apical surface that 
play a key role in mucociliary clearance. Similarly, gastrointestinal cells must traffic proteins 
designed to metabolize and absorb nutrients to the apical membrane. Renal cells that line the 
nephron must organize an apical membrane face with a variety of ion transporters for 
regulating the body’s electrolyte balance. 
In order to promote polarization and allow cells to fully recapitulate the in vivo 
physiology, the most meaningful studies of polarizing cells grow those cells on microporous 
substrates that provide an in vitro mimic to the microenvironment seen in vivo.
4-5
 Many 
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studies in the field of respiratory biology have informed our understanding of the role of 
permeable supports on the ability of cells to properly replicate the in vivo architecture. Cells 
grown on permeable supports have been shown to polarize and differentiate to a higher 
degree than similar cells grown on impermeable supports.
6-10
  
4.1.2 Advantages of microfabricated devices for studies of fundamental cell processes  
The application of microfabricated platforms to the study of biological systems has 
enabled unparalleled control of the physical and chemical microenvironment to which a cell 
or group of cells is exposed. Microfabrication technology allows for precise customization of 
the shape, size, and surface chemistry of the area used for cell growth.
11-14
 By achieving such 
control, researchers gain the ability to interrogate the mechanisms and regulation of 
fundamental cellular processes and to create novel bio-inspired platforms.
15-19
 As mentioned 
in Chapter 1, the most common methods and materials in use in the microfabrication field 
include soft lithography using polydimethylsiloxane (PDMS), photolithography using 
photoresists, and injection molding using cyclic olefin co-polymer, with a number of others 
also available.
20-23
 Despite the availability of so many methods and materials, however, the 
vast majority of microfabricated platforms grow cells on impermeable surfaces. 
4.1.3 Microfabricated devices for study of polarized cells 
Given the advantages of microfabrication technologies as described above, a method 
to fabricate micropatterned platforms that feature porous or otherwise permeable areas for 
cell growth would be a useful advance for the study of polarized cell types. To date there has 
been some success in combining microscale technologies with porous or otherwise 
permeable materials. Porous membranes are used most commonly in microfluidic setups 
fabricated with PDMS. A common design for these systems involves the fabrication of 
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devices using stacked PDMS layers with a microporous membrane sandwiched in the 
middle, creating separate PDMS flow channels separated by the membrane. A number of 
studies employing this setup are discussed in Chapter 1. Some of these studies describe novel 
strategies to bond microporous membranes with the PDMS layers. Others describe the use of 
these setups for establishing standing chemical gradients without exposing cells to excessive 
shear forces or for blood plasma filtering applications. Reader is referred back to Chapter 1 
for discussion of these devices. 
However, some reports do utilize the membrane to recapitulate the polarization seen 
in vivo of certain types of non-respiratory epithelial cells. For example, a seminal study by 
the Ingber Group engineered a “lung-on-a-chip” device that featured a microporous 
membrane separating two microchannels.
24
 On one side of the membrane, a sheet of 
immortalized endothelial cells were exposed to a fluid filled microchannel. The opposite side 
of the membrane was covered with sheets of cells from either small airway NCI H-441 or 
alveolar A549 cell lines, creating an ALI across the membrane. This device concept was later 
extended to grow cells from an immortalized colon adenocarcinoma-derived cell line, hence 
the term “gut-on-a-chip.”25 A noteworthy feature of these devices was the pair of 
microchannels that laterally bordered the membrane: reducing or normalizing air pressure to 
these side channels created stretch or relaxation forces that simulated the expansion of the 
pulmonary tissues that occurs during inspiration and peristaltic movements in the gut. Jang 
and Suh created a microfluidic “kidney-on-a-chip” using PDMS bonded to a porous 
membrane on which sheets of primary rat inner medullary collecting duct (IMCD) cells were 
cultured.
26-27
 While impressive engineering feats, a drawback shared by all of these studies is 
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the continued reliance on bulk populations of cells: little is done to decrease the scale of 
study towards smaller groups of cells. 
A few devices do attempt to introduce micropatterns onto porous membranes. The 
McGuigan Group successfully patterned epithelial cells into microcolonies atop 
commercially-available porous substrates, but this approach did not allow control over the 
thickness of the patterned material and the size range of its features appeared limited by the 
ability to establish a good seal between the PDMS stamp and the membrane.
28
 Similarly, 
Torisawa et al. reported a strategy to microstamp commercially-available track-etch 
membranes with a PDMS layer 5 µm thick that could generate features on the order of 50 µm 
to a side.
29
 However, this approach offers no ability to control the height of the PDMS layer; 
cells seeded onto this device quickly overgrew the well spaces and formed a monolayer over 
the entire device area. Two reports – one of which used a combination of electrospun 
polyblend fibers and soft lithography, the other using a mesh-supported submicron 
membrane of parylene C – combined microscale patterning with a unique permeable surface, 
but fabrication of these devices requires both considerable manpower and highly specialized 
equipment.
30-31
 A similar requirement for specialized equipment is one drawback to a recent 
report describing the ability to thermoform polyester or polycarbonate into films with 3D 
topographies.
32
 The fabricator must have ready access to not only a specialty thermoforming 
apparatus, but also to a heavy ion accelerator in order to track-etch pores into the final 
product. 
4.1.4 Design of a protocol for micropatterning a track-etch membrane 
Thus, devising a strategy for generating precise micropatterns atop commercially-
available membranes would be a useful advance for enabling ensemble studies of 
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biochemistry and physiology in populations of cells that adopt a polarized phenotype. A 
successful system that achieves this goal will have several key characteristics. First, the 
system should feature a micro- or nano-porous material that is biocompatible and easily 
manipulated. Second, the fabrication method should permit micron-level precision in the 
patterning of cell growth areas with customizable shapes and sizes, while simultaneously 
being both time-efficient and reproducible. Lastly, the ideal system will enable the seeding 
and study of single or small groups of cells so that heterogeneity of cellular responses and 
function can be analyzed in a high-throughput fashion. 
Most of the membranes available commercially for the culture of polarized cells are 
composed of polyester (most commonly polyethylene terephthalate, PET), polycarbonate 
(PCT), or polytetrafluoroethylene (PTFE). PET and PCT are made porous by a process 
known as track-etching, in which sheets of each polymer are irradiated with high energy ions 
that ‘track’ through the sheet and cause local disruption of the polymer backbone. 
Subsequent soaking of these sheets in strong bases leads to etching of cylindrical pores 
through those regions that saw exposure to the heavy ion particles.
33-34
 PTFE membranes, by 
contrast, consist of a distribution of microfibers randomly entangled at the microscale; pores 
with a distribution of sizes result from incomplete entanglement. Among these three 
materials, PTFE offers the best solvent chemical resistance due to the presence of its 
unreactive fluorine residues, while PCT has the greatest temperature stability. PET offers 
generally good resistance to both temperature and chemical solvents. Mixed cellulose ester 
supports, though less commonly used, are also available. 
Of the materials in common or demonstrated use in the microfabrication field, 
photoresists present the most logical choice for combination with commercially-available 
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microporous membranes. PDMS is the most common overall material for microfabrication, 
but the fabrication of full-thickness through-holes in PDMS is technically difficult. While a 
report by Folch et al. details two methods for forming PDMS films with through-holes on a 
glass substrate, the ability to translate these approaches to a track-etch membrane is 
questionable.
35
 Agarose has been used to micropattern PET membranes, but the maximal 
feature resolution with this method was suboptimal, and use of it and other hydrogels may 
affect the ability to measure transepithelial electrical resistance (TEER) values in cells seeded 
onto devices fabricated with hydrogels as the structured material.
28
 
Photoresists present a more enticing material with which to work. A method to 
fabricate freestanding photoresist films was recently developed and characterized.
36
 These 
films, in which full-thickness microscale through-hole wells could be patterned with a high 
degree of precision via UV photolithography, could be released from their fabrication 
substrate to give a flexible and mechanically stable product. Given the advantages of such 
films and the ease with which they could be fabricated and micropatterned, a strategy to 
combine this approach with commercially-available microporous membranes in a fashion 
that would yield an array of microwells patterned directly atop a microporous membrane was 
investigated. 
4.1.5 Overview 
This Chapter presents a reliable strategy to spin coat even layers of 1002F photoresist 
onto commercially-available track-etch microporous polyester membranes. These photoresist 
layers can be patterned with microwells that expose the pores in the underlying membrane. 
Features as small as 25 µm could be micropatterned, with the potential to achieve an even 
higher resolution. This fabrication process does not appear to destabilize the membrane 
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micropores, meaning that macromolecules can easily traverse the membrane and enter or exit 
the microwells. Preservation of the micropores allows MDCK cells to grow and polarize in 
the wells. These results are the first known report of photopatterning microwells directly atop 
track-etch membranes for cell culture, and hold promise in growth of microcolonies of 
polarized cells for drug screening applications and studies of fundamental cell processes. 
 
4.2 Experimental design 
4.2.1 Materials  
γ-butyrolactone (GBL), photoresist developer (propylene glycol methyl ether acetate, 
PGMEA), FITC-dextran (average molecular weights 70 kDa), and mineral oil were 
purchased from Sigma-Aldrich (St. Louis, MO). EPON resin 1002F photoresist was obtained 
from Miller-Stephenson (Sylmar, CA). UVI-6976 photoinitiator (triarylsulfonium 
hexafluoroantimonate salts in propylene carbonate) was purchased from Dow Chemical 
(Torrance, CA). Polydimethylsiloxane (PDMS, Sylgard 184 elastomer kit) was obtained 
from Dow Corning (Midland, MI). Chrome photolithography masks were designed in-house 
using TurboCAD software and printed by FineLine Imaging (Boulder, CO). Transwell™ 
permeable cell culture supports, 24-mm in diameter and track-etched with pores 0.4 µm in 
diameter, were obtained from Corning (Tewksbury, MA) via Thermo Fisher Scientific 
(Waltham, MA). DMEM/F-12 (1:1) medium, fetal bovine serum (FBS), 
penicillin/streptomycin, Alexa Fluor-488 goat anti-mouse IgG, and SlowFade anti-fade kit 
were obtained from Life Technologies (Grand Island, NY). Madin-Darby Canine Kidney 
(MDCK) type II cells transfected with a pLXSN retroviral expression vector containing HA-
tagged human P2Y2 purinergic receptor were a kind gift of Dr. Robert Nicholas at the Univ. 
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of North Carolina School of Medicine. Transwell
™
 polystyrene cassettes 12-mm in diameter 
and hereafter referred to as “cassettes,” were kind gifts from Dr. Brian Button at the Univ. of 
North Carolina School of Medicine. Mouse anti-HA monoclonal antibody (monoclonal 
antibody HA.11 from clone 16B12, catalog MMS-101R) was obtained from Covance, 
(Princeton, NJ). 
4.2.2 Photoresist-based micropatterning of track-etch membranes 
Transwell™ permeable culture supports 24 mm in diameter and in an inverted 
orientation were attached to square glass slides 3.5 cm to a side via a PDMS mortar, which 
was cured by baking at 65
o
C for 25 min. Following a 2-min air plasma treatment, 
micropatterned films of 1002F negative photoresist were fabricated atop the outward facing 
side of the track-etch membrane using a protocol similar to previously published methods, 
save for the soft- and post-exposure baking times and temperatures.
36
 Briefly, EPON resin 
1002F negative photoresist, dissolved in GBL and mixed with UVI-6076 photoinitiator, was 
spin-coated onto the outward-facing, upright side of the track-etch membrane to a desired 
thickness of 25-50 µm and soft-baked at 65
o
C for a number of hours to remove organic 
solvent. After exposure to UV light through a patterned chrome photomask and a post-
exposure bake at 65
o
C for several hours, unpolymerized photoresist monomer was removed 
via development in PGMEA. A variety of masks were tested on films with varying 
thicknesses. The resulting micropatterned hybrid film was hard-baked at 65
o
C for several 
hours to solidify the photoresist layer. Afterwards, a 12 mm-diameter polystyrene 
Transwell™ cassette was mated to the area of the film containing the patterned array and 
attached with a thin PDMS mortar layer. After curing the mortar, the hybrid film was cut 
away from its original 24 mm-diameter cassette and excess unpatterned membrane outside of 
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the 12 mm-diameter cassette was trimmed away. In this orientation, the photoresist pattern 
directly faces the inner compartment of the cassette. 
4.2.3 Imaging of freestanding, micropatterned track-etch membranes 
Track-etch membranes micropatterned with photoresist films were imaged using an 
FEI Quanta 200 FEG scanning electron microscope (SEM) with a shottky field emission gun, 
operated under low-vacuum conditions (0.38 torr) (Chapel Hill Analytical and 
Nanofabrication Laboratory (CHANL)). A Nikon Eclipse TE2000-U inverted fluorescence 
microscope was additionally used to image films during diffusion experiments. Brightfield 
and fluorescence micrographs recorded with a cooled CCD camera (Photometrix Cool Snap 
fx, Roper Scientific, Tucson, AZ) controlled by NIS Elements software (Nikon, Melville, 
NY). Fluorescence micrographs were analyzed using Image J (NIH, Bethesda, MD). MDCK 
cells seeded onto micropatterned track-etch membranes were later immunostained and 
analyzed with a Zeiss CLSM 710 spectral laser scanning confocal microscope equipped with 
40X/1.3 Oil Plan Neo and 63X/1.4 Oil Plan Apo objective lenses and 405 and 488 nm 
excitation lines (UNC School of Medicine Microscopy Services Laboratory). Confocal 
images were analyzed using the Imaris software package. 
4.2.4 Assessing micropore patency by measuring solute diffusion 
 Track-etch membranes were spin coated with 1002F photoresist, which was patterned 
as described above with 900 100 µm-diameter wells. After attachment of a polystyrene 
cassette and release as described above and a 2 min air plasma treatment, the films where 
placed into the macro-scale wells of a 12-well plate, suspended by the cassette approximately 
1 mm from the well bottom. PBS was supplied into the cassette (upper) and the dish (lower) 
compartments at volumes (0.5 and 1.5 mL, respectively) recommended by the plate 
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manufacturer to give an equal height between the two compartments. The cassette (upper) 
compartment was then supplied with a solution containing 200 g/mL of FITC-dextran 
(average molecular weight 70 kDa). After incubating for 1 min, the dextran mixture was 
carefully aspirated off so as to leave droplets of the dextran solution remaining in the 
microwells. Mineral oil (500 L) was then deposited into the cassette compartment to cover 
the microwell array and prevent evaporation, and the cassette was incubated in the dark. At 
regular time intervals, fluorescence images of the microwell array were obtained with an 
inverted fluorescence microscope. Fluorescence micrographs were analyzed using Image J to 
generate quantitative fluorescence values for each microwell. Films of 1002F fabricated with 
the same micropattern as listed above that had not been released and whose microwells were 
thus blind-ended were used as negative diffusion controls to correct for any photobleaching. 
Fluorescence values, averaged for each microwell, were used to construct a time course of 
dextran diffusion across the chitosan membrane and out of the well. 
4.2.5 Testing epithelial cell polarization on micropatterned track-etch membranes 
 MDCK cells were maintained in polystyrene tissue culture flasks in DMEM/F-12 
(1:1) medium supplemented with penicillin-streptomycin, 5% v/v FBS, and G418 (500 
µg/mL for selection pressure). Track-etch membranes patterned with 1002F microwells 100 
um in diameter were fabricated and released as described above. Devices were sterilized with 
ethanol and placed in 12-well plates. MDCK cells were dislodged via trypsinization and 
seeded into the microwells at a density of 6.5 x 10
5
 cells/cm
2
. Unpatterned membranes were 
used as controls. MDCK cells were grown on devices for 7 days with daily medium changes. 
On day 7, cells were washed with ice-cold PBS supplemented with 2 mM CaCl2 and MgCl2, 
fixed with 4% (w/w) paraformaldehyde at 4
o
C for 30 min, and permeabilized using 100% 
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methanol (stored at -20
o
C) for 60 s. Cells were washed with blocking buffer (1X PBS 
containing 1% non-fat dry milk) for 5 min three times at room temperature. Cells were then 
incubated overnight at 4
o
C in a primary antibody solution composed of blocking buffer 
containing mouse monoclonal anti-HA Ab at 1:1000 dilution of stock Ab solution. The 
following day, the primary antibody solution was removed and cells were washed with 
blocking buffer for 15 min and then labeled for HA-tagged hP2Y2 receptors with secondary 
anti-mouse Alexa Fluor 488 Ab for 1 h at room temperature. Hoescht 33342 (1 µg/mL) was 
included to label nuclei. Secondary Ab solution was removed and cells washed five times 
with PBS. The films were then excised from the cassettes and mounted on glass microscope 
slides with SlowFade anti-fade mounting medium. Confocal microscopy was performed on 
the films to visualize hP2Y2 receptor location as an indicator of cell polarization. 
Representative xz confocal images were obtained. 
 
4.3 Results and Discussion 
4.3.1 Method development for micropatterning photoresist atop track-etch membranes 
Freestanding, commercially-available track-etch membranes composed of polyester 
(specifically, polyethylene terephthalate, PET) and polycarbonate, as well as membranes of 
interwoven PTFE fibers were initially investigated and tested for basic compatibility with 
microfabrication procedures. Polycarbonate membranes lost integrity and became distorted 
when exposed to solvents involved in microfabrication (namely PGMEA) and were not 
investigated further. Polyester and PTFE membranes displayed resilience in the presence of 
solvent and did not experience loss of integrity and were therefore investigated further. 
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A number of approaches were tested for their ability to generate flat, even films of 
1002F atop PET and PTFE membranes for subsequent UV photolithography. Placement of 
membranes on glass slides and spin coating 1002F frequently resulted in the presence of 
bubbles in the space between the membrane and the overlying 1002F layer. Attempting to 
remedy this problem by placing the membranes first on slides coated with a layer of PDMS 
(instead of bare glass) increased membrane evenness and reduced bubbling. However, the 
adhesion to the PDMS made films difficult to release in later steps, and often resulted in 
shearing apart the membrane and the overlying 1002F layer. 
To circumvent these issues, attempts were made to spin coat 1002F directly onto 
commercially-available Transwell™ cell culture membranes, which are shipped by the 
manufacturer pre-attached to a polystyrene cassette. This route was taken because 
membranes attached to cassettes in this form are taut and resistant to stretching, folding, and 
bending and so do not need to be flattened on another surface and later removed. In order to 
yield films with the desired general thickness (on the order of 10-100 um), the Transwell™ 
films had to be inverted and the 1002F spin coated onto the membrane face opposite the one 
on which cells are traditionally seeded (Figure 4.1A). This is because the viscosity of 1002F 
prevents a given small volume from being evenly spin coated into a thin film, and spin 
coating the necessary volume within the cassette compartment would result in back-flow of 
1002F that would thicken the resulting layer. Inverted Transwell™ supports were thus 
attached to square glass slides using a PDMS mortar layer to keep the support steady during 
the spin coating process. 
Using this approach, even, uniform films of 1002F could be reproducibly spin coated 
atop PET and PTFE Transwell™ membranes. Taking these films through the 1002F UV 
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photolithography process resulted in the successful patterning of full-thickness 1002F 
microwells atop PET, but not PTFE, membranes. The micropatterns atop PTFE membranes 
did not faithfully replicate the mask features, presumably due to scattering of incident UV 
light by air pockets trapped in the membrane spaces. Further work in remedying this issue 
was left to future directions, and the remainder of the efforts described here focused on work 
with PET films only. During the development process, the outside of the polystyrene cassette 
was observed to be damaged by the developer solvent. However, given the disposable nature 
of the Transwell supports (in their usual use), and the lack of any precipitate observed in the 
microwells, this was of no concern. In order to maintain the flatness of the final product but 
still re-orient the hybrid film back to an orientation useful for cell culture (i.e. microwells 
facing the cassette compartment), a 12 mm-diameter Transwell™ cassette was mated in the 
opposite orientation to the hybrid film (still facing out from the original 24 mm-diameter 
cassette). After bonding the smaller cassette to the film using a thin PDMS mortar layer, the 
hybrid film was cut away from the larger cassette and excess hybrid film lying outside the 
smaller cassette space was trimmed away. 
4.3.2 Optimization of fabrication parameters 
Subsequent analysis of the track-etch membrane at the bottom of the microwells 
using scanning electron microscopy revealed that many of  the micropores, grossly visible by 
brightfield light microscopy, had a distorted or shrunken appearance and were smaller in 
diameter than those pores examined on control membranes that had not been spin coated with 
1002F. 
It was hypothesized that the temperatures employed in the soft-, post-exposure, and 
hard-bake steps of the fabrication process were the cause of the micropore distortions. 
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Indeed, the glass transition temperature (Tg) for PET is reported to be 67-80
o
C, evidence that 
the 95
o
C and 120
o
C baking temperatures, combined with the presence of organic solvents, 
may be inducing structural changes that cause the micropores to collapse.
37-38
 Based on 
previous in-lab work showing that SU-8, a negative photoresist similar to 1002F, can be 
cured by baking at 65
o
C for longer periods of time compared to the times required for curing 
at 95
o
C or 120
o
C, a revised fabrication protocol that featured soft-, post exposure, and hard-
bake steps being completed at 65
o
C for longer times was devised. A temperature of 65
o
C was 
chosen in one part based on the required cure temperature for SU-8 photoresist, and in 
another part based on a report of the 1002F melting temperature of 56.8
o
C.
39
 By baking 
above the melting temperature of 1002F but below the Tg of the PET membrane, efficient 
solvent removal and crosslinking could be achieved for 1002F, while preserving the pore 
structure in the PET membrane. Subsequent SEM analysis of hybrid films with 1002F spin 
coated at 2500 rpm to a thickness of 45 µm and patterned with microwells 100 µm in 
diameter using 6 h-long 65
o
C soft- and post exposure bakes revealed that pore integrity was 
greatly improved. Figure 4.1 illustrates the final optimized fabrication strategy, and Table 4.1 
lists the optimized fabrication protocols for three different thicknesses of 1002F. Figures 
4.2A and 4.2B show the open pores at the completion of the fabrication process, suggesting 
that the lower temperature baking steps result in improved retention of pore structure and 
integrity. 
Having successfully devised a spin coating and micropatterning strategy, the ability to 
generate films with a variety of thicknesses and to pattern microwells with even smaller sizes 
and higher aspect ratios was explored. 1002F films spin coated at various speeds were found 
to give film thicknesses atop track-etch membranes identical to previously-reported 
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thicknesses of films spin coated onto glass.
36
 Additionally, 1002F layers atop track-etch 
membranes could be patterned with microwells as small as 25 µm to a side. Maximal aspect 
ratios for these small features of at least 1.8:1 could be obtained (Figure 4.2D). These results 
suggest that this fabrication protocol offers a greater degree of parameter control relative to 
other micropatterning strategies described previously, which offered either no control over 
film thickness or a higher reported minimum feature size.
28-29
 
4.3.3 Testing membrane micropore patency using solute diffusion 
Mindful that results of early experiments showed that pores viewed under brightfield 
microscopy were actually distorted (when viewed with higher resolution SEM), the need to 
assess pore patency of the full thickness of the track-etch membrane was recognized. To 
show that membrane micropores remained functionally patent from one side to the other, the 
ability of a macromolecule – FITC-dextran 70 kDa – to diffuse from the microwell spaces 
and through the membrane was assessed. A method to track and measure molecular diffusion 
in individual microwells in an ensemble fashion was employed (Figure 4.3A). Depositing a 
solution containing FITC-dextran into the upper cassette compartment, and then aspirating 
the solution, caused discontinuous de-wetting of the film surface, leading to the entrapment 
of droplets containing fluorescent dextran in the membrane-bottomed microwells. Overlay of 
a layer of mineral oil to prevent water evaporation and immediately supplying an aqueous 
solution to the bottom compartment allowed the entire track-etch membrane and the 
microwells to remain hydrated. Via serial imaging of the microwell array, quantitative 
fluorescence values and hence dye concentration in each microwell were obtained, and time 
courses of dextran diffusion across the PET membrane and out of the well were generated.  
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Data generated in this fashion, shown in Figure 4.3B and Figure 4.3C, revealed that 
micropores at the bottoms of the majority of microwells were functionally patent and 
permeable to FITC-dextran. Fluorescence in the microwells was observed to decrease to 
near-baseline over ~ 24 h (Figure 4.3B). Quantitation of fluorescence in each microwell 
suggested that, on average, half-maximal reduction in microwell fluorescence (relative to a 
standard) was reached between 1 and 2 h of incubation (Figure 4.3C). However, variability in 
dextran diffusion out of the microwells was quantitatively observed. Interquartile ranges for 
the relative well fluorescence values were as high as 21.2% (at 2 h), though by 26 h it had 
fallen to 7.7%. Future work will attempt to ascertain the reason for this variation. While it is 
true that microwells with a different number of patent micropores would be expected to have 
different absolute rates of diffusive flux due to differences in porous surface area, the 
reported micropore density of the PET membranes used here is sufficiently high that 
microwells 100 µm in diameter would be expected to have on average ~300 pores; Poisson 
statistics suggest that a well with a micropore number low enough to cause such a large 
reduction in diffusion would be highly improbable. However, one potential and more likely 
explanation is that some of the micropores are clogged with unpolymerized photoresist 
monomer that was not removed by developer. Application of developer to the inside 
compartment during development may help reduce this.  
4.3.4 Growth of polarized MDCK cells in microwells patterned atop track-etch 
membranes 
 
To evaluate the ability of a model cell line to form polarized monolayers, MDCK 
cells expressing an HA-tagged variant of the hP2Y2 purinergic receptor were seeded into 100 
µm-diameter microwells patterned atop PET track-etch membranes. After 7 days of culture, 
cells were stained using Hoescht 33342 to label nuclei and immunostained with an anti-HA 
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Ab to mark the location of hP2Y2 receptors. In cells that have undergone polarization and 
established segregated apical and basolateral membranes, the hP2Y2 has previously been 
shown to be preferentially trafficked to the apical membrane of polarized cells, at which 97 ± 
2% of expressed molecules are found, whereas in unpolarized cells the receptor is 
homogeneously distributed over the entire membrane.
4
 MDCK cells seeded into microwells 
atop the PET membranes had qualitative localization of hP2Y2 fluorescence at the apical 
membrane (Figure 4.4A), suggesting that cells grown in these microwells were able to 
achieve polarization. Control cells seeded onto an unpatterned PET membrane had a similar 
staining pattern. Data from these imaging studies suggests that receptor localization observed 
in cells grown on microdevices was not due to a culture artifact, but rather to the ability of 
MDCK cells, when grown on microdevices, to properly polarize. 
 Interestingly, MDCK cells were not observed to remain confined to the microwells, 
but rather formed a 3D monolayer along the entire profile of the surface, growing along the 
microwell bottoms, up the side walls, and across the wall tops and into the adjacent 
microwell. In a recent report, Paz et al. reported that aspiration of media from the upper 
compartment effected a removal of cells that had not landed in a microwell, and that cells 
grown in microwells did not migrate out. That procedure will be repeated in the future work 
with the microplatform developed here; other approaches to confine cells only to the 
microwells will be to seed at a lower overall cell density or to graft a PEG or cell-repellent 
organosilane to the 1002F surface. Where possible in these future experiments, quantitative 
measurements of TEER will be employed. Due to technical issues regarding the PDMS 
mortar layer used to seal the films with the cassette, TEER values were not able to be 
obtained, but efforts are underway to achieve this. 
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What was surprising about the 3D monolayer observed was the observation that all 
cells appeared to have polarized (as evidence by hP2Y2 receptor segregation to the apical 
membrane), even those cells whose basal surface was not in direct contact with the 
permeable PET membrane. This observation is but one example of how this microplatform 
will enable future study of the fundamental process of cell polarization. For example, it is 
possible that polarization of cells on the microwell wall is brought about by cell-cell 
signaling mechanisms originating from the polarized cells sitting on the PET membrane that 
induce cells on the well wall to polarize as well. By varying the micropattern design of the 
overall film, this and other questions about cell polarization can be investigated. 
 
4.4 Conclusions 
Here, a reliable strategy to spin coat even layers of 1002F photoresist onto 
commercially-available track-etch microporous polyester membranes and pattern microwells 
into the photoresist layer that expose the pores in the underlying membrane is detailed. These 
films can be micropatterned with features as small as 25 µm, with the potential to achieve an 
even higher resolution. This fabrication process does not appear to destabilize the membrane 
micropores, meaning that macromolecules can easily traverse the membrane and enter or exit 
the microwells. Preservation of the micropores allows MDCK cells to grow and polarize in 
the wells. These results are the first known report of photopatterning microwells directly atop 
track-etch membranes for cell culture, and hold promise in growth of microcolonies of 
polarized cells for drug screening applications and studies of fundamental cell processes. 
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4.5 Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Fabrication and release of photoresist-micropatterned track-etch membranes. 
(A) Fabrication and release protocol. Photoresist films are micropatterned directly atop a 
commercially-available track-etch membrane attached to a polystyrene cassette. The 
cassette (with membrane attached)  is inverted and attached to a glass slide using a PDMS 
mortar layer. After deposition of a small amount of photoresist (ii), the assembly is spin 
coated to distribute the photoresist into a film across the membrane (iii). After UV 
exposure through a patterned photomask (iv) and subsequent development, microwells are 
patterned atop the membrane (v). Attachment of a smaller cassette directly onto the 
membrane (vi) and trimming of excess membrane material and photoresist film yields a 
freestanding track-etch membrane with microwells patterned into the photoresist layer 
bonded to it above (vii). (B) Photograph showing the microwell pattern atop the track-etch 
membrane at step (v) (top panel) and step (vii) (middle panel) in (A) at left; lower panel 
shows brightfield micrograph of microwells patterned into a photoresist layer bonded to 
an underlying track-etch membrane. Pores give the membrane a finely speckled 
appearance. Scale bars (top to bottom): 4 mm, 4 mm, 100 µm. 
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Figure 4.2. Imaging of track-etch membranes micropatterned with photoresist.  Scanning 
electron microscopy was used to assess pore structure and stability after  completion of the 
microfabrication process. (A-B) A microwell 100 µm in diameter (A) and a magnified 
view of its pores (B). (C-D) Microwells with diameter of 40 µm (C) and side length of 25 
µm (D). Microwells in (D) were patterned into photoresist 48 µm thick (aspect ratio 
1.8:1). Scale bars: (A) 25 µm; (B) 15 µm; (C) 10 µm; (D) 25 µm. 
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Figure 4.3. Verification of pore patency via solute diffusion. (A) Workflow diagram for 
assessing pore patency via diffusion of FITC-dextran 70 kDa. Images of the microwell 
array are taken at regular intervals to determine dextran concentration in the microwell 
spaces. Retention of dextran in the microwell space suggests pores in that microwell space 
are not patent. (B) Fluorescence micrographs for one region of the microwell array at the 
indicated timepoints. Scale bars: 100 µm. (C) Quantitation of FITC-dextran 70 kDa 
concentration in the microwell spaces. Data are presented as mean ± SD for n = 70 
microwells. 
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Figure 4.4. Polarization of MDCK cells grown on photoresist-patterned track-etch 
membranes. MDCK II cells expressing HA-tagged human P2Y
2
 receptor were seeded into 
microwells 100 µm in diameter patterned atop polyester track-etch membranes with pores 
400 nm in diameter. Cells were also seeded atop identical track-etch membranes that had 
not been micropatterned. The P2Y
2
 receptor is normally sorted to the apical membrane in 
polarized epithelial cells. After seven days of culture, cells were fixed and immunostained 
against the HA epitope to mark the cellular locations where the P2Y
2
 receptor was found. 
Green fluorescence indicates staining for the HA-tagged P2Y
2
 receptor; Hoescht 33342 
was used to counterstain cell nuclei in blue. The upper panel shows an xz cross-sectional 
confocal fluorescence micrograph of cells grown atop a control permeable support lacking 
a micropattern; the lower panel shows cells grown in microwells patterned atop track-etch 
membranes. Scale bars: 10 (top panel) and 20 (bottom panel) µm, respectively. 
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Table 4.1 Process conditions for micropatterning track-etch membranes with 1002F 
photoresist.  
 
Photoresist 1002F-10 1002F-50 1002F-50 
Spin step 1 (rpm / seconds) 500 / 10 500 / 10 500 / 10 
Spin step 2 (rpm / seconds) 1000 / 30 2500 / 30 3000 / 30 
Soft bake (65
o
C)
a
 3 h 6 h 4 h 
UV exposure (mJ / cm
2
) 450 450 450 
Post-exposure bake (65
o
C)
a
 3 h 6 h 4 h 
Develop (min) 7 7 7 
Maximum resolution (µm)
b
 25 25 25 
Thickness (µm) 20 45 30 
 
a
 Note the use of hours instead of minutes soft- and post-exposure baking steps. 
b
 These were the lowest resolutions that were tested. Features with smaller sizes  
   might be possible to micropattern, given sufficient optimization. 
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Ch. 5 Conclusions and Future Directions 
 
5.1 Overall summary and conclusions 
 In summary, work detailed in this dissertation has directly led to the development of 
three novel microscale technology platforms that, having now been characterized, are poised 
for both immediate and long-term applications in the bioMEMS fields. 
5.1.1 Freestanding 1002F photoresist films 
Chapter 2 demonstrates that the photoresist 1002F can be micropatterned with good 
replication of a master using UV photolithography and released without damage from the 
fabrication substrate in a matter of hours, all without the need for an underlying sacrificial 
layer. 1002F photoresist films are shown to be mechanically resilient, have low 
autofluorescence, require only basic UV photolithography to micropattern, and can be made 
with through-holes with dimensions much smaller than those of other materials typically 
used in microfabriation. While 1002F microstrainers, featuring both microwells and an 
underlying pore layer, are impractical for use with primary AT1 cells, these 1002F films hold 
outstanding potential in forming the overall structure of freestanding microwell arrays in 
which to grow primary AT1 cells. Even so, freestanding photoresist films can be used as 
stencils for material deposition, as patterned supports for cell culture, and as platforms to 
interrogate single cells within a monolayer. Thus, freestanding photoresist films have
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 potential in future chemical and biological applications and particularly as lab-on-a-foil 
devices. 
5.1.2 Chitosan-bottomed microwell arrays 
Chapter 3 presented the development of a microfabricated cellular analysis platform 
to enable high-throughput study of cellular heterogeneity in response to user-defined and 
dynamically controlled cell stimulation. This platform features an array of microscale wells, 
formed via the first reported co-fabrication of a photoresist film with chitosan to form a 
freestanding array of microwells bound by a semi-permeable hydrogel layer. After seeding 
cells into the chitosan-bottomed microwells, deposition of a layer of inert mineral oil allows 
physically confinement of clonally expanding cells, preventing cellular migration and 
reducing biochemical crosstalk that might confound results while maintaining a user’s 
chemical access to the cells. Use of this platform will enable future high-throughput studies 
of the diversity in cellular biochemistry and genetics. In addition, the observation of a limited 
number of primary AT2 cells spreading out over the microwell surface and adopting an AT1-
like molecular phenotype suggests the potential of this platform, after optimization, for 
growth of primary AT1 cells. 
5.1.3 Photoresist-based micropatterning of polyester track-etch membranes 
Chapter 4 details a reliable strategy to spin coat even layers of 1002F photoresist onto 
commercially-available track-etch microporous polyester membranes and pattern microwells 
in a photoresist layer with the membrane pores exposed in the microwells. The ability to 
micropattern features as small as 25 µm, with the potential to achieve an even higher 
resolution, was demonstrated. This fabrication process does not appear to destabilize the 
membrane micropores, meaning that macromolecules can easily traverse the membrane and 
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enter or exit the microwells. Preservation of the micropores allows MDCK cells to grow and 
polarize in the wells. These results are the first known report of photopatterning microwells 
directly atop track-etch membranes for cell culture, and hold promise in growth of 
microcolonies of polarized cells for drug screening applications and studies of fundamental 
cell processes. 
 
5.2 Anticipated future work 
5.2.1 Freestanding 1002F photoresist films 
Development of freestanding photoresist films, presented in Chapter 2, described the 
novelty of fabricating microwell patterns into photoresist films and then releasing the 
patterned films from the fabrication substrate. Ironically, the novelty of this method – the 
release of the intact photoresist films – was sufficiently characterized and future will work 
will instead center around refinement of the patterning process and novel applications for this 
technology. A future direction that can be immediately investigated concerns the ability to 
fabricate small features into the photoresist film. In practice, the fabrication of features 
smaller than 10 µm has been technically difficult. Significant optimization of the UV 
exposure energy and post-exposure bake and development times was needed in order to 
prevent excessive tapering of the pore through the depth of the film, while at the same time 
preventing premature detachment of the entire film during development. In those instances in 
which films detached, it was theorized that the exposure energy was too low, resulting in a 
very thin layer of photoresist lying just above the fabrication substrate that was not fully 
exposed and which therefore dissolved during development, causing film detachment. 
Therefore, use of a UV exposure system offering a greater degree of collimation or 
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alternatives to conventional UV photolithography such as microscope projection 
photolithography, focused ion beam (FIB) milling, deep reactive ion etching (DRIE), or 
electron beam lithography might be explored to fabricate smaller pores. 
Based on the demonstrated capability of 1002F single-pore films to load single cells 
with exogenous molecules, an additional longer-term future direction for such a platform lies 
in testing the permeability of single cells, as they exist in a monolayer, to exogenously 
supplied agents – drugs, hormones, etc. An additional application might be a 
pharmacologically-based study or mapping of the gap junction networks within a monolayer 
of cells, based on the radial spreading of an exogenous agent such as calcein AM that is 
loaded into a monolayer cell connected to other cells via gap junctions. 
5.2.2 Chitosan-bottomed microwell arrays 
 Based on results of diffusion experiments, the chitosan films fabricated in the manner 
described in Chapter 3 were found to have a molecular exclusion limit of 16200 ± 6300 Da. 
While this cutoff is sufficiently high to allow for diffusion of some serum growth factors 
(such as insulin, amino acids, or vitamins) into the microwells and to thus maintain viability 
and growth of entrapped Ba/F3 cells, it is unknown whether other cell types will require 
larger protein growth factors that are not able to diffuse across the chitosan layer. Therefore, 
an immediate direction for further work will entail modifying the chitosan film so as to 
increase its permeability.  
 One advantage many microtechnologies have over conventional traditional platforms 
is the ability to recover cells of interest in post-analytical steps. As it currently exists, the 
chitosan platforms would be amenable to micropipetting to recover cells of interest. 
However, technology developed in the Allbritton Lab allows for cells to be arrayed on 
192 
 
polystyrene microrafts and release of individual rafts with a microneedle release system for 
subsequent collection and expansion.
1
 One strategy to recover cells from chitosan microwells 
might be to adapt the microneedle release system to create holes in the chitosan membrane 
that allow cells to fall through the membrane and into a collection vessel below. 
5.2.3 Track-etch membranes micropatterned with an overlying photoresist layer 
 The results of Chapter 4 suggest that low-temperature processing conditions can be 
used to micropattern 1002F photoresist atop polyester track-etch membranes. Anecdotal 
evidence from collaborators suggests that primary bronchial epithelial cells exhibit different 
degrees of differentiation (mainly ciliagenesis) when grown on polyester versus PTFE 
membranes, despite similar average pore size and ECM coating. Thus, expanding the 
micropatterning protocol to allow successful micropatterning of PTFE fiber membranes will 
be a logical next step and will add micropatterned PTFE membranes alongside polyester 
membranes in the available toolkit. 
As shown in Figure 4.4, MDCK cells could be shown to adopt a polarized phenotype 
when grown in microwells patterned atop commercially-available polyester track-etch 
membranes. While these cells were polarized, as demonstrated by distribution of HA-tagged 
P2Y2 receptor only to the apical membrane surface, cells nonetheless were shown to migrate 
out of the microwells. In a protocol for cell growth atop agarose-patterned track-etch 
membranes, Paz et al. aspirated apical fluid once cells had settled into the wells; the report 
that included this step did not note cell migration out of the well spaces. Replicating this 
protocol will be a logical step for immediate future work as a manuscript describing this 
platform is prepared. Longer-term, the ability of MDCK cells to successfully polarize in the 
microwells of this platform opens the door to numerous future studies of the fundamental 
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processes involved in cell polarization. By providing a customizable cell culture platform, 
micropatterned track-etch membranes offer potential to begin addressing these processes. 
5.2.4 Adaptation of technology prototypes for specific study of primary AT1 cells 
Consideration can now be given to the original biological problem that motivated the 
work described in this dissertation. While AT1 surrogates were used to assess compatibility 
with each stage of device development, the author was required to direct time and effort first 
to fully characterizing these platforms. As mentioned in Chapter 1, section 4, this was so that, 
armed with a complete knowledge of the characteristics of the device, results of later 
experiments with primary AT1 cells could be properly interpreted. 
A full characterization having been achieved, experiments with primary AT1 or AT1-
like cells can now begin in earnest. The first general step will involve a precise tailoring of 
the device for consistent and reproducible culture of cells with AT1 morphological and 
physiological characteristics. The diameter of AT1 cells in culture is usually between 50-100 
um, and so the devices presented here easily satisfy that requirement. Next, an ECM coating 
that promotes consistent spreading of cells (either primary AT1 or AT2) into an AT1-like 
morphology should be identified. As mentioned above, components of the alveolar basement 
membrane include laminin, fibronectin, and collagen types I and VI.
2
 
As surface optimization is proceeding, a microelectrodes experimental setup should 
be constructed. Because conventional Ussing chambers distribute current over the entire area 
of a permeable culture support, use of micropatterned devices in conventional Ussing 
chambers might result in concentration of current flow across cells. To avoid this, a 
microelectrode approach will be considered to determine whether or not single or small 
discrete numbers of AT1 cells grown in microwells spontaneously develop a potential 
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difference across their membranes, an indicator of active ion transport. Determining whether 
this potential difference is affected by ion transport inhibitors will be a key experiment. 
 
5.3 Potential for future therapies for and insights into ARDS 
 Over the long term, the successful transition of these microdevices to the study of 
AT1 cells has the potential to significantly affect the clinical standard of care for patients 
with diseases that lead to flooding of the alveolar space, most commonly pulmonary edema 
and ARDS. Most directly, the microdevices stand to enable an improved understanding of 
the mechanisms and regulation of ion and fluid transport by AT1 cells, and the role of AT1 
cells in fluid clearance from the overall alveolus. A direct consequence of understanding the 
mechanisms and regulatory pathways might be the identification of strategies, most likely but 
not necessarily pharmacologic in nature, to potentiate ion and fluid transport out of the 
alveolar space. 
 A useful model for employing such strategies to potentiate fluid clearance out of the 
alveolus can be found in a seminal clinical study describing the benefits of early goal-
directed therapy in patients with severe sepsis.
3
 Adaptation of this strategy for ARDS might 
take the form of clinical guidelines that recommend the early administration, either 
intravenously or inhalationally, of ion transport potentiator drugs in clinical cases, e.g. sepsis, 
with potential to develop ARDS. 
Clinically, the first and most direct question that can be addressed with alveolar ion 
transport potentiation strategies is whether or not the reversal – or at least the attenuation – of 
alveolar fluid flooding can improve patient oxygenation status and avoid the need for 
respiratory support via mechanical ventilation, which brings a host of potential 
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complications. While studies suggest that mortality from ARDS is due to end-organ failure 
and not from respiratory failure, this finding suggests only that current ventilation strategies 
are sufficient for oxygenation: in the absence of ventilator use, patient oxygenation would be 
expected to be severely reduced.
4
 Thus, a primary clinical goal of ion transport potentiators 
would not be to further improve the oxygenation that comes from ventilator use, but to avoid 
the need for a ventilator in the first place. 
A second and pressing clinical goal would be to reduce alveolar basement membrane 
disruption and hyaline membrane formation. Study of the clinical and pathological course of 
ARDS suggests, interestingly, that while the alveolar spaces experience significant flooding 
in the first 24-48 hours of the clinical course, by day 3 this fluid has been resorbed.
5-6
 
However, by the time this spontaneous resorption has occurred, hyaline membrane formation 
is already in full swing, necessitating further ventilator support.
5-6
 A question that can be 
addressed by the early reversal of alveolar fluid accumulation is whether rapid removal of 
alveolar fluid early in the clinical course might stave off hyaline membrane formation and 
avert further pathological progression of the disease. 
A third way that fluid clearance strategies can have benefit is in investigating the role 
that alveolar fluid flooding plays in ARDS progression in settings of different etiologies. For 
example, sepsis is the most common cause of ARDS, but likely originates due to a disruption 
of the alveolar-capillary barrier that begins on the endothelial or pulmonary microcirculatory 
side, not within the alveolus.
7
 By contrast, aspiration syndromes, inhalation of toxic gases, 
and near-drowning are all alternative ARDS etiologies that originate on the epithelial or 
airspace side.
7
 Determination of the role of fluid accumulation and early fluid removal might 
yield results that would fundamentally differentiate treatment schemes for ARDS developed 
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from a circulatory versus a respiratory side. For example, fluid accumulation might be found 
to play a more minor role to inflammation in cases of sepsis – in which anti-inflammatory 
and anticoagulation treatments might be more effective – compared to cases of toxic 
inhalational injury, which might benefit from more aggressive potentiation of fluid clearance 
due to the relatively greater damage to epithelial versus endothelial cells.  
Additionally, the potentiation of alveolar fluid clearance could yield potentially 
critical information about ARDS pathophysiology, especially concerning the role of 
inflammation. While both ARDS and pulmonary edema are circulation-sided causes of 
alveolar flooding, the lack of hyaline membrane formation in patients with pulmonary edema 
suggests some role for a pro-inflammatory immune response in the comparatively worse 
clinical course and prognosis of ARDS relative to pulmonary edema.
8-9
 Additionally, in 
pulmonary edema alveoli are flooded with a transudative fluid most similar to plasma, while 
alveoli in ARDS are flooded with fluid that is more exudative in nature, similar to serum. 
Comparing clinical courses and outcomes in patients with pulmonary edema versus ARDS in 
response to ion and fluid clearance potentiators would provide even greater insight into 
ARDS pathophysiology that could open up avenues for even more treatment options. 
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